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Abstract
Base excision repair (BER) is a pathway that repairs DNA damage inflicted by oxidative
stress, certain alkylating agents, and spontaneous hydrolysis. Assays to measure the BER
pathway are usually limited by being low-throughput, time consuming, and unable to measure
each step of the pathway in addition to complete repair. The aim of the present work was to
develop an assay format to overcome these limitations, and use this to develop a mathematical
model to examine differences between cell types on flux through the pathway.
A novel assay format was developed and optimised to measure uracil DNA glycosylase,
AP endonuclease, DNA polymerase β , DNA ligase, AP site repair and complete base
repair. Data was generated for each enzyme activity in HepG2, Caco-2, and peripheral
blood mononuclear cells (PBMCs), and the effects on the pathway were predicted using
a mathematical model. In addition, the assay was used to examine variability in enzyme
activity between the two cell lines, correlations between enzyme activities in primary human
cells, and the effects of caloric restriction on BER in a human weight loss intervention trial.
The model revealed marked differences in the response to aberrant uracil between the two
immortalised cell lines and the PBMCs, with PBMC nuclear extract in general excising the
base more slowly and causing a smaller and slower accumulation of harmful intermediates,
such as abasic sites and single strand breaks, compared to the immortalised cell lines. The
model underestimated complete repair when compared to the biological data for all cell
types, potentially due to cooperativity between BER enzymes not captured when repair
steps were measured individually under experimental conditions. There were also significant
correlations found between enzyme activities in PBMC extracts from different individuals,
and a significant predictive effect of weight loss method on polymerase β activity in the
caloric restriction trial.
In conclusion, the research described here uncovered novel information regarding the
effects of weight loss on DNA repair, and correlations between BER enzyme activities in
healthy volunteers. This is also the first work to compare BER profiles of different cell types
using biological data and mathematical modelling.
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Chapter 1
Base Excision Repair: Importance,
Measurement, and Modelling
1.1 Introductory comments
The research described in this thesis centres on the DNA repair pathway of base excision
repair (BER). DNA repair pathways are an essential cellular mechanism for the maintenance
of genomic integrity. There are several areas concerning BER that require further research; of
relevance to this thesis are the development of reliable, sensitive, and high throughput assay
format to quantify the activity of BER enzymes, the investigation of pathway coordination
and lifestyle influences on BER capacity, and the determination of the rate limiting step
and the effect of this on the generation of BER intermediates that may be harmful, such
as abasic sites and single strand breaks (SSBs), during the repair process. The following
literature review will explore the existing research in these areas as well as giving a thorough
explanation regarding the function and role of BER enzymes and other DNA repair pathways.
The research carried out for this body of work will add to the knowledge in the field of DNA
repair, ultimately aiming towards improved prevention, detection, and treatment of human
diseases of genomic instability, such as neurodegeneration and cancer.
1.2 The importance of DNA repair
The importance of DNA repair becomes obvious when considered in the context of the
implications of damage to DNA; to that end, this literature review will begin with a brief
summary of DNA structure and function. DNA has a double helix structure, famously
discovered by Watson, Crick, and Franklin in 1953 [1, 2]. The double helix is composed of a
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‘backbone’ made up of deoxyribose sugars linked by phosphate groups, and bases attached to
these sugars; adenine (A), guanine (G), cytosine (C), and thymine (T). These bases pair by
hydrogen bonding across the helix in a specific manner. Cytosine pairs with guanine with
three hydrogen bonds linking the bases, and adenine pairs with thymine with two hydrogen
bonds linking the bases. A single deoxyribose, phosphate and base compose a nucleotide,
making DNA a polynucleotide (figure 1.1).
Figure 1.1. The structure of DNA. P - phosphate linkage group; R - deoxyribose; O - oxygen;
A - adenine, C - cytosine, G - guanine, T - thymine; Purine bases in circles, pyrimidine
bases in squares; Dashed lines indicate hydrogen bonds; Red box indicates a ‘codon’ (in this
example ACA, which codes for the amino acid threonine); Green box shows the components
of a nucleotide.
The structure of DNA allows for both protein coding and DNA replication before cell
division [3]. When DNA is either transcribed to messenger ribonucleic acid (mRNA) for
protein coding, or replicates, it is ‘unzipped’ and a DNA or RNA polymerase scans along
and adds complementary nucleotides to each base. The bases in DNA in transcriptionally
active regions of the genome code for proteins, as each set of three bases is known as a
‘codon’ which denotes a specific amino acid, and the order that these are compiled produces
cellular proteins via the transcription and translation of the DNA code. DNA replication is
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semi-conservative, whereby one strand of the new DNA was originally part of the parent
DNA strand. Therefore, any alterations to the bases of DNA, known as mutations, can lead
to downstream effects on both protein structure and function, and cell division [4].
1.3 Causes and consequences of DNA damage
The genetic integrity of DNA is under constant threat; bases in DNA are estimated to undergo
104 - 105 damaging events per cell per day [5], including both spontaneous decay and
interactions with exogenous agents. If left unrepaired by the multiple DNA repair systems in
the cell, the major outcomes of a DNA damaging event are cell cycle arrest, inhibition of
DNA metabolism, or mutation which can then lead to apoptosis, cancer, and ageing (figure
1.2).
Figure 1.2. The major cellular outcomes of a DNA damaging event. Adapted from [6].
In a healthy cell, unrepaired DNA damage should be detected at the stage of cell division
and lead to cell cycle arrest, and inhibition of transcription, replication and chromosome
segregation whilst the damage is repaired. If these genomic integrity protective mechanisms
are not correctly carried out, and DNA damage leads to mutations during cell division,
mutations and chromosome aberrations can be introduced and lead to a range of disease
states. For example, the build-up of mutations, specifically in proto-oncogenes involved
in the cell cycle, is a direct contributor to cancer development [6]. In fact, a key dogma
in cancer biology concerns ’The Hallmarks of Cancer’, a collection of disease features set
out by Hanahan and Weinberg in 2000, and updated in 2011 [7, 8]. The initial Hallmarks
include sustaining proliferative signalling, evading growth suppressors, resisting cell death,
enabling replicative immortality, inducing angiogenesis, and invasion. The later additions
to the Hallmarks concerned the reprogramming of energy metabolism and evading immune
destruction. These Hallmarks are largely underpinned by genomic instability arising from
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unrepaired DNA mutations. Clearly, the avoidance of these outcomes by DNA repair is
favourable.
Individual bases can be directly damaged by methylation, oxidation and deamination.
Methylation can occur due to aberrant action of S-adenosyl methionine (SAM), alkylating
environmental pollutants, carcinogens in tobacco, and the action of a range of chemotherapy
drugs which act in an alkylating manner [9, 10, 11]. Oxidation of bases can occur through the
action of reactive oxygen species (ROS). ROS is a term that encompasses both free radical
and nonradical oxygen-containing species, which includes superoxide radicals, hydroxyl
radicals peroxyl radicals, and hydrogen peroxide, amongst others. These are produced by
agents such as radiation, alkylating agents, and most commonly as by-products of normal
metabolic processes within cells [12, 13]. The oxidation of bases such as guanine to 8-
oxoguanine is reasonably common in cells, and can lead to G → T transversions in DNA
[14]. Bases can also spontaneously deaminate, seen in the conversion of cytosine to uracil,
or be deaminated oxidatively, seen in the conversion of adenine to hypoxanthine. Either of
these deamination events can have major consequences for genome integrity as they can
cause C→ T transitions in the case of cystosine deamination [15], and A→ C transversions
in the case of adenine deamination [16].
Individual bases can also be lost from the sugar-phosphate backbone of DNA due to the
labile nature of the N-glycosidic bond that joins each base to a ribose, leaving an abasic
site that is quickly converted to an SSB [17]. If more than one abasic site occurs in a small
section of DNA the DNA can become fragmented, leading to double strand breaks (DSBs)
which are highly cytotoxic [18].
DNA sequence errors can be caused during DNA replication, as this is an error prone
process dependant on DNA polymerase adding correct bases to the DNA chain. If errors
are not recognised by ‘proofreading’ enzymes, downstream mutations can be introduced
following the replication of the DNA strand containing a mismatched base [6].
As well as being formed due to the conversion of abasic sites to SSBs in close proximity,
DSBs can be formed by ionising radiation and cross-linking agents such as cisplatin [6]. At
this point, it is worth mentioning that the mechanism of action for many chemotherapeutics
is to damage the DNA of cancer cells, adding to the complexity of whether increasing DNA
repair activity has a positive or negative effect on overall health status. Some cancer cells
upregulate DNA repair systems in response to treatment, thereby promoting drug resistance,
where in healthy cells well-regulated DNA repair activity is important to minimise the risk of
mutations and cancer development [19].
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Certain types of damage affect the entire nucleotide; for example, ultraviolet (UV) radia-
tion induces the formation of cyclobutane-pyrimidine dimers and 6-4 pyrimidine-pyrimidone
photoproducts, and chemicals can lead to bulky adducts on nucleotides [20].
The following section (1.4) will describe the DNA repair mechanisms found in the cell to
counter the types of damage described above.
1.4 DNA repair mechanisms
DNA repair is a relatively new discovery, as initial views on DNA were that it was a very
stable structure; however, research carried out by Tomas Lindahl in the 1970s highlighted
that DNA is in fact unstable, and cells require several distinct DNA repair mechanisms to
survive [21]. Work carried out by the groups of Lindahl, Modrich and Sancar contributed to
the elucidation of the DNA repair pathways BER, mismatch repair (MMR), and nucleotide
excision repair (NER), respectively [21, 22, 23], leading to the award of a joint Nobel prize
in Chemistry in 2015 [24]. A summary of the DNA repair pathways discovered so far is
shown in table 1.1.
Repair pathway Damage repaired Sources of damage Disease if defective
Direct reversal O6-meG; CPD; (6-4)PP Alkylating agents, UV light None identified
Base excision repair Oxidised bases, AP sites, SSB ROS, alkylating agents, hydrolysis None identified
Mismatch repair Mismatched base pairs Replication errors HNPCC
Nucleotide excision repair Bulky helix distorting lesions UV light, cigarette smoke XP, TTD, CS
Double-strand break repair DSB, cross-links IR, cisplatin, replication errors AT, WS, FAn, BS
Table 1.1. Summary of DNA repair pathways. Diseases shown here are genetic syndromes
directly linked to a defect in DNA repair. O6-meG - O6-methylguanine; CPD - cyclobutane
pyrimidine dimers; (6-4)PP - pyrimidine (6-4) pyrimidone photoproducts; UV - ultraviolet;
HNPCC - Hereditary non-polyposis colorectal cancer; AP - apurinic/apyrimidic; SSB -
single strand break; ROS - reactive oxygen species; UV - ultraviolet; XP - xeroderma
pigmentosum; TTD - trichothiodystrophy; CS - Cockayne syndrome; DSB - double strand
break; IR - ionising radiation; AT - ataxia telangiectasia; WS - Werner syndrome; FAn -
Fanconi anaemia; BS - Bloom’s syndrome. Table adapted from [25].
1.4.1 Direct reversal
Section (1.3) explained that several factors can cause the unwanted methylation of bases.
If guanine is methylated to form O6-methylguanine (O6MeG), it can cause mispairing
with thymine, leading to a transition mutation from GC→ AT if uncorrected before DNA
replication. Therefore, the methylation of guanine can be a contributing factor to mutation,
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carcinogenicity, and toxicity in the cell. O6-methylguanine-DNA methyltransferase (MGMT)
is a protein, comprehensively reviewed by Christmann and colleagues [26], that can directly
reverse the methylation of guanine by transferring the alkyl group from the damaged base to
a cysteine residue in its active site. MGMT is known as a suicide enzyme as this transfer
of an alkyl group is not reversible and so the protein is degraded following one reaction
[27]. Additionally, proteins of the AlkB family are capable of directly reversing the harmful
methylation of bases in DNA using an oxidative mechanism [28].
Some of the damage caused to DNA by UV light can be directly reversed by enzymes
known as photolyases, which use blue and near-UV light to restore DNA lesions commonly
caused by UV light; namely, cyclobutane pyrimidine dimers (CPDs) and pyrimidine (6-4)
pyrimidone photoproducts ((6-4)PP) [29].
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1.4.2 Base excision repair
The BER pathway repairs abasic sites and SSBs in DNA, as well as damaged bases that
occur due to the damaging agents described in section (1.3), namely methylation, oxidation,
and deamination. BER is a multi-step, enzymatically mediated process whereby a damaged
base, abasic site or SSB is identified and replaced with a new, undamaged base (figure 1.3;
[30, 31]).
There are two main subpathways of BER; single-nucleotide BER (SN-BER) involves
the replacement of only the single nucleotide on which the damage to the base has occurred,
whereas long-patch BER (LP-BER) replaces the damaged site as well as a short sequence
of undamaged nucleotides on the 3’ side of the damage. The conditions causing the choice
between each of these subpathways is still a matter of ongoing investigation. Some hypotheses
to favour SN-BER over LP-BER include increased ATP concentrations at the AP site, and
efficient removal of the deoxyribose phosphate (dRP) blocking group [32, 33]. However, if
there are clusters of damaged bases in the DNA, there is some evidence that LP-BER may be
favoured [34, 35].
A recent paper by Woodrick and colleagues introduced a new sub-pathway of LP-BER,
in which a 9-nucleotide gap is formed 5’ of the damage site [36]. The mechanism proposed
by this group was thoroughly investigated and was proven distinct from NER by the use of
XPA-deficient cells (for more details on XPA see section (1.4.4)). Furthermore, the work
highlighted a new regulation point for the choice between SN-BER and LP-BER in the form
of the helicase RECQ1; RECQ1 impedes SN-BER through poly(ADP-ribose) polymerase
(PARP) inhibition, whilst promoting LP-BER initiation 5’ to the damage site. The discovery
of a new sub-pathway of BER as recently as 2017 emphasizes the relevance of this area of
research.
In this thesis, the main subpathway of interest is SN-BER due to the use of cell-free
extract during enzyme activity measurement. Emerging evidence has begun to suggest
that although SN-BER was classically found to be the most prevalent sub-pathway when
measured in cell free extracts, the LP-BER pathway is often common in live cell experiments
[37, 38]. Despite this, many insights can still be gained from measuring the SN-BER pathway
with regards to individual BER enzyme activity.
When BER is initiated from the point of a damaged base, a DNA glycosylase is the first
enzyme to act on the DNA strand. A DNA glycosylase will hydrolyse the N-glycosidic bond
between a base and the sugar-phosphate backbone of DNA, leaving an AP site. There have
been 11 glycosylases discovered in human cells that can excise a wide range of damaged
bases (table 1.2); for example, uracil-DNA glycosylase (UDG in E.coli; UNG in human)
recognises uracil in DNA, which may have occurred via the deamination of cytosine or
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Figure 1.3. The base excision repair pathway initiated at the point of a damaged base (red
X), showing alternative pathways initiated by monofunctional and bifunctional glycosylases,
and the divergent ‘short-patch’ and ‘long-patch’ methods of repair. Ald - aldehyde; dRP -
deoxyribose phosphate; OH - hydroxyl group; P - phosphate.
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misincorporation during DNA synthesis. Alkyladenine-DNA glycosylase (AAG; also known
as N-methylpurine DNA glycosylase (MPG)) acts on a wider range of damaged bases, such
as methylated purines, and hypoxanthine which results from the deamination of adenine.
Additionally, 8-oxoguanine glycosylase (OGG1) excises oxidised guanine [39]. OGG1 is
known as a bi-functional enzyme as it also possesses β -lyase activity and so cleaves the
backbone of DNA following the removal of the damaged base, leaving an aldehyde group
on the 3’ free end and a phosphate group on the 5’ end at the nick [40]. Glycosylases in the
endonuclease VIII-like family (NEIL1-3) are also bifunctional and cleave the DNA backbone
following oxidised base excision in a manner that leaves phosphate groups at both the 3’ and
5’ DNA backbone ends. Polynucleotide kinase phosphatase (PNKP) excises 3’-phosphate on
the DNA backbone if previously cleaved by an endonuclease VIII-like protein, ultimately
resulting in a BER process that occurs independently of AP endonuclease (APE1) [41].
Glycosylase Substrate acted on: β -lyase?
Alkyl-adenine DNA glycosylase (AAG) Variously methylated A and G; 8-oxoG; Hx; εA No
8-oxoguanine-DNA glycosylase (OGG1) 8-oxoG; FapyG Yes
Uracil-DNA glycosylase (UNG) Isodialuric acid; alloxan; 5-hydroxyU; U No
Single-strand-selective monofunctional UNG (SMUG1) U; 5-OH-methylU No
Thymine DNA glycosylase (TDG) U; T mispaired with: G, O6meT, C, T No
Methyl CpG binding domain protein 4 (MBD4) T, U, 5-fluoroU mispaired with G No
Adenine-specific mismatch-DNA glycosylase (MUTYH) A mispaired with: G, 8-oxoG, C No
EndoIII homologue (NTH1) T glycol; oxidised pyrimidines; formamidopyrimidines Yes
Nei-like DNA glycosylase (NEIL) 1, 2, and 3 Oxidised pyrimidines; formamidopyrimidines; Sp; Gh Yes
Table 1.2. Glycosylases found in human cells, their substrates and β -lyase activity. A -
adenine; C - cytosine; G - guanine; T - thymine; U - uracil; Hx - hypoxanthine; εA - 1,N6-
ethenoadenine; FapyG - 2,6-diamino-4-hydroxy-5-formamidopyrimidine; Sp - spiroiminodi-
hydantoin; Gh - guanidinohydantoin. Sp and Gh are further oxidation products of 8-oxoG.
Adapted from [39] and updated from [42].
Monofunctional DNA glycosylases such as AAG and UNG have either weak or absent
β -lyase activity. Therefore, if a monofunctional DNA glycosylase initiates BER rather than a
bifunctional glycosylase, APE1 cleaves the DNA backbone, leaving a hydroxyl group on the
3’ end and a dRP on the 5’ end at the nick [43]. Further end processing of the phosphodiester
backbone is required at this stage to prepare the DNA substrate for DNA polymerase and
ligation. A DNA polymerase is responsible for attaching new nucleotides to a DNA strand,
and relies on a 3’ hydroxyl to perform its function. A 5’ phosphate group is needed adjacent
to the hydroxyl group for the ligation step of BER. Aldehyde groups are removed and
replaced with hydroxyl ends by APE1, followed by DNA polymerase β (Polβ ) adding a
replacement nucleotide to the gap in the DNA strand, and then the dRP lyase activity of Polβ
removing the dRP on the 5’ end of the nick and replacing with a phosphate group in SN-BER
[44]. Finally, DNA ligase III seals the nick left in the backbone [45]. In LP-BER, between
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two and 12 bases are replaced by Polβ adding one nucleotide and then DNA polymerase δ
or ε extending the chain of nucleotides. The displaced nucleotide sequence is then cleaved
from the repaired DNA by flap endonuclease 1 (FEN-1) and the DNA backbone is rejoined
by DNA ligase I (reviewed in [30, 32]).
Additional proteins associated with BER, other than the specific enzymes already men-
tioned, are X-ray repair cross-complementing protein 1 (XRCC1), proliferating cell nuclear
antigen (PCNA), replication factor C (RFC), and PARP. XRCC1 is recruited to nicks in
DNA, including those that occur after the action of DNA glycosylases and APE1, and has
been shown to interact with both Polβ [46] and DNA ligase III [47] within its remit as a
scaffold protein. XRCC1 is not essential for BER, but does allow for more efficient ligation
of the DNA strand by DNA ligase III in the SN-BER variation of the pathway only [48].
Whilst XRCC1 is only required in a non-essential capacity for SN-BER, PCNA is necessary
for LP-BER [49]. PCNA acts as a processivity factor for DNA polymerase δ to anchor the
polymerase to the DNA template, and interacts with FEN-1 during the LP-BER pathway
[50, 51]. RFC is a ‘clamp loader’ that facilitates the interaction between PCNA, DNA, and
polymerase δ during LP-BER [52].
PARP is a family of proteins that initiates the DNA damage response (DDR) by detecting
and binding to SSBs in DNA. PARP then produces polymeric adenosine diphosphate ribose
(PAR) to recruit BER enzymes such as Polβ and DNA ligase III to the site, along with
XRCC1 [53]. Similarly to XRCC1, PARP is not essential for BER, but a hypersensitivity to
DNA damage has been demonstrated in XRCC1 deficient cells treated with PARP inhibitors.
The increase in cell death in these cells indicates that although not individually essential, the
presence of either functional XRCC1 or PARP is highly important for SSB repair and cell
viability [54].
A reduction in BER function has been linked to a variety of detrimental consequences to
health, including increased risk of colorectal cancer with MUTYH deficiency [55], hyper
IgM-syndrome with UNG deficiency [56], low OGG1 activity in Alzheimer’s disease [57],
reduced capacity to repair base adducts in colon cancer patients [58], and a low DNA repair
score (based on OGG1, MPG, and APE1 activities) predicting increased risk of lung cancer
[59]. However, studies into mutant phenotypes in mice have shown that in general, the loss
of function of a single DNA glycosylase yields a normal phenotype. The reason for the
apparently healthy phenotype of DNA glycosylase deficient mice is thought to be the overlap
in function between different DNA glycosylases. The exception to this is mice deficient in
UNG, where B-cell lymphoma is developed after 18 months [60]. The later stages of the
pathway show a much more detrimental effect if function is lost, with mutations of APE1,
Polβ and DNA ligase III all being lethal phenotypes [60].
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The following sections provide more detail regarding each of the enzymes of BER that
are measured in the subsequent results chapters; namely, UNG, APE1, Polβ , and DNA
ligase.
Uracil DNA glycosylase
UNG is a monofunctional glycosylase that excises uracil in DNA with a fairly narrow
substrate specificity; however, it can also remove 5-hydroxyuracil and other uracil derivatives,
and can function on both single stranded and double stranded DNA [61]. An important point
to consider is that the glycosylases SMUG1, TDG, and MBD4 are also able to excise uracil
from DNA, and so there is a reasonable level of redundancy with regards to uracil excision
from DNA [39].
Uracil may be found in DNA for two main reasons; from misincorporation in the place of
thymine, or from the spontaneous deamination of cytosine [39]. Of these, misincorporation
is a more benign change as during replication or transcription, uracil will base pair with
an adenine and so no miscoding will take place. However, if uracil occurs in DNA due to
cytosine deamination, it will then base pair with an adenine during replication instead of the
guanine that the cytosine would have originally base paired with, leading to a miscoding
error which could have major downstream consequences on protein coding.
Deamination of cytosine is one of the most common forms of spontaneous hydrolytic
DNA damage [17]. In fact, it has been estimated that cytosine deamination would contribute
to approximately 100 mutations per cell per round of replication if not repaired; consequently,
BER initiated by UNG is of vital importance for maintenance of genomic DNA fidelity [62].
Further evidence to support the importance of UNG in preventing mutations is the 3-fold
higher spontaneous mutation frequency observed in human cells following inactivation of
UNG by an inhibitor [63]. UNG deficiency has been reported in human patients with the
immunodeficiency condition hyper-IgM syndrome; this is proposed to be due to UNG’s
role in gene alterations observed in the B cell response to antigens [56]. Conversely, high
levels of expression of UNG in lung cancer cells are associated with reduced sensitivity to
the antifolate chemotheraputic, pemetrexed [64]. Taken together, these examples highlight
the importance of careful cellular regulation of UNG activity to prevent DNA mutations
and allow proper functioning of the immune system, and also the benefit of reducing UNG
activity in cancer cases.
UNG activity measurement is of particular interest to the present work due to a combina-
tion of both its substrate specificity and constitutively high expression levels in comparison to
other glycosylases. These features have practical advantages, as the use of a double stranded
oligonucleotide with a uracil in the sequence should be a sufficent substrate to capture all
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UNG activity, and comparatively smaller volumes of nuclear extract from samples should be
sufficient to measure activity of the more abundant UNG than less abundant glycosylases.
Furthermore, UNG activity is of separate biological interest for reasons discussed earlier in
this section.
AP endonuclease
In BER, APE1 is needed to cleave the DNA backbone at the abasic site, but it has also been
found to have other functions in redox within the cell; it is alternatively known as redox
effector factor (Ref-1) when being referred to in terms of its redox function. APE1 cleaves
DNA via hydrolysis to leave a product with 3’-hydroxyl and 5’-dRP end groups proximal to
a DNA SSB [65]. APE1 requires Mg2+ ions to perform its cleavage activity [66].
As a redox regulator, APE1/Ref-1 reduces several transcription factors including p53,
AP-1 and HIF-1α , to enhance their DNA-binding activity and in this manner affects gene
expression [67, 68]. The main targets activated indirectly by APE1/Ref-1 include DNA repair
and stress response genes. Notably for this project, the AP-1 transcription factor promotes
expression of the UNG2 gene, and the p53 transcription factor promotes expression of POLB,
AAG and APE1 itself (thoroughly reviewed by [68]), the protein products of which are all
involved in the BER pathway.
In mice, haploinsufficient models have been engineered to study the effects of a 50%
reduction in APE1 protein levels on the response to oxidative stress [69]. Research groups
have used a variety of oxidative stress agents on animals with Apex+/− and measured a
range of endpoints including tumour incidence, mutation rate, apoptosis and blood pressure
[70, 71, 72, 73]. Overall, APE1 haploinsufficient mice tend to show increased sensitivity to
oxidative stress [70], which leads to a higher mutation rate and apoptosis [71, 72]. There is
also some evidence that APE1 is involved in the regulation of blood pressure [73].
In humans, APE1 protein levels have been used as a potential prognostic tool in breast
cancer, as tumour cells with higher APE1 levels were found to have a worse prognosis regard-
ing disease-free survival [74]; however, this association did not reach statistical significance
and so APE1 levels may not be a reliable tool for breast cancer prognosis. Alternatively,
APE1 can be of prognostic value in hepatocellular carcinoma cases based on the localisation
of APE1 within the cell. If APE1 is found in higher levels in the cytoplasm of tumour cells,
the survival time is significantly shorter than when APE1 is localised to the nucleus [75].
Finally, APE1 has been found to be increased in the hippocampus of Alzheimer’s patients, but
whether this contributes to disease progression or occurs in response to increased oxidative
stress associated with the disease is not yet understood [76, 77].
1.4 DNA repair mechanisms 13
Polymerase β
Polβ has two functions in the BER pathway, which are to fill in a gap with a new nucleotide,
and to cleave the dRP blocking group from the DNA backbone to allow for ligation [44].
Unlike UNG and APE1, Polβ has not been reported to have functions in the cell other than its
role in DNA repair. Research in genetically engineered mouse has found that total deletion
of the POLB gene is lethal to the animals postnatally due to defective neurogenesis [78],
and in POLB+/− mice, various studies have shown that protein levels of Polβ are reduced
by 50% [79], leading to higher endogenous DNA damage levels [80] and a 5-fold rate of
incidence of spontaneous lymphomas [81]. In addition to this, tumour cells in humans have
been found to have missense mutations in the POLB gene that are thought to contribute to
the carcinogenic process [82], and overexpression of POLB is regarded as a contributor to
mutagenesis [83]. Altogether, these pieces of data indicate that Polβ activity at wildtype
levels are essential for cellular health, and regulation of Polβ levels are equally important to
prevent cancer propagation.
DNA ligases
There are several human DNA ligases, with DNA ligase I and DNA ligase III being associated
with BER; DNA ligase I is primarily involved in the LP-BER subpathway, whereas DNA
ligase III complexed with XRCC1 is the major rejoiner of the DNA backbone in SN-BER
[84]. In terms of deficiency, DNA ligase III is essential for early embryonic development in
mice [85], whilst DNA ligase I deficient mice are able to survive until adulthood but have
increased incidence of spontaneous tumours and also haematopoietic defects [86]. There
appears to be almost no literature available examining any effect of alterations in DNA ligase
capacity on health or disease status in humans.
1.4.3 Mismatch repair
As the name suggests, MMR is a pathway that responds to mismatched bases in DNA that
occur during replication and recombination [87]. The glycosylases TDG and MUTYH
mentioned in table (1.2) are responsible for removing mispaired bases in the initial stages of
MMR.
Key enzymes in this pathway in humans, which differentiate it from BER, are MLH2/MLH2
and MLH1. These interact with each other and the DNA to find mismatched bases and facili-
tate their removal by identifying the newly synthesised DNA strand due to the strand nicks
generated during replication. The mismatched base is removed and DNA is resynthesized
for a small section of DNA before the backbone is rejoined by DNA ligase [88]. Several
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aspects of the mechanism of MMR remain unknown, particularly regarding the differentiation
between newly synthesized and template DNA by the MSH2/MSH6 and MLH1 proteins
[87]; however, what is clear is that loss of the pathway is associated with a much greater level
of both spontaneous mutations, and hereditary non-polyposis colon cancer (HNPCC) [89].
1.4.4 Nucleotide excision repair
NER is a complex DNA repair pathway with a multitude of proteins involved, and is not the
focus of the current work; therefore, for brevity much detail will be spared in this section.
The NER pathway removes bulkier damage than that seen in BER, by removing the entire
nucleotide rather than a single base [90]. NER is subdivided into global genome (GG-NER)
or transcription-coupled (TC-NER) subpathways; as their names suggest, GG-NER occurs
anywhere in a cells genome, whilst TC-NER repairs lesions in actively transcribed genes in
each cell [91, 92].
Damage recognition in GG-NER is the role of an XPC-RAD23B protein complex, whilst
in TC-NER, RNA polymerase II (RNAP II) recognises damage along with a complex of
CSA, CSB, and XAB2 [91, 92]. Following recognition, both pathways proceed in the same
fashion. A protein complex of TFIIH and XPA associates with either XPC-RAD23B or CSA-
CSB-XAB2 and separates the DNA strands at the damage site. An XPF-ERCC1 complex
binds and incises at one end of the damage site, and XPG incises at the other, so as to remove
the aberrant nucleotide. Then, undamaged nucleotides fill the gap during strand synthesis by
polymerase δ /ε , before the strand is sealed by DNA ligase III in complex with XRCC1 [93].
Defects in NER have been found to be the cause of the genetic disorder xeroderma
pigmentosum (XP), a condition that leads to a sensitivity to sunlight and a high risk of
skin cancer due to an inability to repair UV-induced DNA damage [94]. Other genetic
disorders are also linked to defects in NER genes, namely trichothiodystrophy (TTD) and
Cockayne syndrome (CS). TTD and CS do not tend to result in skin cancer as with XP due
to different proteins in the NER pathway being affected, but instead patients suffer with
a range of neurological and developmental abnormalities; TTD patients presenting with
photosensitivity, brittle hair and IQ impairment, and CS patients displaying photosensitivity,
growth impairment, premature ageing, and neurodegeneration [95].
1.4.5 Double-strand break repair
The most genetically dangerous event that can occur to DNA is a double strand break (DSB),
as this involves the separation of parts of a chromosome. Therefore, a DSB will lead to
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apoptosis if not repaired [96]. However, there are two DNA repair pathways that may rejoin
DSBs; homologous recombination (HR) and non-homologous end joining (NHEJ) [97].
The HR pathway is complex with several variations dependant on the cell type and
chromosome involved in the DSB event, thoroughly reviewed by Jasin and Rothstein [98].
Briefly, the repair pathway is initiated by the resection of the 5’ ends of the DNA at the break
point, in order to produce 3’ single stranded DNA lagging ends. These are then extended by
using another matching chromosome as a template. The newly synthesized strand is then
displaced from the template DNA and re-anneals to the original chromosome to resolve the
strand break [98]. Key proteins in the HR process include the MRN complex made up of
Mre11/Rad50/Xrs2 [99, 100], and the CtIP protein [101], both of which are responsible for
the initial DNA resection. The well-known tumour suppressor protein BRCA1 interacts with
both MRN and CtIP, and promotes HR [102, 103, 104].
NHEJ differs from HR as no template of matching DNA is used in the NHEJ repair
mechanism, but instead the nicked DNA ends are religated directly to one another. NHEJ is
initiated by the binding of a Ku heterodimer protein to the DSB ends [105]. The Ku protein
then recruits other DSB repair factors, including the protein kinases ATM and DNA-PKcs,
XRCC4, and DNA ligase IV to aid in the ligation of the ruptured DNA ends (reviewed in
[106]).
The loss of function of either of the DSB repair pathways is associated with a number
of diseases including Ataxia Telangiectasia (AT), Werner syndrome, Fanconi anaemia, and
Bloom’s syndrome. AT occurs due to the loss of the ATM protein involved in NHEJ, and has
symptoms including poor co-ordination, neurodegeneration, predisposition to infections and
cancer. Werner syndrome leads to premature ageing, cancer and atherosclerosis, Fanconi
anaemia is associated with blood abnormalities and leukaemia, and Bloom’s syndrome is
typified by a short stature, face rash, and cancer [107]. An interesting point to note from the
studies of syndromes resulting from defective DNA repair is the diverse range of symptoms,
highlighting the importance of DNA repair for healthy function of a range of cell types.
1.5 Co-ordination of the base damage-repair response
Biologically, a co-ordination between the steps of BER would be sensible, to avoid the
build-up of toxic intermediates [108], which can ultimately result in cell cycle arrest or cell
death [109]. The following sections (1.5.1) - (1.5.3) will discuss the importance of, evidence
for, and factors known to affect BER co-ordination.
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1.5.1 Importance of DNA damage-repair balance
As previously discussed in section (1.3), base damage can have several downstream conse-
quences for the cell, whether that be due to mutation caused by a damaged base, or cell cycle
arrest or apoptosis [109] due to SSBs and DSBs [108] resulting from attempted DNA repair.
Successful BER prevents mutation by replacing a damaged base with an undamaged one,
and reduces the number of SSBs in DNA to avoid cell cycle arrest and apoptosis. However,
if BER becomes either up or downregulated, or does not respond adequately to increased
levels of DNA damage, detrimental cellular outcomes will occur.
A major negative consequence of upregulated DNA repair is cancer chemotherapy
resistance. Many cancer treatments are designed to damage the DNA of rapidly replicating
cancer cells, and cause apoptosis [110]. For example, alkylating agents such as temozolomide
are a widely used class of cancer drugs that cause adducts on bases of DNA; a target of BER.
If DNA repair pathways are upregulated in these instances, the damage to replicating DNA is
abrogated, resulting in drug resistance [111, 112].
Downregulation of DNA repair leads to the accumulation of damage sites, and thereby
an increase in mutation rates and cancer development, as seen in genetic disorders of DNA
repair such as XP and AT. These disorders often have a range of other disease states due to
downregulated DNA repair, such as neurological impairments and accelerated ageing, caused
by apoptosis of neurons and other cells [107].
Overall, the maintenance of adequately regulated and co-ordinated DNA repair mecha-
nisms in response to DNA damage within the cell is vital for genome integrity and overall
cellular health.
1.5.2 Evidence of co-ordination and co-operation in BER
BER is generally thought to be highly co-ordinated to achieve efficient repair of DNA; this
co-ordination is hypothesised to occur through either individual protein-protein interactions
(‘passing the baton’) or via repair complex formation [113]. As well as postulated evidence
for co-ordination between enzymes of the BER pathway, there is also some evidence that the
there is a co-operative effect on activity between certain enzymes.
The ‘passing the baton’ theory stipulates that each BER protein in the repair pathway acts
upon the damaged DNA substrate, and interacts with the next enzyme in the pathway; so a
specific DNA glycosylase would excise a damaged base and interact with APE1, APE1 would
cleave the DNA backbone and interact with Polβ , Polβ would then add in a complementary
nucleotide, remove the dRP blocking group, and interact with DNA ligase III to seal the nick
in the backbone. There are various pieces of evidence to support this theory that indicate
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co-operative enzyme activities as well as co-ordination. APE1 has been found to enhance
thymine DNA glycosylase (TDG) [114], UDG [115] and OGG1 [116] activity, by inducing
release of TDG and UDG from their DNA binding site and preventing reassociation of OGG1
with its product. APE1 has also been reported to interact with Polβ [117], and was found to
increase the efficiency of the dRP lyase step of BER [109]. A substrate channelling study
by Prasad and colleagues found that APE1 channelled incised DNA substrate to Polβ for
gap filling and dRP group removal, and Polβ channelled this substrate to DNA ligase III
for rejoining [118]. More details on potential enzyme activity co-operation can be found in
section (1.7.2).
However, this theory cannot account for all evidence regarding BER co-ordination. PARP
has been found to bind to SSBs before Polβ , meaning that APE1 does not ‘hand over’ directly
to Polβ in all cases of BER processing [119, 120]. There are also several subpathways of
BER dependant on the type of base damage, and different end processing required dependant
on the glycosylase that initiates BER (see section (1.4.2)), leading to an alternative theory of
a large ‘repair complex’ being formed to repair damage [120]. The evidence gathered so far
would point towards a combination of these theories, where glycosylases initiate BER and
‘pass the baton’ to APE1, followed by a repair complex forming to deal with the subsequent
end processing and ligation steps of BER [113]. The regulation and co-ordination of these
myriad DNA repair proteins and subpathways of BER is a complex area that requires more
detailed mechanistic research; furthermore, there is increasing evidence that BER capacity
can be affected by external influences which complicates the picture even more (see section
(1.5.3)). Additionally, at the time of writing, there have been no studies published that
measure correlations between BER enzyme activities in samples from apparently healthy
human volunteers; this area requires further examination.
1.5.3 Lifestyle factors known to affect BER capacity
DNA repair is known to be affected by a number of factors including disease states, ageing,
and diet [42]. As previously mentioned, cancer cells have been shown to upregulate DNA
repair activity as a mechanism for chemotherapy resistance [112], whilst DNA repair is
thought to become less effective with ageing; recent work in mice has shown a reduction
in BER activity as animals entered older age [121]. Even in apparently healthy individuals,
there is evidence of considerable inter-individual variation in BER enzyme activity [122, 123].
As far back as 1983, Hans Krokan’s research group was investigating inter-individual and
tissue specific variation in MGMT and UNG [124].
Tobacco smoke is a known carcinogen and is the predominant risk factor for lung cancer
[125]. The increase in DNA damage in cells of the lung structures caused by tobacco smoke
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could be expected to cause a reactionary increase in DNA repair activity to combat the
damage, but some research has actually found lower DNA repair capacity in the lung tissue
of mice exposed to tobacco smoke [126]. A follow up study from the same group also found
decreased BER activity in mouse lung tissue caused by E-cigarette smoke [127]. As with any
animal study, this data must be carefully considered as the mouse and human DNA repair
reaction to environmental factors will be inherently different, as well as relative exposure
levels.
Micronutrient status could be another potential explanations for the wide variation
observed in BER capacity between individuals [128]. Research groups have investigated
the effects of a variety of micronutrient treatments and deficiency in cultured cells, animal
studies, and human intervention trials. A range of micronutrients have been studied, and
their effects on DNA repair have been measured in several different ways, leading to a
fragmented overall picture; a summary of evidence where BER activity was measured as an
endpoint following dietary supplementation in human intervention trials has been adapted
here from the excellent review by Collins and colleagues (table 1.3; [128]). The majority of
compounds investigated are components of fruits and vegetables, as researchers aim to find
the mechanism underlying the putative relationship between increased fruit and vegetable
intake and decreased incidence of certain cancers [129]. In addition, several studies have
used whole fruits and vegetables as their dietary intervention [130, 131, 132, 133].
1.5
C
o-ordination
ofthe
base
dam
age-repairresponse
19
Supplementation Assay Results (effect of supplementation) Reference
Vit C Repair of SBs and oxidised pyrimidines after H2O2 Mostly slow repair, vit C enhanced in a few [134]
Nicotinamide, Zn, carotenoids Cellular SB rejoining after H2O2 Fewer breaks remaining at 60 min [135]
Lutein; β -ct; lycopene Cellular SB rejoining after H2O2 Repair enhanced by all supplements except lutein [136]
Carotenes + α-tc; vit C; oranges; carrots in vitro assays for SB rejoining and oxidised base repair Carrot group increased repair in both assays [130]
Se, retinol, β -ct, vit C, vit E BER (in vitro comet assay, 8-oxoG substrate) No significant effect [123]
Folate BER (in vitro comet assay, 8-oxoG substrate) Decrease in lowest quartile of initial folate status [137]
Coenzyme Q10 BER (in vitro comet assay, 8-oxoG substrate) Increase in BER (OGG) [138]
Vit E, vit C (conventional/slow-release capsules) BER (in vitro comet assay, 8-oxoG substrate) Increase in BER after slow-release capsules [139]
Kiwifruit (1, 2 or 3) BER (in vitro comet assay, 8-oxoG substrate) Increase in BER (OGG) [131]
AntOx-rich fruit and veg; 3 kiwifruits In vitro comet assay; BER (8-oxoG substrate) Increase in BER [132]
Broccoli (250g) BER (in vitro comet assay, 8-oxoG substrate) No change [133]
Table 1.3. The effect of dietary interventions on BER activity in primary human samples. SB included as a measure of BER although
non-specific. α-tc - α-tocopherol; β -ct - β -carotene; 8-oxoG - 8-oxoguanosine; AntOx - anti-oxidant; BER - base excision repair;
OGG - 8-oxoguanine DNA glycosylase; NER - nucleotide excision repair; Se - selenium; SB - strand break; UV - ultraviolet; veg -
vegetables; Vit - vitamin; Zn - zinc. Adapted from [128].
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Caloric intake and weight loss has also been investigated with regards to DNA repair
capacity, and will be the subject of further research in the current work (chapter (3)). In
animals, an increase in Polβ activity was seen in rats subjected to caloric restriction compared
to rats on an ad libitum diet as the animals aged [140]. At the time of writing, only two
randomised controlled trials have investigated the effects of weight loss on DNA repair
endpoints in humans, and both included intervention groups that altered both calorie intake
and physical activity levels [141, 142].
Heilbronn and colleagues assigned overweight but non-obese participants to one of four
intervention groups for a six month time period; controls, calorie restriction of 25% of
baseline energy requirements, calorie restriction of 12.5% of baseline energy requirements
and exercise increase by 12.5% of baseline energy expenditure, and low calorie liquid diet to
achieve 15% original body weight reduction followed by weight maintenance. In terms of
DNA repair, this study did not measure repair activity directly, but instead measured levels
of oxidative damage via plasma protein carbonyls, and DNA strand breaks in whole blood
cells using the comet assay. The finding that oxidative damage was not affected by any of the
interventions, but DNA strand breaks decreased following all calorie restriction protocols led
to a conclusion that increased DNA repair following calorie restriction is the likely factor to
explain this. However, caution must be used when interpreting these results as DNA repair
activity was not actually measured as a direct endpoint [142].
More recently, Habermann and colleagues conducted a human trial in overweight and
obese post-menopausal women to investigate whether a 10% body weight reduction would
improve DNA repair capacity in response to radiation as measured by the comet assay. The
participants were assigned to intervention groups whereby weight loss was achieved by
either calorie reduction, increased aerobic exercise, or a combination of diet and exercise.
Peripheral blood mononuclear cells (PBMCs) were isolated from blood samples taken at
baseline and 12 months following the commencement of the intervention for comet assay
analysis. However, none of the interventions carried out had any significant effect on DNA
repair capacity in response to radiation [141].
Overall, the evidence procured thus far indicates that lifestyle factors may have some
effect on the wide inter-individual variation in BER capacity observed in humans, but efforts
have been somewhat impeded by a lack of consistent and high throughput methodologies for
measuring BER activities.
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1.6 Published methods for the measurement of BER
Several methods for measuring BER levels have been published, each with their own strengths
and weaknesses; a drawback common to all methods published so far is that they are low
throughput and often non-specific to the BER pathway.
1.6.1 Modified comet assay
A long established technique for analysing DNA damage and repair is the comet assay, a
method that has been extensively reviewed elsewhere [143, 144]. The assay detects DNA
damage in the form of strand breaks, which can be the direct result of DNA damaging agents
or produced in cells prepared for analysis via the action of specific DNA repair enzymes,
such as DNA glycosylases, on other lesions present within the cellular DNA. Two distinct
strategies have been used modify the standard comet assay to analyse DNA repair [143]. One
of these is sometimes termed the ‘challenge assay’, and functions by inducing damage in
viable cells and monitoring the rate of damage removal over time. The other strategy is to
damage the DNA in model cells, then to immobilise and lyse these such that the cellular
DNA can be used as an in vitro substrate for DNA repair activities in cell or tissue extracts
prepared from test samples (figure 1.4). This measures repair as a reduction in SSBs over
time and can be adapted to examine different glycosylase activities based on the type of
damage applied to the substrate cells [145].
The first strategy has the advantage that the repair takes place within the intact cells in the
context of normal chromatin structure and nuclear organisation. One potential disadvantage
of this approach is that in addition to the ongoing repair processes, new DNA damage may
also be produced during the time course and any variation in the rate of damage production
would represent an important confounder [147]. Another issue is that different levels of
damage may be induced in the different samples to start with, creating difficulties when
interpreting the data [143]. The alternative strategy, in which damaged DNA in immobilised
cells is used as a substrate for DNA repair by cell extracts, overcomes the second of these
problems in that DNA damage is introduced into a single cell population that will provide
the template for repair by cell extracts. However, the integrity of the nuclear organisation is
not retained in this assay format.
The comet assay is a fairly labour intensive technique and hence has a relatively low
throughput capacity, although some recent technical refinements may help to resolve this
issue [143, 148]. The assay also cannot measure specific individual BER enzyme activities
in its current form.
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Figure 1.4. The modified comet assay, an in vitro assay for measuring BER activity. The
diagram shows an example of the comet assay being used to measure OGG1 activity of
cell-free extracts. OGG1 - 8-oxoguanine DNA glycosylase. Reproduced from [146].
1.6.2 Plasmid incorporation assays
A radiolabelling method has been developed to assess overall repair whereby plasmid DNA
containing a damage site is incubated with cell extract and radiolabelled bases, and repair
is measured by the incorporation of radiolabelled bases into plasmid DNA [149]. A major
drawback to this method is the use of radiolabelling which is time-consuming, expensive,
and associated with health risks.
A similar type of assay was developed by Choudhury and colleagues, where plasmid
repair was quantified by the formation of plaques when the plasmids were transformed
into E. coli [150]; a greater level of repair leads to reduced plaque formation as restriction
endonucleases are used to specifically cleave only repaired plasmids (figure 1.5). This
technique was expanded on by the same lab to monitor the size of patch repairs [36].
1.6.3 Oligonucleotide-based assays
Oligonucleotide cleavage
Alternative methods have been developed to assess individual enzyme activity, including
the use of radiolabelled oligonucleotides to measure BER enzyme activity in healthy human
blood samples [151]. Double stranded synthetic oligonucleotide containing a damaged base
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Figure 1.5. A plasmid repair based method to quantify the in vivo repair of 1,N6-
Ethenoadenine (εA) by alkyladenine DNA glycosylase (AAG)-initiated base excision repair.
Reproduced from [150].
site is treated with cell extract and then denatured, which causes the radioactively tagged
oligonucleotide to be cleaved if acted upon by BER enzymes. The oligonucleotide solution
then undergoes electrophoresis which separates the small and large fragments of DNA. A non-
radioactive method has been published which uses fluorescent dye-tagged oligonucleotides to
assess glycosylase and APE1 activity but is otherwise similar in concept to the radiolabelling
method described above [152, 153].
Molecular beacons
A molecular beacon technique has been used to assess APE1 activity, whereby a stem-loop
structure of synthetic oligonucleotide with a 5’ fluorophore and 3’ quencher, containing
APE1 substrate, is constructed and treated with cell extract [154, 155] in place of the
classical linear double stranded oligonucleotides as substrates. More APE1 activity causes
the release of more fluorescent substance from the hairpin loop structure and away from the
quencher, leading to an increase in fluorescence. The same method has been employed to
determine glycosylase and APE1 activity in both cell-free extracts and within live cells by
using synthetic oligonucleotides with specific damaged sites [156]. These assays have the
important advantage that they can provide real time kinetic readouts for the rate of repair.
However, they can only be applied to the early steps in the BER pathway that produce abasic
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sites or single strand breaks, which destabilise the hairpin loop structure and so reduce the
quenching of the fluorophores attached to the adjacent free ends of the molecular beacon.
Immobilised oligonucleotides for multiplexed detection of glycosylase and AP endonu-
clease activities
The biotechnology company LXRepair has marketed a biochip containing a series of lesion-
containing oligonucleotides, which has been used with moderate success to measure mono-
and bifunctional DNA glycosylase activity in cell extracts. The assay works by providing
immobilised oligonucleotides with a range of base lesions to assess several DNA glycosylase
activities within the same cell extract sample. The DNA glycosylases currently available
to measure with this assay include OGG1, AAG, and UNG. After incubation with either
recombinant enzyme or cell extract, the extent of base lesion excision can be measured
with fluorescence detection of oligonucleotide remaining on the biochip [157]. A similar
assay was introduced by Flaender and colleagues in 2016, who used hairpin oligonucleotides
attached to glass slides to measure UNG and APE1 activities in much the same way as
the assays developed for this thesis, with the exception that the assays were not adapted to
measure DNA polymerase and DNA ligase BER enzymes and were immobilised to glass
slides rather than 96-well plates and so are lower throughput [158].
1.6.4 Reporter gene assay (host cell reactivation)
Classically the reporter gene assay, or host cell reactivation assay, is based on a plasmid
containing a reporter gene, commonly the luciferase sequence, that is damaged by exposure
to UV light. The plasmid is then transfected into a host cell and repair activity can be related
to the amount of luciferase detectable following an incubation period, as the damage to the
plasmid must be repaired before the reporter gene can be transcribed and used to create the
end product [159].
The reporter gene assay has most commonly been used to assess NER as the DNA
damage has to be bulky enough to block transcription of the plasmid before repair, but recent
modification by the Samson group has enabled it to be used in measuring other DNA repair
pathways including BER [160]. The addition of a multiplex flow-cytometry element to
the assay yields a highly useful tool that can simultaneously measure complete repair of
all the major DNA repair pathways; NER, MMR, BER, NHEJ, and HR. Reporter genes
that would give protein products with five different fluorescence signals were inserted into
plasmids containing damage specifically repaired by the distinct DNA repair pathways,
before incubation in a host cell as in the classic reporter gene assay. The cells containing the
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plasmids are then analysed for fluorescence on a flow cytometer. More recently, the same
group has further expanded this assay to measure the glycosylases UNG, AAG and MUTYH
in addition to OGG1 and used it to assess inter-individual variation in B lymphoblastoid
cell lines from healthy individuals [161]. Again, this assay is rather time intensive and
low-throughput, and only measures total repair instead of individual BER enzyme activities.
1.7 Modelling of biological systems
A more recent area of scientific endeavour aims to combine the fields of mathematics and
biology in order to gain new understanding of biological systems. A multidisciplinary
approach, commonly known as systems biology, should allow for reduced time in the lab,
more directed experiments, and more meaningful interpretation of results. There are several
options available for the modelling of biological systems that can be selected dependent
on the features of the biological system to be modelled. Common systems biology models
include Boolean networks, flux balance analysis (FBA), metabolic control analysis (MCA),
deterministic and stochastic models, and ordinary or partial differential equations (ODE
and PDE, respectively). Boolean networks are used to describe gene-regulatory networks,
where genes are set as either ’expressed’ or ’not expressed’. These models can give insights
into dynamic gene-regulation systems within cells [162]. FBA models are concerned with
large-scale analyses of biochemical networks, and contain all known metabolic reactions
within an organism [163]. These can be used to determine the extent that different metabolic
reactions contribute to an overall process, when given appropriate biological constraints.
MCA models are not dissimilar to FBA models, but on a smaller scale to examine the control
points in metabolic, signaling, and genetic pathways. MCA models are particularly relevant
to the current work as they determine control points in pathways; particularly, examining
which aspects of a pathway are rate limiting and how the dynamics of a pathway change when
the most rate limiting step is altered and a new rate limiting step is then established [164, 165].
ODE models contain differential equations that have the derivative of just one variable, and
can be used to quantitatively describe several biological systems [166]. PDE models are more
complex and involve at least one partial derivative and two or more independent variables.
These are used to describe complex systems, such as fluid movement and biological gradient
formation [167].
Mathematical models of biochemical reactions can be categorised as deterministic or
stochastic. In deterministic models, all parameter values are set and there is no randomness
included in the model output, whereas stochastic models allow for random fluctuations in
reactant concentrations. Sokhansanj and colleagues explained that in BER, the enzyme
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amounts involved are far greater than the level where stochastic modelling is relevant [168],
and so a deterministic modelling approach will also be used here. For the modelling of BER,
a kinetic, deterministic approach using ODEs is a common choice due to the quantitative data
available, the speed of reactions in a system and the amount of product formed. In general,
kinetic models are used for smaller, more self-contained systems due to the computing power
needed as the model size grows. As BER is an enzyme directed pathway, Michaelis-Menten
enzyme kinetics are the obvious starting point for building a mathematical model.
1.7.1 Michaelis-Menten enzyme kinetics
Enzyme kinetics are based on the equation E + S
 C → E +P, whereby E = enzyme
concentration, S = substrate concentration, C = enzyme-substrate complex concentration,
and P = product concentration. The first stage of the reaction is E + S → C, interaction
between E and S, described mathematically as EaSb for some a,b > 0. An assumption
made for Michaelis-Menten reactions is that a = b = 1, meaning that this is a second order
reaction according to the law of mass action; simply put, the rate of the reaction is directly
proportional to the product of the concentrations of the reactants. The next component of the
enzyme reaction is the dissociation of the enzyme and substrate complex into its component
parts, E +S←C. This rate is assumed to be proportionally related to the concentration of
the C complex. The final stage of the enzymatic reaction is the formation of the product,
shown by C→ E +P, which follows the previous assumption whereby the formation of the
product occurs proportionally to the concentration of the C complex. These three processes
can be expressed mathematically by as the following set of nonlinear differential equations:
dS
dt
= −k f ES+ krC (1.1)
dE
dt
= −k f ES+ krC+ kcatC (1.2)
dC
dt
= k f ES− krC− kcatC (1.3)
dP
dt
= kcatC (1.4)
The initial conditions for this system of equations are S(0) = S0,E(0) = E0,C(0) = 0, and
P(0) = 0, where S0 and E0 are the substrate and enzyme initial concentrations, respectively.
To simplify these equations, a conservation law can be implemented due to the nature of
enzymatic reactions; enzymes are catalysts and so are not used up in the reaction, meaning that
the total enzyme concentration remains constant over time. First, total enzyme concentration,
Etot = E +C, is found by adding equations (1.2) and (1.3), as these equations contain enzyme
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both in free form, E, and bound to substrate, C:
dEtot
dt
=
d(E +C)
dt
=
dE
dt
+
dC
dt
= (−k f ES+ krC+ kcatC)+(k f ES− krC− kcatC)
= 0
Therefore,
Etot(t) = E(t)+C(t) = c
where c is a constant. Now, the value of c must be determined by evaluating E and C at t = 0.
c = E(0)+C(0) = E0
and so the conservation law becomes
E(t)+C(t) = E0 (1.5)
which demonstrates that total enzyme concentration does indeed remain constant over time,
and is composed of the total of both free enzyme concentration and enzyme-substrate complex
concentration at any given time point. Equation (1.5) can then be solved for E whereby
E = E0−C, and substituted into (1.1) and (1.3):
dS
dt
=−k f ES− krC
=−k f (E0−C)S+ krC
=−k f E0S+ k fCS+ krC
gathering like terms, (1.1) becomes:
dS
dt
=−k f E0S+(k f S+ kr)C (1.6)
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For equation (1.3):
dC
dt
= k f ES− krC− kcatC
= k f (E0−C)S− krC− kcatC
= k f E0S− k fCS− krC− kcatC
gathering like terms as previously, (1.3) becomes:
dC
dt
= k f E0S− (k f S+ kr + kcat)C (1.7)
The next stage of mathematically describing an enzyme reaction is to make an assumption
that the overall enzyme-substrate complex concentration follows substrate concentration very
closely. As the formation of the enzyme-substrate complex is comparatively much faster
than the reduction in substrate concentration, equation (1.7) can be set to 0 (dC/dt = 0) as a
quasi-steady-state approximation. If (1.7) is set to 0 and solved for C, the following equation
is obtained:
C =
k f E0S
kr + kcat + k f S
=
E0S
km +S
where
km =
kr + kcat
k f
is known as the Michaelis constant. E0Skm+S can then be substituted for C in (1.6) to give a
term for substrate depletion in the enzyme reaction
dS
dt
=−kcatE0S
km +S
, S(0) = S0 (1.8)
A term to describe product accumulation can by substituting C = E0Skm+S into equation (1.4) to
give the following term:
dP
dt
=
kcatE0S
km +S
, P(0) = 0 (1.9)
To summarise, the four original equations (1.1)-(1.4) have been reduced to the two equations
(1.8) and (1.9) for substrate depletion and product accumulation.
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1.7.2 Modelling of the base excision DNA repair system
At the time of writing, there have been two papers published concerning the construction
of ODE-based mathematical models of BER [168, 35]; this section will contain a review of
these papers and the modelling approaches used, as well as details of published applications
of, and extensions to, the original models.
Sokhansanj and colleagues published a paper in 2002 titled ‘A quantitative model of
human DNA base excision repair. I. mechanistic insights’ [168]. In brief, the paper uses
previously published kinetic data for individual, purified enzymes of BER to construct a
model of abasic site repair based on ODEs. The model is then used to examine the effects of
perturbations in the system on overall repair rate and on combinations of different steps of
the pathway.
The paper begins by giving examples of previous models of biological pathways and the
advantages to creating such models, before specifically introducing the concepts of DNA
damage and the BER pathway. The aims of the paper are clear; to make a mathematical
model of BER and to apply it to understand aspects of pathway mechanism and cooperativity.
There was no hypothesis put forward, and a prediction of the type of enzyme cooperativity
expected would have been useful here.
The model was created using kinetic values published in the literature for purified BER
enzymes. The following key assumptions were made during model development; that
BER enzymes act according to Michaelis-Menten kinetics, that the chemical kinetics were
deterministic rather than stochastic, and that BER enzymes are distributed homogeneously.
These assumptions are reasonable and each was justified using examples from biological
data. The model equations used were ODEs describing the rate of appearance of each
BER intermediate based on substrate concentrations, enzyme concentrations, and reaction
velocities.
The initial finding when comparing the model output to experimental data was that the
model results underestimated the rate of abasic site repair by >5-fold. To explain this, the
authors examined the existing literature concerning BER enzyme cooperativity, and made
alterations to the parameters of the model to reflect different levels of cooperativity between
APE1 and Polβ dRP lyase. These changes continued to underestimated repair activity
compared to biological data, and so the next stage was to alter the equations to account
for the gap filling and dRP lyase activities being carried out by the same physical Polβ
enzyme. When the initial concentration of damaged substrate was adjusted, this model fitted
the experimental data well. The authors note that ‘this finding suggests an alternative means
of BER cooperativity not yet experimentally demonstrated’, and indeed since this model was
published biological data has emerged showing recruitment of DNA ligase III by Polβ [120].
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Upon establishing a BER model that accurately predicted experimental pathway be-
haviour, the authors carried out a sensitivity analysis to determine which enzymes would
have the greatest effect on the overall pathway if their activity was altered; this concept
is similar to the aforementioned MCA models in which the control points of the system
are determined. A single rate limiting step is a common and well understood concept in
biological systems, but where a system has several reactions with similar levels of activity,
increasing the rate limiting step would have only a small overall effect on the system as
the next lowest control point would then become the new rate limiting step. Unsurprisingly
dRP lyase, the enzyme with the lowest activity according to published kinetic data, had the
greatest effect on the pathway if the parameters were increased. Gap filling by Polβ had
the second biggest effect on overall pathway throughput when the kcat was altered, whilst
changing APE1 and DNA ligase I kinetic parameters did not have much effect on pathway
dynamics.
Next, the authors used the model to explore the contribution of different subpathways of
BER to overall DNA adduct repair. Some key assumptions made in their efforts to model
these pathways were the concentration of DNA ligase I, and that BER enzyme concentration
was homogeneously distributed across the whole cell volume. DNA ligase III and XRCC1
were excluded from the analysis. Although these assumptions were necessitated by a lack of
experimental data at the time this model was published, they are potential sources of error in
the model and should be revisited - particularly, DNA ligase III has been found to be a major
protein in SN-BER, and it is likely that BER enzymes are more concentrated in the nucleus
than distributed homogenously throughout the cell [169]. Under these caveats, the model
found that by far the biggest contributor to overall BER was the monofunctional glycosylase
initiated short patch pathway. The authors added in glycosylase activity to the model at this
stage and used kinetic data for OGG1 and UNG, although they did not have any experimental
data to compare these results to.
Finally, the authors used the model to explore the sensitivity of BER to the type of DNA
polymerase involved in repair. The paper investigated the major BER DNA polymerases
Polβ , Polδ , and Polε . To do this using the model, the authors reduced each DNA polymerase
concentration independently and observed the effects on overall BER throughput. The
findings of the model were in agreement with experimental data from the literature that Polβ
inhibition had the greatest effect on overall BER [170]; a logical result when taken in context
with the the mechanistic data showing that Polβ is required for both SN-BER and LP-BER.
Follow up papers from Sokhansanj and Wilson were published in 2004 and 2006, both of
which used the model to predict the outcomes of oxidative DNA damage under different repair
enzyme activities [171, 172]. A different group also employed Sokhansanj’s model, with
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modifications to include inhibition dynamics, to predict effectiveness of cancer therapeutics
on reducing overall BER [173]. Furthermore, Crooke and Parl published a paper titled ‘A
mathematical model for DNA damage and repair’ in 2010 [174]. The repair compartment of
the model was closely based on Sokhansanj’s work in 2002, and the authors added another
compartment dealing with the formation of DNA adducts caused by oestrogen metabolism.
A second BER model was published in 2014 by Rahmanian and colleagues, in a paper
titled ‘Radiation induced base excision repair (BER): A mechanistic mathematical approach’
[35]. The most striking difference between this model and Sokhansanj’s is the use of repair
enzyme accumulation data from whole cells, instead of enzyme activity data from individual,
purified enzymes. As this paper is focused on radiation damage induced repair, a particular
focus is on areas of complex damage where aberrant bases, abasic sites, and SSBs are found
closely spaced together in a DNA strand. The paper hypothesises that long-patch repair is
involved in the repair of complex lesions and short-patch repair is the main subpathway for
simple, non-clustered base damage.
The authors describe an SSB repair model that includes the BER enzymes APE1, Pol β ,
δ , ε , and ligase I and III. Some notable additions to the equation terms for this model are
accessory BER proteins including PARP, RFC, PCNA and XRCC1, and the BER processing
enzymes PNKP and FEN1. There are also equations to describe an OGG1 dependent model.
The parameters used to fit this model were based on accumulation kinetics of BER proteins
from in vivo imaging experiments. Although this data provides a good insight to accumulation
of BER proteins within cells, it does not capture the rate of processing of the DNA substrate
by each enzyme.
For this paper, the prediction of the model was remarkably close to biologically measured
values for SSB rejoining, base lesion repair, and accumulation kinetics. The authors also
found that their model confirmed their hypothesis that complex DNA damage is primarily
repaired by the long-patch BER subpathway. A strength of this model is the addition of BER
accessory proteins to further capture some of the complexity of the pathway. However, this
model does not differentiate between different species of BER intermediates and makes no
comment on the potential rate limiting step of the pathway.
In conclusion, the models of BER published so far all use a kinetic approach based on
ordinary differential equations to describe the pathway. The model developed by Sokhansanj
and collegaues is the first attempt to mathematically model the BER pathway and as such
is an extremely valuable addition to the field of BER pathway research. The conclusions
drawn are a good springboard for future pathway analysis. The main areas for improvement
to more closely match the model to in vivo BER would be to use data derived from cell
extracts rather than purified enzyme. Furthermore, BER commonly begins from the point of
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a damaged base, as well as from an abasic site, and so a model including glycosylase activity
compared to experimental data would be a valuable addition to this line of research. The
model published by Rahmanian and colleagues does use in vivo data to accurately predict
SSB rejoining and base lesion repair, but as the parameters were based on accumulation data
rather than enzyme activity there may be scope for improvement of this model as well.
1.7.3 Problem statement
Throughout the literature review presented in this introductory chapter, four common themes
became clear:
• Careful cellular regulation of DNA repair pathways is vital to maintain genomic
stability and prevent the occurrence of progressive diseases borne of DNA damage
such as cancer and neurodegeneration.
• A method by which to accurately, consistently, and easily assess BER capacity in a
high-throughput manner in human samples has not yet been definitively established.
• Lifestyle factors are likely to contribute to the wide inter-individual variation in BER
capacity seen in humans, but the specific factors and the mechanism by which they
cause this variation have not been elucidated.
• The contribution of each repair enzyme to the rate of the overall pathway, and coordi-
nation between these different enzymes, has not yet been fully investigated.
The current work sets out to contribute to the furthering of knowledge in these areas,
by first and foremost providing a simple and cost-effective novel assay format capable of
measuring each step of the BER pathway. Moving forward, researchers will be able to use
the panel of assays for a multitude of investigatory work into the BER pathway which in time
will provide valuable insight to the areas mentioned above.
Here, the assay format will be used to identify the rate limiting step of the BER pathway
and assess correlation between enzyme activities in a cohort of apparently healthy individuals,
as well as variability in BER enzyme activity in different cell lines and the effects of a weight
loss programme on BER capacity in a human intervention trial. Furthermore, mathematical
modelling techniques will be employed to generate detailed predictions regarding the rate of
accumulation of DNA repair intermediates and compare these repair profiles in cancer cell
lines and healthy human cells.
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1.7.4 Aims of project
The research carried out for this thesis aims to contribute to three main areas concerning the
base excision DNA repair pathway:
1. To develop a high throughput, sensitive and reliable method for determining the activity
of glycosylases, AP endonuclease, DNA polymerase, DNA ligase, and complete BER
capacity in nuclear extracts from human cells.
2. To use the enzyme activity assays to investigate correlation between enzyme activity
levels in apparently healthy individuals, and the effect of nutritional interventions on
BER capacity.
3. To generate a mathematical model of BER using enzyme activity data, and employ
this model to identify the rate limiting step and examine any differences between the
BER profiles of cancer cell lines and healthy human cells.
1.7.5 Hypothesis
The multi-step, enzyme-mediated base excision DNA repair pathway has an overall rate of
repair of damaged bases in DNA that is controlled by a single rate-limiting step, that can be
altered by lifestyle factors to directly influence pathway throughput; furthermore, distinct
cell types have differing baseline BER enzyme activities leading to altered flux through the
BER pathway.
Chapter 2
Measuring the Activity of Base Excision
Repair Enzymes
2.1 Introduction
The current chapter describes the development of a set of assays that can measure the
activity of BER enzymes; specifically, assays to measure the activity of UNG, APE1, DNA
polymerase, Polβ , DNA ligase, AP site repair and complete repair of an aberrant base.
UNG is a glycosylase responsible for locating and excising damaged bases in DNA. UNG
removes uracil that has occurred by spontaneous deamination of cytosine, and can also
remove uracil that has been misincorporated during DNA synthesis [175, 61]. APE1 cleaves
the DNA sugar-phosphate backbone at AP sites generated by the removal of a damaged base
by glycosylase, leaving a one-nucloetide gap with a hydroxyl group at the free 3’ DNA strand
end and a deoxyribose phosphate group attached to the 5’ DNA strand terminus (5’ dRP)
[176]. A DNA polymerase, most commonly polymerase β (Polβ ) in short patch BER, adds
one undamaged base to the gap left by APE1, and uses its dRP lyase activity to remove the 5’
dRP from the DNA backbone at the repair site [177]. A DNA ligase then acts to rejoin the
DNA backbone to complete the DNA repair [48].
Assays for measuring BER activity have been developed with varying degrees of speci-
ficity and complexity. The most widely used is the modified comet assay, a detailed review
of which is provided by Azqueta and Collins [146]. Other methods include the fluorescence-
quencher molecular beacon assay [156], measurement of the incorporation of radiolabelled
bases into plasmid DNA [178], and various techniques measuring the cleavage of radio- or
fluorescent-labelled synthetic oligonucleotides by glycosylases and APE1 [153, 152, 151].
Although invaluable in gaining an insight to BER enzyme activity, each of these techniques
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has its own drawbacks and limitations; in general, they are often low throughput, time
consuming, and cannot be utilised to measure the gap filling and ligation steps of BER in
isolation.
Described here is the development and validation of a set of assays that can measure
each enzyme of BER separately, as well as overall repair of a base lesion or an abasic site,
in a high throughput fashion. With assays of this capability, research can be carried out to
link DNA repair capacity to health outcomes in a more robust and enzyme specific way, as
well as analyse health outcomes of interventions aimed at altering DNA repair activity. All
the assays employ the same core strategy, whereby a hairpin loop oligonucleotide substrate
is covalently bound by one end to wells of 96-well plates. Each oligonucleotide complex
carries a single internal lesion within the double stranded region of the hairpin loop that
is representative of a lesion or intermediate in the BER pathway. A fluorescein moiety is
incorporated at the opposite end of the oligonucleotide structure to that bound to the wells of
the plate. Purified recombinant DNA repair enzymes or repair enzymes present in nuclear
extracts act on the substrate, either creating or removing an SSB or an AP site in the complex.
During the subsequent denaturation step, the end of the oligonucleotide carrying fluorescein
will be lost from the wells of the plate if the oligonucleotide hairpin structure contains an
SSB. If alkaline denaturation is used, AP sites are converted to SSBs and the same effect
is achieved. Consequently, enzyme activity is determined by quantifying the amount of
fluorescein retained in (or eluted from) the wells as a result of the denaturation step using a
colorimetric detection strategy. In the current work, the technique has been optimised and
used to measure distinct BER enzymes in human cells in a concentration-dependant fashion,
and has been defined in terms of sensitivity and reproducibility.
2.2 Methods
2.2.1 Reagents
All chemicals were purchased from Sigma-Aldrich (Dorset, UK), unless otherwise speci-
fied. Nunc® Immobiliser™ amino 96-well plates, adhesive plate seals, and Halt™ protease
inhibitor cocktail were purchased from Thermo Scientific (Loughborough, UK). Synthetic
oligonucleotides were designed using assistance from Integrated DNA technologies (IDT)
OligoAnalyzer 3.1 web-based tool, and ordered from IDT (Leuven, Belgium) and Sigma-
Aldrich, and were purified by high performance liquid chromatography. Oligonucleotide
length standard 20/100 ladder was ordered from IDT (Leuven, Blegium). Recombinant T4
DNA ligase, recombinant 3’ → 5’ exonuclease minus Klenow fragment of E. coli DNA
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polymerase I (exo− Klenow), deoxynucleotide triphosphates (dNTP), and herring sperm
DNA were purchased from Promega (Southampton, UK). All other recombinant DNA repair
enzymes were purchased from New England Biolabs (NEB; Hitchin, UK). The liquid sub-
strate system 3,3’,5,5’-tetramethylbenzidine (TMB) was purchased from Seracare (Milford,
MA, USA) and antibody to fluorescein conjugated to horseradish peroxidase (HRP; ab6656)
was purchased from AbCam (Cambridge, UK). Cell lines were purchased from the American
Tissue Culture Collection (ATCC; Manassas, VA, USA) and cell culture consumables were
purchased from Lonza (Slough, UK).
2.2.2 Cell culture
The hepatocellular carcinoma derived HepG2 [179] and the colorectal adenocarcinoma de-
rived Caco-2 [180] human cell lines were cultured in Dulbecco’s Modified Eagle’s Medium
(DMEM) containing 25mM glucose for HepG2 and 5mM glucose for Caco-2, and supple-
mented with 10% v/v foetal bovine serum, 100 units/ml penicillin, 100 units/ml streptomycin,
2mM L-glutamine, and 1x non-essential amino acids for both cell lines. Cells were incubated
in a humidified atmosphere at 37°C with 5% carbon dioxide and harvested at approximately
80% confluence. Harvested cell pellets were stored at -80°C prior to nuclear extraction and
protein quantification. A pooled extract of HepG2 cells across passages 15 - 20 was used for
assay development, and a pooled extract of Caco-2 cells across passages 54 - 57 was used for
reproducibility analyses.
2.2.3 Nuclear extraction and protein quantification of samples
Nuclear extraction was carried out on each cell pellet using a NE-PER®nuclear and cyto-
plasmic extraction reagents kit (Thermo Scientific, Loughborough, UK) according to the
manufacturer’s instructions, with the addition of 1x Halt™ protease inhibitor to the extraction
reagents. The protein concentration of each nuclear extract was quantified using a microBCA
kit (Thermo Scientific, Waltham, US) according to manufacturer’s instructions. Nuclear
extracts were frozen in 20µ l aliquots at -80°C before thawing for DNA repair enzyme activity
assays.
2.2.4 BER enzyme activity assay
Substrate preparation
For all microplate enzyme activity experiments, the initial oligonucleotide (URA03, AP02,
Contr01, LIG03 or GAP04; sequence information provided in table 2.1) was diluted from
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10µM stock solutions into freshly prepared 0.1M bicarbonate buffer (pH 9.6) to a fi-
nal concentration of 0.5nM, and 100µl of this solution was incubated in the wells of
Nunc® Immobiliser™ amino 96-well plates overnight at 4°C. Plates were then washed
with phosphate-buffered saline containing 0.1% v/v Tween-20 (PBST) and 100µl of a
0.5nM solution of the appropriate complementary oligonucleotide (Loop01A or Loop01G for
URA03, Loop01A for AP02 or Contr01; Loop02 for LIG03 or GAP04; sequence information
provided in table 2.1) was added following dilution in hybridization buffer (6x saline sodium
citrate (SSC) buffer, 5mM EDTA, 0.1% v/v Tween-20). Each plate was then sealed and
heated to 95°C for ten minutes in a hybridisation oven, followed by gradual cooling to 80°C,
maintenance at 80°C for ten minutes, cooling to 70°C, maintenance at 70°C for ten minutes
and then further gradual cooling to 21°C. This process should produce double stranded
oligonucleotide structures containing a site of damage and a hairpin loop, with the 3’ end
bound to the Nunc® Immobiliser™ amino plate and a fluorescein marker on the 5’ end for
GAP04 and LIG03 initial oligonucletides, with an extra ligation step required to complete
the substrate preparation for URA03 and AP02 initial oligonucleotides (figure 2.1; further
detail in subsequent sections).
Name Sequence (5’→ 3’) Modification Substrate for:
URA03 (P)CACGAA(U)CAACTCAGCAACTCCtt(NH2)1,2,3,4 Uracil (U) UNG, UDG
AP01 (P)CACGAA(B)CAACTCAGCAACTCCtt(NH2)5 Abasic site (B) APE1
AP02 (P)CACGAA(H)CAACTCAGCAACTCCtt(NH2)6 Tetrahydrofuran (H) APE1
Contr01 (P)CACGAATCAACTAACTCAGCAACTCCtt(NH2) n/a n/a
GAP04 (P)CAACTCAGCAACTCCtt(NH2) Single nucleotide gap Polymerase β ,δ & ε
LIG03 (P)TCAACTCAGCAACTCCtt(NH2) Ligatable SSB Ligase T4, I & III
Loop01A (Flc)ttGGAGTTGCTGAGTTGATTCGTGAGCACCAACCGGTGCT7 n/a n/a
Loop01AIRD (IRD800)ttGGAGTTGCTGAGTTGATTCGTGAGCACCAACCGGTGCT8 n/a n/a
Loop01G (Flc)ttGGAGTTGCTGAGTTGGTTCGTGAGCACCAACCGGTGCT n/a n/a
Loop02 (Flc)ttGGAGTTGCTGAGTTGATTCGTGAGCACCAACCGGTGCTCACGAA n/a n/a
Table 2.1. Sequences of oligonucleotides used in experiments. 1P indicates phosphorylation;
2NH2 indicates amino group modification; 3lower case letters indicate nucleotides linked
via phosphorothiate bonds; 4U indicates uracil; 5B indicates abasic site created by UDG
treatment; 6H indicates tetrahydrofuran; 7Flc indicates fluorescein;8IRD800 indicates infrared
dye tag.
Substrate concentration optimisation
To determine an appropriate oligonucleotide substrate concentration for the assays, Nunc®
Immobiliser™ amino 96-well plates were prepared as described in section (2.2.4) to construct
URA03 hybridized to Loop01A, with the exception that initial URA03 and subsequent
Loop01A was diluted to 0.08nM, 0.16nM, 0.31nM, 0.63nM, 1.25nM or 2.5nM in freshly
prepared 0.1M bicarbonate buffer (pH 9.6).
2.2 Methods 38
(A) (B) (C)
(D) (E) (F)
Figure 2.1. The expected structure of oligonucleotide substrates used in the novel assay
format, following binding to the well of a 96-well plate and hybridisation. (A) Substrate con-
taining a U:A base pair used for UNG/UDG, and total repair assays; (B) Substrate containing
a U:G mispair used for UNG/UDG and total repair assays; (C) Substrate containing an abasic
site created by treating the URA03 + Loop01A complex with excess recombinant UDG used
for Polβ and AP site repair assays; (D) Substrate containing a synthetic abasic site analogue
(tetrahydrofuran) used for the APE1 assay; (E) Substrate containing a single-nucleotide gap
used for the DNA polymerase (gap filling) assay; (F) Substrate containing a nick in the
DNA backbone used for the DNA ligase assay. Red letters indicate uracil (U), an abasic site
(B) or tetrahydrofuran (H). Red square indicates a one-nucleotide gap. Red lines indicate
ligation points. OH - hydroxyl group; P - phosphorylation; Flc - fluorescein; UNG - human
uracil DNA glycosylase; UDG - E. coli uracil DNA glycosylase; APE1 - apurinic/apyrimidic
endonuclease 1; Polβ - DNA polymerase β .
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Uracil DNA glycosylase activity assay
To measure UNG activity, plates containing URA03 annealed to Loop01A or Loop01G were
treated with 0.05U T4 DNA ligase in 100µl of T4 DNA ligase buffer (30mM Tris-HCl pH
7.8, 30mM NaCl, 10mM MgCl2, 10mM DTT, 1mM ATP) for one hour at 37°C. Plates were
then heated to 60°C for a further 15 minutes before the liquid in the wells was decanted and
the wells washed three times with PBST. This process produces double-stranded substrate
containing a hairpin loop and one U:A or U:G base pair/mispair within the double stranded
region (figure 2.1A and 2.1B). The substrate was then incubated for one hour at 37°C with
varying concentrations of recombinant E. coli uracil DNA glycosylase (UDG) or appropriate
concentrations of nuclear extract sample, both in DNA repair buffer (20mM Tris-HCl pH 7.8,
100mM NaCl, 0.4mM EDTA, 3.4% v/v glycerol, 0.4mM dithiothreitol (DTT), 2mM MgCl2,
1µg/ml herring sperm DNA). Following the repair incubation, the contents of the wells were
decanted and the wells washed three times with PBST. A volume of 150µ l of alkaline buffer
(0.1x SSC, 0.1M NaOH ) was added to the wells and the contents of the plate heated to 95°C
for 10 minutes. This heating in alkali step was repeated before the plate was decanted and
washed three times with PBST.
AP endonuclease activity assay
To measure APE1 activity, substrate was prepared as for the UNG assay except that oligonu-
cleotide AP02, containing an internal tetrahydrofuran (THF) group acting as an AP site
analogue, was bound to the plate and then hybridized and ligated to Loop01A (figure 2.1D).
This substrate was incubated with different concentrations of recombinant APE1 enzyme or
nuclear extract samples in the DNA repair buffer for one hour at 37°C before denaturation as
in section (2.2.4), except that neutral denaturation buffer (0.1x SSC buffer containing 0.1%
w/v sodium dodecyl sulphate (SDS)) was used in place of the alkaline buffer.
DNA polymerase assay
The substrate for the DNA polymerase assay was prepared by coupling oligonucleotide
GAP04 to the plate and then hybridizing oligonucleotide Loop02 to it to produce a double-
stranded substrate containing a hairpin loop and a single nucleotide gap (figure 2.1E).
DNA polymerase activity was determined by incubating the substrate with either various
concentrations of exo− Klenow or nuclear extract sample in the DNA repair buffer, to
which was added 2mM ATP, 30µM of each of dATP, dCTP, dGTP and dTTP plus an
excess (0.05U/well) of T4 DNA ligase. The exo− Klenow fragment was used as it is the only
commercially available enzyme that fills in nucleotides in the desired manner in DNA without
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removing nucleotides 3’ or 5’ to the single-nucleotide gap. Reactions were incubated for one
hour at 37°C. Denaturation was then achieved as described in the uracil DNA glycosylase
activity assay section.
DNA ligase assay
The substrate for the DNA ligase filling assay was prepared by coupling oligonucleotide
LIG03 to the plate and then hybridizing oligonucleotide Loop02 to it to produce a double-
stranded substrate containing a hairpin loop with a ligatable SSB in the sugar-phosphate
backbone (figure 2.1F). DNA ligase activity was determined by incubating this substrate with
varying concentrations of either recombinant T4 DNA ligase or nuclear extract sample in
DNA repair buffer containing 2mM ATP and a final concentration of 10mM MgCl2 for one
hour at 37°C. Denaturation was then achieved as described in the uracil DNA glycosylase
activity assay section.
Multi-step assays
Multi-step assays were developed to measure the combined gap filling and dRP lyase activities
of Polβ , repair of an abasic site, and complete repair of a uracil-containing substrate.
The substrate for the Polβ assay was prepared in the same way as for the UNG assay, with
URA03 as the initial oligonucleotide and Loop01A as the annealed oligonucloetide (figure
2.1A). After ligation and heating to 60°C to remove any unligated Loop01A oligonucleotide,
the double stranded hairpin loop structures were treated with excess recombinant UDG
(0.2U/well) in DNA repair buffer for one hour at 37°C. The UDG treatment excises the uracil
from the URA03 oligonucleotide leaving an abasic site (AP01). To determine Polβ activity,
the substrate was incubated with varying concentrations of nuclear extract under the same
reaction conditions used for the DNA polymerase assay in section (2.2.4). Denaturation
was achieved as in section (2.2.4) except for one triplicate set of control wells, to which
no nuclear extract had been added during the repair incubation, which were denatured with
neutral denaturation buffer instead of alkaline.
A variation of this assay was also developed to determine repair of an abasic site, by
preparing substrate as for the UNG activity assay and pre-treating each well with 0.2U of
UDG recombinant enzyme in DNA repair buffer for one hour at 37°C before incubation with
varying concentrations of nuclear extract under the same conditions as the Polβ assay but
in the absence of excess T4 DNA ligase in the reaction buffer, followed by denaturation as
described in the uracil DNA glycosylase activity assay section.
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To measure complete repair of an aberrant uracil, substrate was prepared as for the UNG
activity assay, with the exception of the standard curve wells prepared with varying ratios
of Contr01 and URA03 (0% - 100% Contr01). Standard curve wells were then incubated
with 0.2U/well UDG, and other wells were incubated with various concentrations of HepG2
nuclear extract for 30 - 240 minutes at 37°C in DNA repair buffer to which was added 2mM
ATP and 30µM of each of dATP, dCTP, dGTP and dTTP. Standard curve wells were then
incubated in DNA repair buffer only, while nuclear extract treated wells were incubated with
0.2U/well UDG for one hour at 37°C. Denaturation was then achieved as described in section
(2.2.4).
Colorimetric detection of fluorescein
After the final denaturation step of each assay, fluorescein retained in the wells of the plates
was quantified by colorimetric detection. Each well was incubated with anti-fluorescein
antibody conjugated with HRP diluted 10,000-fold in PBST/1% w/v bovine serum albumin
(BSA) for one hour at 21°C. The liquid was decanted from the wells and the wells washed
four times with PBST. TMB substrate for HRP was then added and incubated at 21°C for ten
minutes. Reactions were stopped by addition of 100µ l/well 1M phosphoric acid. Absorbance
was read at 450nm using an Omega fluostar microplate reader (BMG labtech, Aylesbury,
UK).
2.2.5 Eluted oligonucleotide size verification
Oligonucleotide preparation
Oligonucleotides were prepared within microtubes or by elution from Nunc® Immobiliser™
amino 96-well plates.
For microtube reactions, 3µM URA03 was annealed using the same heating and cooling
process described in section (2.2.4) to 3µM Loop01A with an 800 infrared dye tag in the
place of the fluorescein marker (Loop01AIRD; table 2.1), in a buffer containing 30mM Tris
Hcl and 10mM MgCl2 with total reaction volume 40µ l. After annealing, 10mM DTT, 1mM
ATP, and 6U T4 DNA ligase were added to the reaction mixture and the microtubes were
incubated for one hour at 30°C, and then overnight at 4°C. An alcohol precipitation was then
performed using 0.3M sodium acetate and 96% ethanol. The ligated URA03 and Loop01A
oligonucleotide was resuspended in ultrapure water, and half of the total oligonucleotide was
treated with 10U recombinant UDG in 20mM Tris-acetate, 1mM EDTA, and 1mM DTT
for one hour at 37°C before undergoing a second alcohol precipitation and resuspension in
ultrapure water.
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For microplate reactions, 25.0nM AP02 or URA03 in bicarbonate buffer of total volume
100µl/well was incubated overnight at 4°C in the wells of Nunc® Immobiliser™ amino
96-well plates. Following washing with PBST, 100µl/well of 25.0nM Loop01AIRD was
added in hybridisation buffer and the standard heating and cooling procedure from section
(2.2.4) was followed. Substrate preparation was completed by ligation and heating to 60°C
in the same way as for the UNG substrate in section (2.2.4). The URA03 + Loop01AIRD
substrate was incubated with 3.0µg/well Caco-2 nuclear extract and the AP02 + Loop01AIRD
substrate was incubated with 50ng/well HepG2 nuclear extract in 96 wells of each Nunc®
Immobiliser™ amino 96-well plates, in standard DNA repair buffer with 2mM MgCl2 for two
hours at 37°C. The reaction mixture was decanted and 100µl/well of alkaline denaturation
buffer was added before heating the plates to 95°C for ten minutes. The liquid in the wells
was then collected and pooled for each treatment type. The eluted oligonucleotide solutions
were concentrated at 4°C using Vivaspin 15R centrifugal ultrafiltration units with a 2kDa
nominal molecular weight cutoff (Sartorius, Epsom, UK). The concentrated samples were
extracted with phenol:chloroform:isoamyl alcohol (25:24:1) and the aqueous phase then
diafiltered into 20mM Tris-HCl, 1mM DTT, 1mM EDTA (pH 8) and further concentrated
using Vivaspin 500 centrifugal ultrafiltration units with a 3kDa nominal molecular weight
cutoff.
All oligonucleotides were quantified using a NanoDrop 2000 microvolume spectropho-
tometer to ensure consistent loading amounts (Thermo Scientific, Loughborough, UK).
Gel assay conditions
Ten nanograms of each preparation of oligonucleotide or 0.2µg of oligonucleotide length
standard 20/100 ladder was added to loading buffer (47.5% formamide, 2.5mM EDTA and
0.1% OrangeG) and incubated at 65°C for five minutes before loading. A total loading
volume of 20µl was added to each well of a 15% polyacrylamide gel and electrophoresed
at 200V for 60 minutes at 21°C in TBE buffer (178mM Tris base, 178mM Boric acid, and
4mM EDTA pH 8.0). The gel was firstly imaged on a Li-Cor Odyssey CLx Infrared Imaging
system (Lincoln, NE, USA) to detect the IRDye tagged oligonucleotides and subsequently
stained with 1x SYBR® Green I nucleic acid gel stain and read immediately on a Li-Cor
photoimager (Lincoln, NE, USA) to confirm the size of the oligonucleotide fragments by
comparing with the oligonucleotide length standard 20/100 ladder.
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2.2.6 Data analysis
Data are presented as mean ± SD of three technical replicates unless otherwise stated. For
recombinant enzyme standard curves and nuclear extract serial dilutions, the data were
background corrected and all values were divided by the highest absorbance value from
each plate, with the exception of figure 2.3, the initial oligonucleotide concentration curve,
which is shown as actual reported absorbance at 450nm. Nuclear extract enzyme activities
were determined by interpolation from the recombinant enzyme standard curve, fitted with
Y = (S0e−xE0)+C for UNG and APE1 datasets, and Y = S0(1−e−xE0) for DNA polymerase,
DNA ligase, Polβ , abasic site repair and complete repair datasets. Lower limits of detection
for the assays were calculated by interpolation of the activity corresponding to the mean
- 2 × SD of the absorbance for the zero enzyme controls of the UDG and APE1 standard
curves or mean + 2× SD of the absorbance for the zero enzyme controls of the exo− Klenow
fragment and T4 DNA ligase standard curves. Intra and inter-assay coefficients of variation
(CV) were calculated based on apparent enzyme activities, interpolated from recombinant
enzyme standard curves, for quality control nuclear extracts prepared from HepG2 or Caco-2
cells.
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2.3 Results
2.3.1 Development and optimisation of the BER enzyme activity assay
For each assay, a synthetic oligonucleotide complex bearing a single modified base or lesion
representative of an intermediate in the BER pathway was attached to the surface of a
microplate (figure 2.2). Firstly, a single oligonucleotide was covalently attached, via an
amino modification at its 3’ end, to the surface of wells in Nunc® Immobiliser™ amino
96-well plates. A second oligonucleotide, complementary to the first in the region of its 5’
end, with a hairpin loop structure at its 3’ end and a fluorescein moiety at the 5’ terminus
was hybridized to the first. The oligonucleotides were designed such that there was a two
nucleotide ‘spacer’, composed of nucleotides joined by phosphorothiate bonds, between the
NH2 binding group and the first base of the double stranded section of the oligonucleotide
complex. In the case of the UDG/UNG assay, the APE1 assay and the DNA ligase assay,
the oligonucleotides used form an immobilized double stranded hairpin loop complex with a
ligatable single strand nick between the 5’ end of the first oligonucleotide bound to the plate
and the 3’ end of the second hybridized to the first. For the DNA ligase assay this formed
the final assay substrate. For the UDG/UNG and APE1 assays, the nick was ligated by the
incubation with excess T4 DNA ligase to generate intact hairpin loop structures bearing a
single uracil or abasic (THF) site (each at the same site in the structure with an adenine
opposite on the complementary strand), respectively. In the case of the DNA polymerase
assay the structure was essentially identical to that used for the DNA ligase assay except that
there was a single nucleotide gap between the 5’ end on the first oligonucleotide and the 3’
end of the second.
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Figure 2.2. Assay schematic to show proposed mechanism to measure uracil DNA glycosylase (1), AP endonuclease (2), DNA
polymerase (3), and DNA ligase (4) activity. Numbers indicate the initial substrate for each enzyme activity assay. White rectangles
represent a single well surface of a Nunc® Immobiliser® plate. U – uracil; A – adenine; F – fluorescein; H – tetrahydrofuran; T –
thymine. For more details, see section (2.2.4).
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The hairpin loop structure was incorporated into the assay substrate design for two
reasons. Firstly, following the ligation of the two oligonucleotides used to generate the
UDG/UNG and APE1 substrates, it is important to remove any unligated complexes which
could confound assay results if ligases present in the nuclear extract acted on these complexes
during the enzyme incubation step. The differential between the melting temperature of
the unligated complex and the ligated hairpin structure is greater than it would be for an
equivalent linear double stranded complex melting temperature, making removal of the
unligated oligonucleotide without denaturing the ligated complex easier. Secondly, the loop
structure reduces the number of free strand ends accessible to degradation by non-specific
exonucleases that could be present in cell extracts. As an additional protection against
exonucleases, phosphorothioate linkages were incorporated between the three terminal
nucleotides at the 3’ end of the oligonucleotides attached to the well surface and at the 5’
ends of the oligonucleotides hybridized to those attached directly to the wells.
In initial experiments, a range of different oligonucleotide concentrations were tested to
determine the minimum concentrations usable that would provide adequate signal. Direct
fluorescence detection of the fluorescein retained in the wells required an initial oligonu-
cleotide concentration of >5.0nM (data not shown) whereas robust colorimetric detection of
fluorescein retained in the wells based on the use of a HRP-conjugated anti-fluorescein anti-
body could be achieved using substantially lower oligonucleotide concentrations (≤0.5nM;
figure 2.3) by measuring the colour generated by the action of HRP conjugated to the anti-
fluorescein antibody on HRP substrate. Based on this observation, the colorimetric detection
system was used routinely in subsequent experiments with an oligonucleotide concentra-
tion of 0.5nM to minimise background signal whilst giving a greatest absorbance value of
approximately 1.0 following ten minutes incubation time.
Alterations to the DNA repair buffer were required when pilot experiments indicated
an inhibitory effect on UNG activity in nuclear extract, but not on the UDG recombinant
enzyme (figure 2.4C). The inhibitory effect was hypothesised to be due to DNA binding
proteins, such as histones, present in the extracts preventing access to the DNA by the UNG.
In support of this hypothesis, we found addition of excess recombinant UDG after incubation
with higher concentrations of nuclear extract failed to excise the uracil and create alkali labile
AP sites (figure 2.4A). The possibility that this was caused by complete repair of the uracil to
become UDG-resistant substrate was discounted as dNTPs and ATP were not included in the
reaction buffer and so complete repair would not have been possible by the HepG2 nuclear
extract. Furthermore, this particular experiment was performed with no magnesium included
in the reaction buffer, which is shown in chapter (4) to be extremely inhibitory for complete
repair reactions (table 4.1).
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Figure 2.3. The effect of increasing initial URA03 oligonucleotide concentrations on
absorbance values after ten minutes incubation of bound anti-fluorescein conjugated to HRP
with TMB substrate. Data shown as mean ± SD of duplicate technical repeats.
In an attempt to counteract possible inhibition by non-specific binding of other nuclear
proteins to the assay substrate, herring sperm DNA was added to the repair incubations to
act as a competitor for DNA binding proteins. The presence of herring sperm DNA in the
reaction mix did not interfere with the action of recombinant UDG, whereas its inclusion
dramatically increased the apparent UNG activity in the nuclear extract (figure 2.4). As this
approach was a success, the DNA repair buffer was made with 1µg/ml herring sperm DNA as
standard for all experiments. The exception to this was for the complete repair assay, where
nuclear extract concentrations of up to 10µg/well were incubated with the substrate, and so a
larger concentration of 2µg/ml herring sperm DNA was used as standard to counteract the
greater proportion of DNA binding proteins coincidentally added.
All assays were developed and optimised with aliquots of a quality control sample
composed of a large volume of pooled HepG2 nuclear extract. A range of concentrations of
this pooled nuclear extract could thereby be used to test each assay, for two major reasons;
firstly, to confirm that a concentration-dependant relationship was seen between nuclear
extract concentration and enzyme activity for each particular assay, as any non-linear activity-
concentration trends would indicate inhibitory effects as seen in the initial UNG assay
development, and secondly to determine an appropriate, mid-standard curve concentration
of nuclear extract to use in each assay in subsequent experiments when assessing cell line
enzyme activity variability at a single concentration. The results of these concentration-
enzyme activity relationship experiments are discussed in sections (2.3.2) - (2.3.6).
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Figure 2.4. Effect of herring sperm DNA in DNA repair buffer on UNG activity in HepG2
nuclear extract. Open circles = no added herring sperm DNA, closed circles = 1µg/ml
herring sperm DNA. (A) Incubation of uracil:adenine base pair-containing substrate with
excess recombinant UDG following the incubation with HepG2 nuclear extract did not
reduce detectable uracil-containing substrate, but instead caused reduction in signal at low
concentrations of initial nuclear extract concentration and an increase in signal as nuclear
extract concentration increased; (B) Recombinant UDG activity was not affected by herring
sperm DNA in DNA repair buffer; (C) Increasing concentrations of HepG2 nuclear extract
reduced detectable uracil-containing substrate in the presence, but not absence, of herring
sperm DNA in the DNA repair buffer; (D) A linear relationship was demonstrated between
nuclear extract concentration and apparent UNG activity in the presence, but not absence,
of herring sperm DNA in the DNA repair buffer, R2 = 0.99. UDG – E. coli uracil DNA
glycosylase; UNG – human uracil DNA glycosylase. Data shown as mean ± SD of triplicate
technical repeats.
2.3 Results 49
2.3.2 UNG activity assay
When incubated with the uracil-containing substrate URA03 annealed to Loop01A, the
recombinant UDG generated AP sites in the oligonucleotide substrate in a concentration
dependant manner as evidenced by the production of alkali-labile sites converted to strand
breaks in the alkaline denaturation step. Therefore, as the recombinant UDG concentration
increased, the retention of fluorescein-conjugated oligonucleotide detectable in the wells
decreased (figure 2.5A).
In the optimised DNA repair buffer described in (2.3.1), the expected concentration
dependent decrease in signal was observed with increasing amounts of nuclear extract (figure
2.5B). Under these conditions, the apparent UNG activity in the HepG2 nuclear extract,
determined by interpolation from the UDG standard curve, was directly proportional to the
amount of nuclear extract added across the range of at least 0 - 4µg/well (figure 2.5C).
2.3.3 AP endonuclease activity assay
APE1 activity was measured using a substrate containing THF, a synthetic abasic site
commonly used for research purposes [181, 182]. The THF was positioned at the same
location in the oligonucleotide substrates as the uracil in the UDG/UNG substrate. Both
recombinant APE1 and HepG2 nuclear extract acted on this substrate to produce a strand
nick leading to a concentration-dependent decreased in the amount of intact THF-containing
oligonucleotide bearing a 3’ fluorescein following neutral denaturation (figure 2.6).
APE1 activity in the HepG2 nuclear extract was markedly higher than UNG activity
in the same extract; UNG activity at 4.0µg/well reduced absorbance to 0.14 (figure 2.5B),
whereas 0.04µg/well was required in the APE1 assay to reduce absorbance to an equivalent
level (figure 2.6B), a 100-fold difference. APE1 activity was directly proportional to the
amount of extract added in the range 0 to 0.0015µg/well (figure 2.6C).
2.3.4 DNA polymerase activity assay
Following the action of APE1, the next step in the BER pathway requires a DNA polymerase
to fill in the single nucleotide gap generated at the site of repair as a result of the preceding
steps (figure 1.3), and also DNA backbone end processing by dRP lyase. To determine the
activity of DNA polymerase capable of working on a single nucleotide gap with processed
DNA backbone ends in nuclear extracts, the substrate prepared was identical to that used
in the assays described above but with a single nucleotide gap at the same position in the
sequence as the uracil and THF used for the UDG/UNG and APE1 assays, respectively.
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Figure 2.5. Effect of uracil DNA glycosylase on uracil:adenine base pair containing oligonu-
cleotide substrate. (A) Increasing concentrations of recombinant UDG decreased the amount
of uracil-containing substrate retained in the wells; (B) The same effect on uracil-containing
substrate was shown with increasing concentrations of HepG2 nuclear extract; (C) A linear
relationship was demonstrated between nuclear extract concentration and apparent UNG
activity, R2 = 0.95. UDG – E.coli uracil DNA glycosylase; UNG – human uracil DNA
glycosylase. Data shown represent the mean ± SD of triplicate technical repeats.
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Figure 2.6. Effect of AP endonuclease on AP site-containing oligonucleotide substrate. (A)
Increasing concentrations of recombinant APE1 decreased the amount of AP site-containing
substrate retained in the wells; (B) The same effect on AP site-containing substrate was
shown with increasing concentrations of HepG2 nuclear extract; (C) A linear relationship was
demonstrated between nuclear extract concentration and apparent APE1 activity, R2 = 0.94.
APE1 – AP endonuclease; Data shown represent the mean ± SD of triplicate technical
repeats.
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This assay requires not only the action of DNA polymerase to fill the gap but also DNA
ligase to seal the single strand break so that enzyme activity is detected as an increase in
intact oligonucleotide carrying the 3’ fluorescein moiety following the repair reaction and
subsequent denaturation step. Therefore, excess T4 DNA ligase was added to the DNA repair
bufffer in all reactions to ensure that the polymerase activity was rate limiting. A standard
curve, constructed using serial dilutions of recombinant exo− Klenow fragment, produced
the expected concentration-dependent increase in signal (figure 2.7).
Incubation of the substrate with HepG2 nuclear extract also produced a concentration
dependent increase in signal (figure 2.7B). The apparent polymerase activity in the nuclear
extract, based on interpolation from the standard curve produced using exo− Klenow, was
directly proportional to the amount of extract added in the range 0 to 0.06µg/well (figure
2.7C).
2.3.5 DNA ligase activity assay
The substrate prepared for the DNA ligase assay was identical to that used in DNA polymerase
assay except that an additional nucleotide (T) was included at the 3’ end of the oligonucleotide
attached directly to the surface of the wells to generate an oligonucleotide complex with
a single ligatable nick in it. Serial dilutions of recombinant T4 DNA ligase were used to
generate the standard curve (figure 2.8A).
As with the other assays reported, incubation of the substrate with HepG2 nuclear extract
produced a concentration-dependent increase in signal (figure 2.8B). The apparent DNA
ligase activity in the nuclear extract, based on interpolation from the standard curve produced
using T4 DNA ligase, was directly proportional to the amount of extract added in the range 0
to 0.5µg/well (figure 2.8C).
2.3.6 Assays for measuring multiple steps of the BER pathway
An advantage of the assay format developed here is that it is flexible enough to be adapted
for measurement of more than one step of the BER pathway. As well as the individual
enzyme activity steps already described in this chapter, assays were developed to measure the
combined gap filling and dRP lyase activities of Polβ , repair of an abasic site, and complete
repair of a uracil.
For the multi-step repair assays, standard curves of recombinant enzyme activity could
not be used in the same way as for the UNG, APE1, DNA polymerase and DNA ligase assays,
and so a different approach was used. By mixing oligonucleotides URA03 and Contr01 in
different ratios prior to coupling the oligonucleotide mixtures to the microplate wells, hairpin
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Figure 2.7. Effect of DNA polymerase on single nucleotide gap-containing oligonucleotide
substrate. (A) Increasing concentrations of recombinant exo− Klenow increased the amount
of substrate retained in the wells; (B) The same effect on one nucleotide gap-containing
substrate was shown with increasing concentrations of HepG2 nuclear extract; (C) A linear
relationship was demonstrated between nuclear extract concentration and apparent DNA
polymerase activity, R2 = 0.94. Data shown represent the mean ± SD of triplicate technical
repeats.
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Figure 2.8. Effect of DNA ligase on oligonucleotide with a nick in the DNA backbone.
(A) Increasing concentrations of recombinant T4 DNA ligase increased the amount of
substrate retained in the wells; (B) The same effect on backbone-nicked substrate was
shown with increasing concentrations of HepG2 nuclear extract; (C) A linear relationship
was demonstrated between nuclear extract concentration and apparent DNA ligase activity,
R2 = 0.97. Data shown represent the mean ± SD of triplicate technical repeats.
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loop structures were generated with Loop01A that contained varying proportions of uracil
lesions and it was demonstrated that the colour developed following treatment of these with
excess UDG and subsequent alkaline denaturation was directly proportional to the amount
of substrate retained in the wells (figure 2.9A). Thus, by including control wells in each
assay that are treated with no cell extract and then subjected to UDG treatment followed by
alkaline or neutral denaturation the signal equivalent to zero and 100% repair, respectively
was determined, and from this percentage repair of each multi-step assay substrate achieved
with different amounts of nuclear extract could be interpolated.
The substrate for Polβ is a single-nucleotide gap with a dRP group on the DNA backbone
3’ to the lesion, and a hydroxy group on the DNA backbone 5’ to the lesion. To create
this substrate on the assay plate, URA03+Loop01A oligonucleotide was prepared and then
pre-treated with excess UDG to excise the uracil in the substrate, leaving an abasic site.
Further treatment of this substrate with recombinant APE1 to cleave the abasic site and create
the single-nucleotide gap with dRP group proved unnecessary as APE1 activity in the HepG2
nuclear extract is so high (figure 2.6B) that it acts as an excess APE1 treatment. Excess
T4 DNA ligase was included in the reaction buffer to ensure that DNA ligase was non-rate
limiting, and so the combined gap filling and dRP lyase activities of Polβ were captured in
this assay. As the dRP lyase action of Polβ is the rate limiting step (see chapter (4) for more
details), this assay is principally considered a dRP lyase activity assay.
With this assay format, a concentration dependent increase in percentage repair of the
abasic site-containing substrate was observed using HepG2 nuclear extract ranging from 0 -
1µg/well (figure 2.9B).
The substrate for abasic site repair was prepared in the same way as for the Polβ assay,
with the absence of excess T4 DNA ligase during the nuclear extract incubation step in
order to measure the contribution of APE1, Polβ , and DNA ligase in the nuclear extract to
the repair of the substrate. A concentration-dependant increase in percentage repair of the
abasic site-containing substrate was observed using HepG2 nuclear extract ranging from 0
- 2µg/well (figure 2.9C). Approximately double the amount of HepG2 nuclear extract was
required to achieve 40% repair of abasic sites when excess T4 DNA ligase was absent from
the reaction mixture, indicating that DNA ligase activity in nuclear extract may contribute to
limiting the rate of repair of abasic sites.
Complete repair of the uracil contained in the URA03/Loop01A complex should lead to
incorporation of a deoxythymidine at the lesion site and the resultant repaired complex will
be resistant to excess UDG treatment to create abasic sites, followed by alkaline denaturation.
When incubated with HepG2 nuclear extract, a concentration-dependant increase in percent-
age of UDG resistant substrate was observed from 0 - 10µg/well (figure 2.9D); approximately
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Figure 2.9. Assays developed that measure multiple steps of the BER pathway. (A) Colour
development in assay plate wells was directly proportional to the amount of fluorescein mod-
ified oligonucleotide retained in the wells (R2 = 0.99); (B) Effects of varying concentrations
of HepG2 nuclear extract on the extent of single-nucleotide gap repair by gap filling and dRP
lyase activities of polymerase β , data generated by Dr Ruan Elliott; (C) Effects of varying
concentrations of HepG2 nuclear extract on the extent of abasic site repair by APE1, Polβ
and DNA ligase enzyme activities in combination; (D) Effects of varying concentrations
of HepG2 nuclear extract on the extent of total repair of a substrate containing a U:A base
pair by UNG, APE1, Polβ and DNA ligase enzyme activities. UNG - human uracil DNA
glycosylase; APE1 - AP endonuclease. Data shown represent the mean ± SD of triplicate
technical repeats.
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six times more HepG2 nuclear extract was needed to repair 40% of uracil-containing substrate
than abasic site-containing substrate.
2.3.7 Specificity of the microplate-based BER enzyme activity assay
To confirm that the concentration-dependent signal reduction produced by the nuclear extract
acting on uracil:adenine-containing oligonucleotide substrate was specifically due to the
excision of the uracil only, and not to non-specific degradation of the oligonucleotide substrate,
HepG2 nuclear extract was incubated under the same conditions as in the uracil-containing
oligonucleotide experiment, but using a control substrate lacking any internal uracil or other
DNA damage. Under these control conditions, neither the recombinant UDG preparation nor
nuclear extract decreased the signal to the same extent as the effect shown on uracil-containing
substrate (figure 2.10A and 2.10B).
To further establish the specificity and mechanism of action of the activity assays, a gel
mobility experiment was used to determine the size of the oligonucleotide fragments released
by UNG and APE1 in Caco-2 and HepG2 nuclear extract, respectively. The bands produced
by the electrophoretic mobility assay confirmed that oligonucleotide fragments released from
substrate bound to a Nunc® Immobiliser™ amino 96-well plate by Caco-2 or HepG2 nuclear
extract, were of the same size as oligonucleotides prepared in a suspension and digested by
recombinant UDG (figure 2.10C).
2.3.8 Assay sensitivity and reproducibility
As the assays described here are novel, it was important to assess their sensitivity and
reproducibility prior to experiments examining biological differences between cell lines and
primary human cells. The lower limits of detection for each of the assays were estimated
based on the standard curves as explained in section (2.2.6) and the minimum amount of
nuclear protein needed to detect activity was found using the lower limit of detection for
each enzyme. The intra- and inter-assay coefficients of variation (CV) were determined
by repeat analyses of nuclear extract quality control samples (table 2.2). These analyses
demonstrate that the four assays for UDG/UNG, APE1, DNA polymerase and DNA ligase
are highly sensitive and give good reproducibility, with intra-assay CVs generally <10%
and inter-assay CVs generally <15% for samples with activities in the central region of the
assay range. Taken together, these results demonstrate that a sensitive and reproducible
panel of microplate-based assays have been generated, that are capable of measuring each
enzymatically-controlled step of the BER pathway.
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Figure 2.10. Specificity of the novel oligonucleotide enzyme activity assay format. (A)
Increasing concentrations of recombinant UDG had no apparent effect on non-damage
site-containing substrate detectable on the plate; (B) The same lack of effect on non-uracil
containing substrate was shown with increasing concentrations of HepG2 nuclear extract.
Data shown represent the mean ± SD of triplicate technical repeats. (C) Oligonucleotide
fragments eluted from uracil- or THF-containing substrates bound to Nunc® Immobiliser™
amino 96-well plate and treated with Caco2 or HepG2 nuclear extract, were the same size as
oligonucleotide fragments prepared in a suspension by incubation with recombinant UDG.
Samples shown left to right: Loop01AIRD only, URA03 ligated to Loop01AIRD, URA03
ligated to Loop01AIRD treated with recombinant UDG, resultant elution of plate bound
URA03 ligated to Loop01AIRD and treated with Caco-2 nuclear extract, resultant elution of
plate bound AP02 ligated to Loop01AIRD and treated with HepG2 nuclear extract. Eluted
oligonucleotide samples were prepared by Dr Ruan Elliott. APE1 - AP endonuclease. UDG
– E. coli uracil DNA glycosylase.
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Assay Lower LoD (U/well)1,2 Minimum NE (µg/well)3,4 Amount of NE (µg/well)5 Intra-assay CV (%)6,7 Inter-assay CV (%)8
UDG/UNG
1.0 18 ± 3 18
0.009 0.181 2.0 10 ± 2 10
3.0 8 ± 2 6
APE1
0.002 28 ± 11 14
0.005 0.002 0.004 14 ± 3 8
0.008 4 ± 0.3 13
DNA polymerase
0.0125 12 ± 4 12
8.0×10−7 2.0×10−4 0.025 5 ± 1 15
0.05 9 ± 3 9
DNA ligase
0.1 5 ± 1 6
2.0×10−6 0.001 0.2 5 ± 2 10
0.4 10 ± 4 20
Table 2.2. Sensitivity and reproducibility of DNA repair enzyme activity assays. Intra- and
inter-assay CVs were generated by Dr Ruan Elliott. 1LoD indicates limit of detection; 2Lower
LoD calculated by interpolating enzyme activity at mean absorbance at 0U enzyme minus 2
× SD for UNG and APE1 assays, and mean absorbance at 0U enzyme plus 2 × SD for DNA
polymerase and DNA ligase assays; 3NE indicates nuclear extract; 4Minimum amount of
NE protein needed to detect enzyme activity was found by interpolating the absorbance for
lower LoD on the HepG2 serial dilution curve for each assay; 5HepG2 NE quality control
sample used for all assays with the exception of UNG, which used Caco-2 NE quality control
sample; 6CV indicates coefficient of variation;7Mean ± SD of intra-assay CV based on four
individual analyses each of eight technical replicates; 8Inter-assay CV calculated from assays
performed on four independent plates.
2.4 Discussion
2.4.1 Development and optimisation of a panel of assays to measure
BER enzyme activity
The work presented in this chapter describes the development, optimisation and validation of
a panel of assays for quantifying the activity of enzymes in the BER pathway. Specifically,
the four main stages of BER have been measured in terms of the related enzyme activity;
base removal by the glycosylase UNG, abasic site strand nicking by APE1, gap filling by
DNA polymerase and DNA strand joining by DNA ligase. Furthermore, the assay format
was adapted to measure multiple steps of BER and so Polβ , abasic site repair and complete
repair of uracil-containing substrate were also quantified in HepG2 nuclear extract.
A substantial amount of time was spent on the design of the oligonucleotide substrate
used in these assays. Phosphorothioate bonds were included between the last two nucleotides
at both the 3’ and 5’ ends of the oligonucleotides in order to prevent non-specific degradation
by exonucleases that may be present in cell extracts. The use of a control oligonucleotide with
no damaged site confirmed the resistance of the oligonucleotides to exonuclease degradation
(figure 2.10). Also built in to the design of the assay oligonucleotides were two non-base
pairing nucleotide spacers at the 3’ and 5’ ends of the oligonucleotide structures, that
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should allow space for plate binding at the 3’ amino binding end of the complex, and for
antibody binding at the 5’ fluorescein end of the complex. The hairpin loop design of the
oligonucleotide and the ligation step required to prepare the substrate for enzyme treatment
were both incorporated to reduce background in the assay caused by inappropriately bound
or annealed oligonucleotides.
When developing these assays, the selection of an appropriate substrate concentration
was important to increase the sensitivity of the assay whilst retaining the ability to detect
fluorescein remaining on the plate via HRP binding. If substrate concentrations were
too high, then end stage colour development would occur too quickly and results could
become inconsistent due to small time delays when pipetting stopping solution on the plate,
particularly when substrating several plates at the same time. High substrate concentrations
could also reduce the sensitivity of the assay as greater concentrations of recombinant enzyme
and cell extract may need to be added to show differences in enzyme effect. Conversely, if
substrate concentration was too low then colour detection may become difficult due to the
extremely low amount of plate-bound fluorescein available for the HRP conjugated antibody
to bind to.
Herring sperm DNA was added to the DNA repair buffer for all assays to act as a
competitive inhibitor of DNA binding proteins in the cell extracts. These unspecified DNA
binding proteins caused an inhibitory effect on DNA repair enzymes at high concentrations
of nuclear extract, which the addition of non-plate bound DNA ameliorated.
As the nuclear extract added to the plate-bound substrate was made up of a complex mix
of all nuclear proteins, rather than purified DNA repair enzymes, it was important to test
if there were any non-specific effects of nuclear DNA exonucleases degrading the hairpin
loop or flourescein end of the synthetic oligonucleotide substrate. To this end, a control
oligonucleotide that had the exact same sequence as the assay substrate, but no damage
site, was incubated with cell extract. No non-specific cleavage was observed by the nuclear
extract on the control oligonucleotide, thus demonstrating that the activities measured in the
assays were that of BER enzymes and not DNA exonucleases; this was also confirmed by
determining the size of the oligonucleotide fragments released from the plate by both nuclear
extract for the UNG and APE1 assays were the same size as oligonucleotide fragments
digested in microtubes by recombinant enzyme, using an electrophoretic mobility shift assay.
APE1 activity was detectable in 100-fold lower quantities of HepG2 nuclear extract than
UNG activity, indicating that HepG2 nuclear extracts are more proficient in incision at AP
sites than in damaged base removal from oligonucleotides. Similarly, DNA polymerase
activity was readily detected in 25-fold lower quantities and 5-fold lower quantities of HepG2
nuclear extract than UNG and DNA ligase activity, respectively. Previous work investigating
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the kinetics of UNG and APE1 action using molecular beacon and radiolabelled cleavage
assays are in agreement that APE1 activity exceeds UNG activity in immortalised human
cell lines [156].
The multi-step assays indicated that to repair 40% of available substrate, 2-fold more
HepG2 nuclear extract was needed for abasic site repair and 6-fold more HepG2 extract was
needed for repair of a uracil-containing substrate compared to Polβ . An important point to
consider with this assay format is that the DNA repair buffer used for complete repair of a
uracil-containing substrate contained 2mM MgCl2, a low enough level to cause sub-optimal
human DNA ligase activity (data not shown), and so the DNA ligase step could have been
made artificially rate limiting in this dataset compared to the abasic site repair assay where
nuclear extract incubation buffer contained 8mM MgCl2. The effects of buffer conditions on
the BER pathway and the rate limiting step will be more fully explored in chapter (4).
2.4.2 Strengths and limitations of the novel assay
The major advantages of these assays fall into both practical and data-generating categories.
The practical aspect of these assays is that they are non-radioactive, inexpensive, require little
specialist equipment, and are reasonably quick and easy to carry out. From a data-generating
point of view, the assays are high throughput, sensitive and can be used to test individual
enzyme activities, including the polymerase and ligase stages of repair, as well as complete
repair, which no other published method for measuring DNA repair enzyme activity has been
able to demonstrate. Importantly, the data shown here demonstrates that these assays can
be used to determine DNA repair enzyme activity not just with recombinant enzymes but
also with the complex matrix of mammalian cell extracts, and that the quantities of extract
required for the analysis are sufficiently small that enough material for detailed analysis
can be obtained even where the amount of starting material is limited, such as with blood
samples from human volunteers. Additionally, the assay format has the flexibility to be
used to determine the activity of other DNA glycosylases beyond those reported here, and
potentially to measure enzyme activities in other DNA repair pathways.
Conversely, the main drawbacks to the assays are the use of a cell-free nuclear extract
system which is inherently non-representative of intracellular conditions, the use of short
oligonucleotides with a single site of damage meaning that rates of repair of complex damage
and the complication of long stretches of undamaged DNA between sites of damage are
not taken into account, and the use of the unit measurement system from the purchased
recombinant enzymes means no direct comparison between enzyme activities; for example,
one unit of E. coli UDG does not equal one unit of APE1, which does not equal one unit of
exo− Klenow or one unit of T4 DNA ligase. Furthermore, some of the recombinant BER
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enzymes were not available to purchase as human enzymes and so bacterial enzymes were
used for the UNG, DNA polymerase, and DNA ligase assays. For these reasons, direct
comparison between, and absolute quantification of, human enzyme activity is not possible.
However, the quantification of each enzyme activity is still valuable for comparing each
specific enzyme activity between different cell lines or individuals.
The panel of assays presented here provide an exciting opportunity to explore various
aspects of BER that have so far only begun to be examined, including disease prediction,
modulation of the pathway, and interaction of BER with disease states. Subsequent chapters
of this thesis will use these assays to investigate BER capacity in a range of cell types,
investigate the variation in BER enzyme activity between healthy individuals, explore the
effects of weight loss via differential weight loss methods on DNA repair enzyme activity,
and parametrise a mathematical model of BER.
Chapter 3
Demonstrating BER enzyme activity
regarding variability, correlations, and
effect of lifestyle influences in cell lines
and primary human samples
3.1 Introduction
Following the development of the novel assay format described in chapter (2), it was important
to test the ability of the method to measure a range of cell types and to differentiate DNA
repair activities between different treatment groups. To this end, the following chapter will
present data showing that the novel DNA repair enzyme activity assay format can be used to
measure UNG, APE1, DNA polymerase, Polβ , DNA ligase and AP site repair activity in
two immortalised human cell lines and primary human extracts. Furthermore, the assays will
be employed to examine variability in enzyme activity across distinct cell line passages and
differences between different cell lines, the effect of base pairing on uracil excision efficiency
by UNG, and the variability within, and correlation between, enzymes of the BER pathway
in primary human samples, as well as examining differences in BER capacity following a
weight loss intervention trial in primary human samples.
Immortalised cell lines are a widely used model for researching biological mechanisms
and drug effects as they are inexpensive and simple to grow, and large quantities of sample
can be generated with relative ease and speed [183]. A useful tool for initial biological
investigations and particularly for showing cancer chemotherapy effects, they have limited
use for comparison to a healthy human due to the numerous genetic and phenotypic changes
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necessary to allow cells to grow in an uncontrolled manner within cell culture conditions
[184]. HepG2 and Caco-2 cell lines were investigated in terms of their DNA repair activities
in order to compare between the two cell lines sourced from liver and colorectal cancers, and
to observe the level of variability within each cell line as the cells replicate over time. The
hypothesis for this section of work was that the variability in DNA repair activities within
each cell line will be low over time, and that there are distinct differences in repair activities
across different cell lines.
A more relevant measure of human physiology is the analysis of primary samples taken
from individuals. In the studies for this chapter, PBMCs isolated from whole blood were
used as a relatively easily accessible and abundant source of human cells. White blood cells
isolated from whole blood are a cell type often used to measure DNA repair capacity for these
reasons [130, 123, 131]. Initially, the novel assay format was optimised for use with PBMCs,
and then samples from healthy volunteers were analysed to assess the variability between
individuals. Furthermore, correlation analyses were used to investigate the relationships
between the activities of different DNA repair enzymes in the BER pathway. This is of
potential interest as the co-ordination of BER has begun to be investigated in the literature,
with some evidence available for interaction and co-ordination between BER enzymes
[117, 114, 120]. In PBMC nuclear extracts from healthy volunteers, it was hypothesised
that there would be greater inter-individual variation than seen in the cell line work, and that
correlations would be observed between sequential DNA repair enzyme activities of the BER
pathway.
Finally, there is mounting evidence that DNA repair can be influenced by external lifestyle
factors, such as diet [128]. Overweight and obesity is increasing in prevalence in the UK,
and has been linked to an increased cancer risk in humans, with obese adults estimated to be
40% more likely to die from cancer than non-obese adults [185]. The cancer risk increase is
potentially due to the increase in oxidative stress and associated DNA damage in overweight
and obese individuals [186]. However, the risk may be reduced or increased by DNA repair
capacity, an area that so far has had very limited scientific attention. It is currently unknown
if weight loss through different methods effects DNA repair enzyme activity, although one
study in rats did find an increase in Polβ activity following caloric restriction [140]. In
this chapter, the use of the new assay format to assess DNA repair activity in cell lines
following fatty acid treatment, and BER capacity before and after weight loss via different
interventions in a human sample group is presented and discussed. The hypotheses to be
addressed by these experiments was that fatty acid treatment of immortalised cell lines will
affect glycosylase activity, and that weight loss in humans would have some effects on DNA
repair capacity, potentially due to altered Polβ activity.
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3.2 Methods
3.2.1 Reagents
All chemicals, reagents and materials for routine cell culture, nuclear extraction, protein
quantification and DNA repair assays were purchased as stated in chapter (2), section (2.2.1).
Additionally, reagents for fatty acid treatment of cells and confirmation of intracellular
lipid accumulation were purchased from Sigma-Aldrich (Dorset, UK). Trypan Blue 0.4%
solution was purchased from Lonza (Slough, UK). Consumables for venepuncture and blood
collection were purchased from Bunzl Healthcare (London, UK).
3.2.2 Cell culture
Routine culture of HepG2 and Caco-2 cell lines was performed as described in chapter (2),
section (2.2.2). For cell variability and comparative analysis, HepG2 and Caco-2 cells were
harvested and extracted at six distinct passages (P15 - P20 HepG2; P57 - P64 Caco-2) to
produce independent replicates.
3.2.3 Fatty acid treatment
HepG2 cells were passaged and grown for 72 hours to approximately 70% confluence before
being treated with vehicle (BSA/dimethyl sulphoxide; DMSO), monounsaturated oleic acid
(OA), or saturated palmitic acid (PA) at final concentrations of 200µM, 300µM, or 400µM
[187]. For vehicle treatment, 5% w/v fatty acid free-BSA (FAF-BSA) was complexed with
10% v/v DMSO. For fatty acid treatments, 5% FAF-BSA was complexed with either OA
or PA at a final concentration of 2.5mM suspended in 10% v/v DMSO. Each solution was
complexed by incubating for one hour at 37°C, with vortexing every ten minutes. Each
solution was then sterile filtered by passing through a 0.2µM sterile filter, and used to prepare
treatment volumes of 9mL per T80 cell culture flask containing final concentrations of
200µM, 300µM or 400µM of OA or PA all at 2% v/v DMSO final concentration, or 2% v/v
DMSO by adding appropriate volumes of OA/FAF-BSA, PA/FAF-BSA and DMSO/FAF-
BSA to serum free DMEM (SF DMEM; DMEM supplemented with 100 units/ml penicillin,
100 units/ml streptomycin, 2mM L-glutamine, and 1x NEAA). The DMSO, OA, and PA-
containing media replaced the serum-containing DMEM culture media in the cell culture
flasks and HepG2 cells were incubated in a humidified atmosphere at 37°C with 5% carbon
dioxide for 24 hours.
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3.2.4 Cell viability assay
Cells were harvested after 24 hours of incubation with vehicle, OA or PA and a 10µ l aliquot
of cells suspended in DMEM was taken from each flask for viability assessment and counting.
The 10µl aliquot of cell suspension was mixed with 10µl of 0.4% Trypan Blue solution
and cells were counted and assessed for viability in duplicate using dye exclusion on an
automated TC20 Bio-Rad cell counter (Bio-Rad, Hercules, CA, USA).
3.2.5 Confirmation of intracellular lipid accumulation
A Nile Red staining assay was used to confirm intracellular lipid accumulation in HepG2
cells following 24 hour incubation with OA or PA [188]. Following cell harvesting and
counting, an aliquot of 5×105 cells were taken and centrifuged at 500×g for 10 minutes at
21°C. The supernatant was removed and each cell pellet was incubated for ten minutes with
1µM of the lipophilic fluorescent stain, Nile Red. Centrifugation at 500×g for ten minutes at
21°C was repeated and then the Nile Red supernatant was removed and the cell pellets were
resuspended in 500µ l of PBS, followed by 100µ l of each sample being pipetted in triplicate
into a black half-area 96-well plate. Fluorescence was read at excitation λ 485-12nm and
emission λ 520nm using an Omega Fluostar microplate reader.
3.2.6 Blood samples for optimisation protocols
A favourable ethical opinion for this work was obtained from the University of Surrey
Ethics Committee prior to the collection of blood samples, and all volunteers provided
written informed consent. A single non-fasted venous blood sample was obtained via
venepuncture from each of 13 adult volunteers, with volumes of 20 - 50ml collected into
K2EDTA vacutainers. For assay optimisation experiments, a pool of PBMC nuclear extract
taken from 11 of the individuals was used; for variability and activity correlation analyses,
repair activities in the PBMC extracts from 13 individuals were measured separately.
3.2.7 Intermittent vs. continuous energy restriction protocol
A weight loss intervention study was carried out by Dr Rona Antoni, full details of which can
be found here:[189]. Briefly, two different weight loss methods were compared for multiple
physiological and metabolic outcomes; continuous energy restriction (CER) or intermittent
energy restriction (IER). The CER intervention consisted of a daily caloric restriction of
2510kJ below each participant’s estimated energy requirements, and the IER intervention
involved normal euenergetic food consumption for five days of the week, and low calorie
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consumption for two consecutive days of the week (2638kJ total energy intake on the low
calorie intake days). Overweight and obese (BMI ≥25kg/m2), but metabolically healthy,
individuals (n = 24; see figure 3.1) were recruited and randomly assigned to either CER
or IER, and postprandial metabolic responses were measured at baseline and following 5%
reduction in overall body weight. A 10ml aliquot of fasted blood sample was taken from each
participant pre- and post- 5% body weight loss for DNA repair analyses via an indwelling
cannula into a K2EDTA vacutainer. As this study was powered for a primary outcome of
changes to postprandial lipaemia and a secondary outcome of postprandial glucose, in terms
of DNA repair activity changes this was a pilot study and likely underpowered for statistical
analysis.
3.2.8 Peripheral blood mononuclear cell (PBMC) isolation
PBMC were isolated from the samples using the OptiPrep™ method described previously
[190]. Briefly, whole blood was added to a working solution of density 1.216g/ml composed
of minimum essential medium (MEM) and Optiprep™, and then layered underneath a density
barrier of density 1.078g/ml composed of MEM and OptiPrep™. MEM was used for the top
layer of this density gradient. Tubes were then centrifuged at 700xg for 20 minutes at 22°C,
causing PBMCs to move up the density gradient and form a layer between the MEM and
density barrier layers. PBMCs were then isolated by removal from the density barrier and
adding to PBS, followed by further centrifugation at 500xg for 10 minutes at 22°C, before
aspirating the PBS to leave a cell pellet. PBMC pellets were stored at -80°C prior to nuclear
extraction and protein quantification.
3.2.9 Nuclear extraction and protein quantification of samples
Nuclear extraction and protein quantification of all cell pellets was performed as described in
chapter (2), section (2.2.3).
3.2.10 BER repair enzyme activity assays
Activity of the BER enzymes UNG, APE1, DNA polymerase, Polβ and DNA ligase, and AP
site repair were measured using the assays described in chapter (2), section (2.2). Briefly,
oligonucleotide substrate specific for the activity of each of the enzymes was prepared by
binding to each well of a Nunc® Immobiliser™ amino 96-well plate, in such a way that the
prepared oligonucleotide consisted of a double stranded, hairpin loop structure with a single
site of damage and a fluorescein marker at the 5’ end, bound to the plate by the 3’ end (for
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Figure 3.1. Flowchart to indicate recruitment, randomisation, group allocation and final
number per DNA repair activity assay group of participants in a randomised weight loss inter-
vention study (adapted from [189]). IER - intermittent energy restriction; CER - continuous
energy restriction; AP - apyrimidic/apurinic; APE1 - AP endonuclease 1; LLoD - lower limit
of detection.
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details see subsection (2.2.4) of chapter (2)). The substrate was then incubated with either
recombinant enzyme or nuclear extract for one hour at 37°C. Denaturation of the double
stranded oligonucleotide and cleavage of any abasic sites generated by glycosylases was
achieved using an alkaline denaturation buffer at 95°C. Fluorescein remaining on the plate
following enzyme treatment and denaturation was detected using an antibody to fluorescein
conjugated to HRP, converted to colour using a TMB HRP substrate system, the reaction
stopped with phosphoric acid and absorbance read at 450nm with an Omega fluostar plate
reader.
3.2.11 Data analysis
Nuclear extract enzyme activities were determined by interpolation from the recombinant
enzyme standard curve, fitted with Y = (S0e−xE0)+C for UNG and APE1 datasets, and
Y = S0(1− e−xE0) for DNA polymerase, DNA ligase, Polβ , and abasic site repair datasets.
Data are presented as mean ± SEM of n = 6 independent replicates for HepG2 and Caco-2
cell line data, mean ± SD of triplicate technical repeats for base pairing excision efficiency
experiments and PBMC optimisation standard curves, activity in U/µg of one enzyme plotted
against activity in U/µg of a separate enzyme for the HepG2, Caco-2, and PBMC correlation
data, mean ± SEM of n = 5 - 6 independent replicates for cell viability, intracellular lipid,
and UNG activity in HepG2 data, and mean ± SEM of n = 11 - 12 biological replicates for
weight loss intervention trial data. Differences between DNA repair enzyme activities in
Caco-2 and HepG2 cell lines were tested using a two-tailed, unpaired t test for each enzyme
assay. Correlations between enzyme activity of HepG2, Caco-2 and PBMC nuclear extracts
were tested for significant associations using Pearson’s correlation, with R2 and p values
reported for each set of data points. A significance value of p < 0.05 was set as there was no
apparent reason to break from convention for these datasets. The effect of fatty acid treatment
on viability, intracellular lipid, and UNG activity in HepG2 cells was tested using a one-way
ANOVA with Dunnett’s post-hoc test.
For the weight loss intervention trial, the change in DNA repair activity from baseline
to post 5% weight loss was calculated (∆ U/µg) for each enzyme measured and used as
the dependent variable in a multiple linear regression analysis (SPSS statistics software,
IBM). Independent variables were selected on the basis of biological relevance to DNA repair
activity as follows: sex, age, change in BMI from baseline to post 5% weight loss (∆ BMI),
DNA repair activity at baseline, and type of weight loss diet. Relationships between each
independent variable and the dependant variable were plotted as histograms or scatter plots
according to whether the independent variables were dichotomous or continuous and R2 and
p values were reported for each set of variables for each assay.
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3.3 Results
3.3.1 BER enzyme activity varied between two immortalised human
cell lines
Following experiments verifying the ability of the assay to detect individual DNA repair
enzyme activity within immortalised cell line nuclear extract in a concentration dependant
manner (chapter (2), figures 2.5C, 2.6C, 2.7C and 2.8C), the method was used to investigate
enzyme activity variability across cell lines. HepG2 and Caco-2 nuclear extracts were
produced across six distinct passages and UNG, APE1, DNA polymerase and DNA ligase
activity were assessed (figure 3.2).
The two cell lines showed some differences in enzyme activity at different stages of
the BER pathway. The Caco-2 nuclear extract had significantly higher UNG activity than
HepG2 cells (figure 3.2A), whilst the reverse was true of DNA polymerase and DNA ligase
activity (figure 3.2C and 3.2D). APE1 activity was not significantly different between cell
lines. In terms of variability in DNA repair activity within each cell line at different passages,
HepG2 nuclear extract had a 1.91-fold difference in UNG activity, a 1.61-fold (1.08-fold
without the outlier) difference in APE1 activity, a 1.75-fold difference in DNA polymerase
activity, and a 6.89-fold (3.51-fold without the outlier) difference in DNA ligase activity.
Caco-2 nuclear extract had comparative within-cell line variability with a 1.38-fold difference
in UNG activity, a 1.27-fold difference in APE1 activity, a 1.80-fold difference in DNA
polymerase activity, and a 2.18-fold difference in DNA ligase activity.
To further investigate this dataset, correlation analyses between each set of BER enzyme
activities were performed using Pearson’s correlation. No significant correlations were found
between any of the enzyme activities in either of the two cell lines when assessed in six
independent replicates from distinct passages of the cell lines (figure 3.3).
3.3.2 Glycosylase excision efficiency was affected by base pairing
When using the assay to measure enzyme activity in PBMC nuclear extract, the initial
experiment had to confirm that the assay could measure activity in a concentration dependant
fashion, as in the immortalised cell lines. To this end, a range of concentrations of a pooled
sample of PBMC nuclear extract were incubated with each of the oligonucleotide substrates
and figures were plotted to show that there was indeed a linear relationship between each
DNA repair enzyme activity and nuclear extract concentration (figure 3.5). However, when
measuring UNG activity in PBMC nuclear extracts, activity was undetectable until 10µg/well
(figure 3.4B), an impractically large amount of extract to obtain from human blood samples.
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Figure 3.2. Variability of BER enzyme activities in two immortalised human cell lines. (A)
UNG activity was significantly greater in HepG2 nuclear extract than in Caco-2 (p = 0.0002;
unpaired t test); (B) There was no significant difference between APE1 activity in HepG2 and
Caco-2 cell lines (p = 0.8201; unpaired t test); (C) DNA polymerase activity in HepG2 was
significantly higher than in Caco-2 nuclear extract (p = 0.0005; unpaired t test); (D) DNA
ligase activity was significantly higher in HepG2 than in Caco-2 nuclear extract (p = 0.0352;
unpaired t test). Black bars represent the mean ± SEM, filled circles represent n = 6
independent HepG2 replicates, open circles represent n = 6 independent Caco-2 replicates.
In the cell nucleus, UNG is responsible for excising uracil in DNA that occurs from
both misincorporation during DNA synthesis, and from the deamination of cytosine. These
two scenarios would mean that uracil would be found paired with either an adenine or a
guanine, respectively. Literature suggests that UNG excises uracil more efficiently from DNA
when it is paired with guanine rather than adenine [191], a biologically sensible hierarchy of
excision due to the downstream mutagenic effect of having a uracil in place of a cytosine
[192]. Therefore, the activity of UNG in PBMC nuclear extracts was measured using a
uracil opposite a guanine (URA03 + Loop01A), and a uracil opposite a guanine (URA03
+ Loop01G). The assay results were in agreement with the literature, with PBMC nuclear
extract exhibiting a 6.17-fold greater excision activity against a uracil base paired with a
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Figure 3.3. BER enzyme activities were not correlated in nuclear extract from HepG2 and
Caco-2 cell lines. (A) UNG activity was not significantly correlated with APE1 activity in
HepG2 (R2 = 0.44, p = 0.15) or Caco-2 (R2 = 0.21, p = 0.36) nuclear extract; (B) UNG
activity was not significantly correlated with DNA polymerase activity in HepG2 (R2 =
0.10, p = 0.54) or Caco-2 (R2 = 0.061, p = 0.64) nuclear extract; (C) UNG activity was not
significantly correlated with DNA ligase activity in HepG2 (R2 = 0.051, p = 0.68) or Caco-2
(R2 = 0.34, p = 0.22) nuclear extract; (D) APE1 activity was not significantly correlated with
DNA polymerase activity in HepG2 (R2 = 0.20, p = 0.38) or Caco-2 (R2 = 0.064, p = 0.63)
nuclear extract; (E) APE1 activity was not significantly correlated with DNA ligase activity
in HepG2 (R2 = 0.076, p = 0.60) or Caco-2 (R2 = 0.016, p = 0.81) nuclear extract; (F) DNA
polymerase activity was not significantly correlated with DNA ligase activity in HepG2
(R2 = 0.33, p = 0.23) or Caco-2 (R2 = 0.072, p = 0.61) nuclear extract. All datasets were
analysed using Pearson’s correlation. Filled circles - HepG2; open circles - Caco-2. APE1 -
AP endonuclease; BER - base excision repair; UNG - uracil DNA glycosylase.
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Figure 3.4. UNG activity on substrate containing a uracil paired to an adenine (U:A; closed
circles) or a uracil paired to a guanine (U:G; open circles). (A) Recombinant UDG enzyme
reduced signal from substrate to baseline levels at 3-fold lower concentration when acting on
a U:G compared to U:A; (B) PBMC nuclear extract reduced signal from substrate to 0.8AU
relative absorbance at 10-fold smaller concentration when acting on a U:G compared to U:A.
UDG - E. coli uracil DNA glycosylase; UNG - human uracil DNA glycosylase; PBMC -
peripheral blood mononuclear cells.
guanine compared to an adenine (figure 3.4). Hence, the URA03 + Loop01G substrate was
used for all subsequent experiments where UNG activity in PBMC nuclear extracts was
measured.
3.3.3 BER enzyme activities were correlated in PBMC nuclear extracts
from healthy volunteers
Blood samples were taken from male (n = 4) and female (n = 9) healthy volunteers with an age
range of 22 - 50. Serial dilution experiments for each enzyme were used to confirm that the
assay could be used to measure enzyme activity in primary human cells in a concentration-
dependant manner, and to select an appropriate concentration of PBMC nuclear extract
for each enzyme activity assay (2.50µg/well for UNG assay, 5ng/well for APE1 assay,
0.15µg/well for DNA polymerase assay, 0.50µg/well for DNA ligase assay; figure 3.5).
However, as BER enzyme activity has been shown to vary up to 10-fold between individuals
[193], a 5-times dilution of each nuclear extract concentration was also included on each
plate to ensure DNA repair enzyme activity was captured in any samples with markedly
greater activity than the pooled sample.
Following determination of the concentration of PBMC nuclear extract to apply to the
assay plate for each enzyme, the activity of each enzyme in the individual PBMC extracts was
determined. Correlation analyses found apparent positive correlations between the enzyme
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Figure 3.5. BER enzyme activity was detectable in a concentration-dependant manner
in a pooled sample of PBMC nuclear extract. (A) UNG excision activity of a U:G base
pair was linear in relation to PBMC nuclear extract concentration in the range 0.08µg -
10.0µg/well (R2 = 0.97); (B) APE1 activity was linear in relation to PBMC nuclear extract
concentration in the range 0.00039µg - 0.0125µg/well (R2 = 0.94); (C) DNA polymerase
activity was linear in relation to PBMC nuclear extract concentration in the range 0.004µg -
0.25µg/well (R2 = 0.99); (D) DNA ligase activity was linear in relation to PBMC nuclear
extract concentration in the range 0.04µg - 0.63µg/well (R2 = 0.98). Data shown represent
the mean ± SD of n = 3 technical replicates.
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activities at each stage of BER (figure 3.6). Significant positive relationships were observed
between APE1 and DNA ligase activities (p = 0.0044, figure 3.6E), and between DNA
polymerase and DNA ligase activities (p = 0.0121, figure 3.6F). No apparent relationship
was observed between APE1 and DNA polymerase activity (p = 0.1771, figure 3.6D). The
variation between individuals was, unsurprisingly, far greater than between cell line passages,
with a 5.56-fold difference across the PBMC dataset for UNG activity, a 3.62- fold difference
across the PBMC dataset for APE1 activity, a 5.69-fold difference across the PBMC dataset
for DNA polymerase activity, and a 6.33-fold difference across the PBMC dataset for DNA
ligase activity.
3.3.4 Exploratory studies into the relationship between caloric intake
and DNA repair activities in human cells
Fatty acid treatment did not affect UNG activity in HepG2 cells
A cell line model was used for initial observations concerning the relationship between
caloric availability, in the form of abundant fatty acids, and DNA repair activity. HepG2 cells
were treated with a concentration range of the fatty acids OA and PA, and effects on cell
viability and intracellular fatty acid levels were measured (figure 3.7A and 3.7B). Treatment
with 400µM OA or PA significantly decreased cell viability (p = 0.0258 and p = 0.0017,
respectively; one-way ANOVA with Dunnett’s post-hoc test) compared to cell viability when
cells were grown in serum free media.
A dose-response relationship was observed between increasing fatty acid in the treat-
ment media and intracellular lipid accumulation in HepG2 cells (figure 3.7B). Treatment
with 300µM and 400µM OA significantly increased intracellular lipid levels compared to
treatment with vehicle only (p = 0.0102 and p = 0.0002, respectively; one-way ANOVA
with Dunnett’s post-hoc test). Similarly, 300µM and 400µM significantly increased intracel-
lular lipid levels compared to vehicle treatment (p = 0.0003 and p = 0.0001, respectively;
one-way ANOVA with Dunnett’s post-hoc test).
No significant differences in UNG activity were detected between vehicle and any of the
fatty acid treated HepG2 cells as tested with one way ANOVA with Dunnett’s post-hoc test
(figure 3.7C); unfortunately, time and sample volume constraints did not allow for testing of
further BER enzyme activities.
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Figure 3.6. BER enzyme activities were correlated between some, but not all, enzymes of
the pathway in nuclear extracts from PBMCs. (A) UNG activity was positively correlated
with APE1 activity (R2 = 0.37, p = 0.03; Pearson’s correlation); (B) UNG activity was not
significantly correlated with DNA polymerase activity (R2 = 0.30, p = 0.053; Pearson’s
correlation); (C) UNG activity was positively correlated with DNA ligase activity (R2 =
0.66, p = 0.0008; Pearson’s correlation); (D) APE1 activity was not significantly correlated
with DNA polymerase activity (R2 = 0.16, p = 0.0044; Pearson’s correlation); (E) APE1
activity was positively correlated with DNA ligase activity (R2 = 0.54, p = 0.0044; Pearson’s
correlation); (F) DNA polymerase activity was positively correlated with DNA ligase activity
(R2 = 0.45, p = 0.01; Pearson’s correlation). APE1 - AP endonuclease; BER - base excision
repair; PBMC - peripheral blood mononuclear cell; UNG - human uracil DNA glycosylase.
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Figure 3.7. Fatty acid treatment of HepG2 cells reduced cell viability, increased intracellular
lipid levels, and did not affect UNG activity. (A) Twenty-four hour incubation of HepG2
cells with 400µM oleic acid and 400µM palmitic acid significantly reduced cell viability
compared to serum free media growth (p = 0.0258 and p = 0.0017, respectively; one-way
ANOVA with Dunnett’s post-hoc test); (B) Twenty-four hour treatment of HepG2 cells
with 300µM and 400µM of oleic acid and 300µM and 400µM palmitic acid significantly
increased intracellular lipid levels compared to vehicle (DMSO) treatment (p = 0.0102,
p = 0.0002, p = 0.0003 and p = 0.0001, respectively; one-way ANOVA with Dunnett’s
post-hoc test); (C) Twenty-four hour treatment with either oleic acid or palmitic acid did
not significantly affect UNG activity in HepG2 cells (one-way ANOVA with Dunnett’s
post-hoc test). Data shown as mean + SEM of 5 - 6 independent replicates. DMSO - dimethyl
sulphoxide; SFM - serum free media; Veh - vehicle.
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Characteristic measured
IER (n = 15) CER (n = 12) p value
Mean SEM Mean SEM IER v. CER*
Age (years) 42 4 48 3 0.289
Sex (n) 0.863
Male 7 6
Female 8 6
Ethnicity (n) 0.255
Caucasian 15 11
Black African 0 1
BMI (kg/m2) 29.8 0.9 30.8 1.1 0.482
Overweight/obese (n/n) 9/6 6/6 0.707
Body fat (%)** 34.8 2.2 37.5 2.0 0.385
Metabolic syndrome (n)*** 4 2 0.535
Table 3.1. Baseline characteristics for study completers of the intermittent energy restriction
(IER) and continuous energy restriction (CER) interventions (Mean values with their standard
errors; numbers of participants). *Unpaired t test or X2 (for ethnicity, metabolic syndrome
classification), **Bioimpedance, ***International Diabetes Federation criteria. Table taken
directly from Dr Rona Antoni and colleague’s article in the British Journal of Nutrition
[189]).
Effects of weight loss on DNA repair activities in human volunteers
With regards to study design and set up, no significant differences were found in baseline
characteristics of the participants who were randomised to the IER and CER intervention
groups and completed the study (table 3.1; data collected and analysed by Dr Rona Antoni).
As a primary purpose of this study was to confirm the viability of the novel DNA repair
assay for use in measuring DNA repair activities in human samples following an intervention,
the standard curves from each of the plates for each assay were assessed for reproducibility
and sensitivity by calculating the inter and intra-assay CVs and LLoD as in chapter (2) (table
3.2).
The standard curves had reasonable levels of reproducibility and the plate to plate
variation observed can be accounted for during the multiple linear regression analysis of the
samples. Importantly, only one sample had to be excluded for falling below the LLoD (AP
site repair assay) and all other samples tested were within the linear range of the standard
curves (figure 3.8).
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Figure 3.8. The standard curves generated to measure DNA repair activity in human samples
from a weight loss intervention trial. (A) APE1 recombinant enzyme standard curves. The
dot-dot-dash line indicates the highest data point from samples assayed on experimental days
1, 2, and 4; (B) Polβ standard curve constructed using HepG2 nuclear extract as the reference
repair activity; (C) T4 DNA ligase recombinant enzyme standard curves; (D) AP site repair
standard curve constructed using HepG2 nuclear extract as the reference repair activity. Data
shown as mean ± SD of triplicate technical repeats. Black circles and black lines represent
assays performed on experimental day 1, dark grey circles and dark grey lines represent
assays performed on experimental day 2, light grey circles and light grey lines represent
assays performed on experimental day 3, and open circles and dashed lines represent assays
performed on experimental day 4. Dotted vertical lines indicate the greatest lower limit of
detection from each of the 4 experimental days that each assay was performed on. The dotted
lines intersecting the x-axis indicate the highest calculated lower limit of detection for each
assay, and shaded areas contained within the dot-dash lines intersecting the x axis indicate
the spread of data from samples across the 4 experimental days. APE1 - AP endonuclease 1;
Polβ - polymerase β .
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Assay Lower LoD (U/well)1,2,3 Intra-assay CV (%)4,5,6 Inter-assay CV (%)7
APE1 0.006 ± 0.006 11 ± 6 74 (24)8
Polymerase β 0.010 ± 0.006 15 ± 5 10
DNA ligase 1.5×10−5±2.1×10−5 5 ± 2 27
AP site repair 0.056 ± 0.031 13 ± 3 14
Table 3.2. Sensitivity and reproducibility of DNA repair enzyme activity assays used to
measure DNA repair activity in samples from a weight loss human intervention trial. 1LoD
indicates limit of detection; 2Lower LoD calculated by interpolating enzyme activity at mean
absorbance at 0U enzyme minus 2× SD for APE1 assay, and mean absorbance at 0U enzyme
plus 2 × SD for DNA polymerase, DNA ligase and AP site repair assays; 3Mean ± SD of
lower LoD based on four individual analyses each of three technical replicates; 4HepG2 NE
quality control sample used for all assays; 5CV indicates coefficient of variation; 6Mean ±
SD of intra-assay CV based on four individual analyses each of eighteen technical replicates;
7Inter-assay CV calculated from assays performed on four independent plates; 8Number in
brackets indicates inter-assay CV when one outlier plate removed from calculations.
Multiple linear regression analyses on each of the DNA repair assays found no significant
predictive effect of age, sex, or ∆ BMI following weight loss on ∆ APE1, Polβ , DNA ligase
or AP site repair activity (figures 3.9, 3.10 and 3.11). Baseline DNA repair activity was found
to be a significant predictor of ∆ Polβ , DNA ligase and AP site repair activity following
weight loss, but not APE1 activity (figure 3.12). Weight loss regimen was a significant
predictor of ∆ Polβ activity following weight loss, but not APE1, DNA ligase, or AP site
repair activity (figure 3.13).
3.4 Discussion
3.4.1 The novel assay was successfully used to measure BER enzyme
activity in nuclear extract from PBMCs as well as immortalised
cell lines
As a newly developed method, it was important to demonstrate that the BER enzyme activity
assays introduced in chapter (2) could be used to measure various BER enzyme activities in
primary human cells, as well as the immortalised cell lines that the assays were developed
with. Importantly, the assay worked well with primary human cells, as shown by the linear
relationship between nuclear extract concentration and enzyme activity of AAG, UNG,
APE1, DNA polymerase, and DNA ligase (figure 3.5). The assays had a dynamic range that
revealed DNA repair enzyme activity variations of up to 6.33-fold within the nuclear extract
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Figure 3.9. Age did not predict change in DNA repair activity following weight loss. (A)
Change in APE1 activity following weight loss was not significantly predicted by age of
the participant (R2 = 0.212, p = 0.912, multiple linear regression); (B) Change in Polβ
activity following weight loss was not significantly predicted by age of the participant (R2 =
0.639, p = 0.581, multiple linear regression); (C) Change in DNA ligase activity following
weight loss was not significantly predicted by age of the participant (R2 = 0.471, p = 0.128,
multiple linear regression;. (D) Change in AP site repair following weight loss was not
significantly predicted by age of the participant (R2 = 0.466, p = 0.198, multiple linear
regression). AP - apurinic/apyrimidic; APE1 - AP endonuclease; Polβ - polymerase β ;
Closed circles - continuous energy restriction diet regimen; open circles - intermittent energy
restriction diet regimen.
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Figure 3.10. Sex did not predict change in DNA repair activity following weight loss. (A)
Change in APE1 activity following weight loss was not significantly predicted by sex of
the participant (R2 = 0.212, p = 0.755, multiple linear regression); (B) Change in Polβ
activity following weight loss was not significantly predicted by sex of the participant (R2 =
0.639, p = 0.155, multiple linear regression); (C) Change in DNA ligase activity following
weight loss was not significantly predicted by sex of the participant (R2 = 0.471, p = 0.755,
multiple linear regression); (D) Change in AP site repair following weight loss was not
significantly predicted by sex of the participant (R2 = 0.466, p = 0.486, multiple linear
regression). AP - apurinic/apyrimidic; APE1 - AP endonuclease; Polβ - polymerase β ; Black
bars represent mean ± SEM. Closed circles - continuous energy restriction diet regimen;
open circles - intermittent energy restriction diet regimen.
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Figure 3.11. Change in BMI following weight loss did not predict change in DNA repair
activity following weight loss. (A) Change in APE1 activity following weight loss was not
significantly predicted by the change in BMI following weight loss (R2 = 0.212, p = 0.442,
multiple linear regression); (B) Change in Polβ activity following weight loss was not
significantly predicted by the change in BMI following weight loss (R2 = 0.639, p = 0.851,
multiple linear regression); (C) Change in DNA ligase activity following weight loss was not
significantly predicted by the change in BMI following weight loss (R2 = 0.471, p = 0.622,
multiple linear regression); (D) Change in AP site repair following weight loss was not
significantly predicted by the change in BMI following weight loss (R2 = 0.466, p = 0.659,
multiple linear regression). BMI - body mass index; AP - apurinic/apyrimidic; APE1 -
AP endonuclease; Polβ - polymerase β ; Closed circles - continuous energy restriction diet
regimen; open circles - intermittent energy restriction diet regimen.
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Figure 3.12. Relationship between baseline DNA repair activity and change in DNA repair
activity following weight loss. (A) Change in APE1 activity following weight loss was
not significantly predicted by baseline APE1 activity (R2 = 0.212, p = 0.062, multiple
linear regression); (B) Change in Polβ activity following weight loss was significantly
predicted by baseline Polβ activity, with a negative correlation observed (R2 = 0.639, p <
0.0001, multiple linear regression); (C) Change in DNA ligase activity following weight
loss was significantly predicted by baseline DNA ligase activity, with a negative correlation
observed (R2 = 0.471, p = 0.002, multiple linear regression); (D) Change in AP site repair
following weight loss was significantly predicted by baseline AP site repair activity, with
a negative correlation observed (R2 = 0.466, p = 0.003, multiple linear regression). AP
- apurinic/apyrimidic; APE1 - AP endonuclease; Polβ - polymerase β ; Closed circles -
continuous energy restriction diet regimen; open circles - intermittent energy restriction diet
regimen.
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Figure 3.13. Relationship between method of weight loss and change in DNA repair
activity following weight loss. (A) Change in APE1 activity following weight loss was
not significantly predicted by weight loss regimen (R2 = 0.212, p = 0.953, multiple linear
regression); (B) Change in Polβ activity following weight loss was significantly predicted
by weight loss regimen, where CER appears to reduce Polβ activity in comparison to
IER (R2 = 0.639, p = 0.038, multiple linear regression); (C) Change in DNA ligase activity
following weight loss was not significantly predicted by weight loss regimen (R2 = 0.471, p=
0.185, multiple linear regression); (D) Change in AP site repair following weight loss was
not significantly predicted by weight loss regimen (R2 = 0.466, p = 0.158, multiple linear
regression). AP - apurinic/apyrimidic; APE1 - AP endonuclease; Polβ - polymerase β ; Black
bars represent mean ± SEM. CER - continuous energy restriction; IER - intermittent energy
restriction.
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of PBMCs from healthy volunteers, although there were two apparent outliers in the APE1
and DNA ligase activity datasets for the HepG2 cell line. With these outliers removed, the
maximum variation across the datasets was 3.51-fold, with an average variation of 1.86-fold,
which indicates fairly consistent BER enzyme activity in these cell lines as they replicate.
The BER enzyme activities of these cell lines were further investigated using correlation
analyses. No significant correlations were found between any of the enzyme activities assayed
in either of the HepG2 or Caco-2 cell lines; this lack of correlation was not unexpected
due to the lack of variability in the datasets. However, this was a fairly small dataset for
correlation analyses as some authors recommend a minimum sample size of n = 20 for robust
interpretation of Pearson’s correlation [194].
3.4.2 Distinct differences were found between BER enzyme activities
in different immortalised cell lines
When comparing the BER enzyme activity between two cell lines, there were significant
differences. Caco-2 cells had higher UNG activity and lower DNA polymerase and DNA
ligase activity than HepG2 cells. This would suggest that Caco-2 cells may be more suscep-
tible to adverse conditions such as uracil misincorporation, as the uracil would be quickly
excised and SSBs would be created, but not repaired by the action of DNA polymerase and
DNA ligase to as great an extent as the SSBs are created. Such an imbalance of repair would
be highly detrimental to the cell as the higher the level of SSBs, the greater the chance of
DSBs which could undermine genomic stability [18]. The flux through the BER pathway
and effects of enzyme activity alterations on SSB generation will be further explored during
the mathematical model construction in chapter (4). APE1 activity was not significantly
different between the two cell lines, but as this activity is comparatively much higher than
all other enzyme activities in the same amount of nuclear extract it is unlikely that small
changes in APE1 activity would affect overall flux through the pathway.
3.4.3 Uracil DNA glycosylase was found to have markedly different
excision activity against damaged bases with different base pairs
The glycosylase UNG was investigated in terms of its excision efficiency against uracil when
the substrate base was paired with different opposing bases in the DNA double helix. UNG
excised uracil most effectively when base paired with guanine rather than when paired with
adenine, a finding that was replicated with both recombinant E. coli UDG and human UNG
in PBMC nuclear extract.
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An interesting finding, which will be more fully explored in chapter (4), was that both
Caco-2 and HepG2 cell lines had detectable excision efficiency of U:A base pairs, but PBMC
nuclear extract had undetectably low activity against U:A compared to U:G base pairs. In the
cell environment, repair of U:G mispairs are more biologically important as they can lead to
C→ T transitions during DNA replication [192], whilst initiating repair of U:A base pairs
might not be as advantageous to genomic integrity as uracil will be continue to be paired to an
adenine during DNA replication and not cause downstream replication errors. Furthermore,
futile repair of U:A base pairs could increase SSB generation and thereby increase the risk of
DSB formation and chromosomal aberrations [18]. Therefore, the differences seen between
immortalised cells and primary human cells may result in a reduction of genomic integrity
in cancer cells compared to healthy cells, although more experiments would be required to
confirm this theory.
A potential explanation for the difference seen in base excision efficiency between the cell
types analysed here could be alterations in the uracil DNA glycosylase profiles between Caco-
2, HepG2 and PBMCs. As mentioned in table 1.2, chapter (1), there are four glycosylases
capable of excising uracil from DNA in human cells: UNG, SMUG1, TDG and MBD4, of
which UNG is predominant in proliferating cells [61]. UNG has been found to have greater
substrate specificity for U:G base pairs than U:A but not to the extent observed in the PBMC
nuclear extract here. However, TDG does excise uracil efficently from U:G mismatches
but not from U:A base pairs [195], and so it is a possibility that HepG2 and Caco-2 cell
lines have greater levels of UNG, whilst PBMCs have TDG as their predominant enzyme
to excise uracil; this may be due to the fact that PBMCs are not typically proliferative and
UNG is known to be more abundant in actively proliferating cells [196]. Again, further
experimentation to quantify the protein levels of each specific uracil DNA glycosylase in
each of the cell types assayed here would be required to test this hypothesis.
3.4.4 Correlations were found between different enzymes of the BER
pathway in primary human cells
To further test the assays, PBMCs were isolated from whole blood samples of 13 volunteers,
and nuclear extracts obtained. PBMCs are peripheral blood cells made up of lymphocytes and
monocytes; the lymphocyte fraction of T cells, B cells and NK cells comprises approximately
95% of PBMCs (of which T cells make up 70%) and the monocyte fraction comprises
approximately 5%. However, the cell composition of PBMCs can vary between individuals
with ranges of 48 - 77% T cells and 5 - 11% monocytes reported [197]. Whether non-
proliferative peripheral blood cells are the most representative of DNA repair capacity in a
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human has not been fully researched, and is beyond the scope of the current work; the use of
PBMCs was favoured for these studies as they are easy to obtain by taking blood through
venepuncture and as they are circulating cells, should be generally representative of overall
bodily DNA damage and repair level, as well as being commonly used in the literature for
the measurement of DNA repair capacity [130, 123, 131]. The volunteers were a reasonably
homogenous group, mostly made up of 21 - 28 year old females, with fewer males and older
individuals.
Despite the lack of obvious variation in the volunteer group, the enzyme activity found in
the PBMC nuclear extracts showed much greater inter-individual variation than was seen
between passages within the same cell lines, and matched previous published work; namely,
the finding that APE1, DNA polymerase, and DNA ligase activity varied by 3.62 - 6.33-fold
between individuals [193].
The correlations observed between APE1 and DNA ligase, and DNA polymerase and
DNA ligase activities is a novel finding due to no other assays being able to measure all these
enzyme activities in a comparable way before. These statistically significant correlations
provide novel evidence for a potential co-ordination between the different BER enzymes in
individuals, although more detailed mechanistic evidence is required to elucidate the reason
for these correlations in activity. There was no significant correlation between APE1 and the
next BER stage of DNA polymerase, an unexpected finding, especially due to the correlations
seen between the other enzyme activities.
Potential confounders for the correlations observed include artefactual relationships
between enzyme activity due to the PBMC isolation and nuclear extraction process, but the
likelihood of this was minimised by treating each blood sample in the same way; furthermore,
the finding that the HepG2 and Caco-2 independent replicate enzyme activities were not
correlated indicates that the correlation observed in the PBMC enzyme activity data is
unlikely to be artefactual.
An expansion of this work could include comparing DNA repair activities and correlations
of these healthy individuals with groups of people that should theoretically have unusual
DNA repair activity, such as cancer patients or DNA repair deficiency syndrome patients, to
ascertain any differences in overall activity levels and correlations between repair activities
in these subgroups. Ultimately, DNA repair activity has the potential to be developed into a
predictive biomarker for disease risk if links can be made between DNA repair activities and
correlations and the likelihood of specific diseases developing.
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3.4.5 Fatty acid treatment of HepG2 cells did not affect UNG activity
The fatty acid concentration range that HepG2 cells were treated with was selected as it
was previously found to have a significant effect on intracellular lipid levels without overt
toxicity [187], as well as being considered physiologically relevant when compared with
the typical estimations of 300 - 600µM free fatty acid (FFA) in plasma following overnight
fasting [198]. Monounsaturated OA (18:1) and saturated PA (16:0) are the most abundant
FFA of their category found circulating in human plasma, with an estimated contribution of
32.7 and 28.3 mol % total FFA, respectively [199]. Incubation of HepG2 cells with these
FAs has been used previously as a model of liver steatosis in the study of non-alcoholic fatty
liver disease (NAFLD; [187]); in the current work, the approach was primarily used as a
proof-of-principle that the novel assay format could be used to measure glycosylase activity
in cells following a nutritional intervention.
Cell viability was measured using a Trypan Blue dye exclusion approach, which was
selected due to the speed and ease of obtaining results, but it is not the most reliable
method to determine cell viability in general. In this case, the response of HepG2 cells to
treatment with OA and PA has been well characterised elsewhere using more robust cell
viability methodology [187] and so this viability result is considered reasonably representative
compared to previous data. Intracellular lipid accumulation was confirmed using a Nile
Red fluorescence assay, which is a validated method for measuring intracellular lipid in the
HepG2 cell line [187]. The findings in this work agreed with previous data in showing a clear
dose-response relationship between FA concentration and relative increase in fluorescence of
the lipophilic dye.
The finding that UNG activity was not significantly affected by fatty acid treatment can
perhaps be explained by the short duration of fatty acid treatment, as DNA glycosylase
activity may take longer than 24 hours to up- or downregulate. There are no comparative
studies of the effect of fatty acid treatment on UNG activity in HepG2 cells, but a study of the
DNA glycosylase hOGG1 in the human colorectal carcinoma cell line HCT116 found that
there was no effect of hydrogen peroxide treatment on hOGG1 mRNA expression or protein
level up to 24 hours post-treatment [200] which indicates that a longer duration of treatment
might be required to see an effect on DNA glycosylase activity. Another explanation for
the failure to see differences in UNG activity with fatty acid treatment was the choice of
glycosylase measured, as there is no direct evidence that intracellular lipid accumulation
affects uracil levels in DNA, which UNG is responsible for excising. Therefore, a valuable
addition to this set of results would have been a measurement of the effects of FA treatment
on DNA damage, in particular uracil levels in DNA, as there is currently no data available
to suggest the effects FA treatment has on different types of DNA damage on this cell line.
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Additionally, examining the effects of this treatment on further BER enzymes, particularly
Polβ activity, in these cells would have been interesting for comparison with the enzyme
activity data from the human weight loss trial.
3.4.6 DNA repair activities were differentially influenced by baseline
repair activity and weight loss method
The weight loss trial that samples were obtained from for DNA repair activity analyses was
well designed and unique as it is the first study of its kind to use percentage weight loss as
an endpoint for comparing intermittent fasting and continuous calorie restriction (IER vs.
CER). The use of percentage weight loss as the study endpoint is advantageous over more
traditional set length of time studies as it controls for different rates of weight loss between
individuals. As samples for DNA repair analysis were taken at baseline and post-5% weight
loss, paired datasets were generated to assess the effects of weight loss on overweight/obese
individuals losing weight through different methods. The intervention trial was designed to
detect changes in postprandial lipaemia following weight loss via the two methods as the
primary outcome, and as such was likely not adequately powered to detect changes in DNA
repair activity between weight loss groups. The most notable metabolic finding as a result of
the trial was a significantly greater reduction in postprandial triacylglycerol following IER
than CER [189].
With regards to DNA repair activity, APE1, Polβ , DNA ligase and AP site repair activities
were chosen to be assayed. As UNG activity had been assayed in HepG2 cells and found
to be unaffected by fatty acid treatment, and as the UNG assay requires a greater amount
of nuclear extract than the other DNA repair enzyme assays (figures 3.7C and 3.5) and the
nuclear extract obtained from the weight loss trial samples was limited, it was decided that
glycosylase would not be assayed in these samples. Ideally, OGG1 activity would have been
measured as this is the enzyme responsible for excising oxidised guanine, the main form of
DNA damage associated with oxidative stress, which in turn has been found to increase in
obesity [201]; however, the optimisation of the OGG1 assay proved to be beyond the time
frame of this project. APE1, Polβ , and DNA ligase are the individual steps downstream from
the initial glycosylase base excision, and so each of these were measured as well as complete
repair of an AP site in order to generate as much data as possible from the amount of sample
available.
Biologically relevant independent variables were included in multiple linear regression
analyses of the DNA repair activity data to examine whether they had any predictive power.
Age, gender, and ∆ BMI due to weight loss did not have any predictive effect on DNA repair
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activity following weight loss, potentially due to the low number of samples as age has been
previously shown to affect DNA repair capacity in relation to caloric restriction in rats [140],
and BMI in humans [202]. The finding that baseline repair activity significantly predicts ∆
activity for Polβ , DNA ligase and AP site repair activities, whereby the lower the baseline
repair activity value, the greater the positive change in repair following weight loss, could
be a useful tool for predicting the potential effect of weight loss on DNA repair based on
baseline DNA repair activity values. The significant predictive effect of weight loss regimen
on Polβ activity is potentially very interesting and merits more detailed investigation with
a larger sample size. Polβ was found to be increased following caloric restriction in rats
[140] but no study, in humans or otherwise, has investigated differential effects of weight
loss methods on DNA repair activity.
Chapter 4
Mathematical Model of Base Excision
Repair
4.1 Introduction
The focus of the current chapter is to model the BER pathway; BER presents a good system
for mathematical modelling as it is sufficiently tractable that modelling attempts are feasible
without requiring unusual computing power, but complex enough that a model can provide
new insights into the pathway. BER is a DNA repair pathway with a number of enzyme-
controlled steps, the ultimate purpose of which is to remove a single damaged base from DNA
and replace it with a structurally sound base. Replacement of damaged bases is essential for
genomic integrity, to prevent mutations in DNA, and other cytotoxic consequences. BER may
be modulated by many factors in the local cell environment and, as demonstrated in chapter
(3), BER enzyme activity can vary by 6-fold between apparently healthy individuals. This
observed variation could be due to lifestyle factors such as physical activity, nutrient intake
and subsequent status, as well as genetic factors [193]. Due to this, there is increasing interest
on the effect of different interventions on the BER pathway, as well as the consequences
of DNA repair enzyme activity on health status [69]. However, the multi-step nature of the
pathway may mean that increasing or decreasing the action of one enzyme of BER may not
correspondingly increase or decrease the overall rate of repair of DNA.
Establishing a mathematical model of the pathway is a useful tool to investigate the
contribution that each individual enzyme in BER makes to overall repair. The rate-limiting
enzymatic step can be identified and predictions can be made regarding the outcome of
altering the activity of each enzyme on total flux through the pathway. Furthermore, a
model of the pathway could predict levels of cytotoxic intermediates that could not be easily
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measured in a biological assay. In this way, the outcome of cellular variations in BER
can be more comprehensively assessed than by looking at their effect on individual enzyme
activity alone. For example, one of the enzymes involved in BER, polymerase β , is reportedly
downregulated under conditions of cellular folate deficiency [203], but the effect of decreased
polymerase β activity on overall repair of damage cannot be inferred from this information
alone.
In its simplest form, the BER pathway can be divided into the action of four main
enzymes, catalysing five reactions (figure 4.1). For the purposes of our model, it is assumed
that these enzymes react according to Michaelis-Menten kinetics. As in Sokhansanj and
colleagues BER model [168], the model described here also assumes deterministic chemical
kinetics and homogenous spatial distribution of repair reactions.
The work presented in this chapter demonstrates the parametrisation of a BER model
using enzyme activity rate data derived from the novel assay format described in chapter
(2), and the use of this model to: determine optimum reaction buffer conditions to maximise
repair, predict overall repair of lesions by human nuclear extracts based on individual enzyme
activity measurements, and compare repair profiles across different cell types and on differing
initial damage substrate. The hypothesis for this work is that cancer cell lines and primary
cells isolated from apparently healthy individuals will respond differentially to a site of
damage in a DNA substrate, but all cell types will have a common rate limiting step.
4.2 Methods
4.2.1 Biological measurement of total repair activity in human cells
Activity assays for total repair of substrate containing either a U:A base pair or U:G mispair
were performed as described in section (2.2) of chapter (2), using a concentration range of
pooled HepG2, Caco-2, or PBMC nuclear extract. Briefly, oligonucleotide substrate was
prepared by binding URA03 to each well of a Nunc® Immobiliser™ amino 96-well plate, and
annealing and ligating Loop01A or Loop01G in such a way that the prepared oligonucleotide
consisted of a double stranded, hairpin loop structure with a single site of damage and a
fluorescein marker at the 5’ end, bound to the plate by the 3’ end (for details see subsection
(2.2.4) of chapter (2). The substrate was then incubated with nuclear extract for a range of
time points from 30 minutes to 240 minutes at 37°C in a DNA repair reaction buffer (20mM
Tris-HCl pH 7.8, 100mM NaCl, 0.4mM EDTA, 3.4% v/v glycerol, 1mM DTT, 8mM MgCl2,
2mM ATP, 30µM of each of dATP, dCTP, dGTP and dTTP, and 1µg/ml herring sperm DNA).
Substrates were then treated with excess recombinant UDG (0.2U/well) to determine the
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Figure 4.1. The enzymatically mediated steps of BER labelled with the corresponding
notation used for constructing the ordinary differential equations. yi refers to substrate
species and ci refers to enzyme properties. Polβ - polymerase β , SSB - single strand break,
SNG - single nucleotide gap.
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percentage of substrate converted to UDG-resistant (repaired) complex by the nuclear extract,
before denaturation of the double stranded oligonucleotide and cleavage of any abasic sites
generated by UDG was achieved using an alkaline denaturation buffer at 95°C. Fluorescein
remaining on the plate following enzyme treatment and denaturation was detected using an
antibody to fluorescein conjugated to HRP, converted to colour using a TMB HRP substrate
system, the reaction stopped with phosphoric acid and absorbance read at 450nm with an
Omega fluostar plate reader.
4.2.2 Ordinary differential equations to describe BER
To create a mathematical model of a biological system, the simplest possible equations are
sought to begin the process. As discussed during section (1.7.1) of chapter (1), equations
to describe enzymatic reactions must consider the levels of E, S, ES, and P. Enzyme levels
are assumed to be constant throughout the reaction as demonstrated by equation (1.5). The
major assumption of Michaelis-Menten enzyme kinetics is that ES is also constant during the
reaction, known as a quasi-steady-state approximation as discussed previously. This leaves
equation (1.8) to describe substrate depletion and (1.9) to describe product accumulation.
These are non-linear equations due to the km +S division term, but a further assumption can
be made that S is very small in relation to km, and can be linearised using a Taylor expansion
to the following: km +S = km. This is a good approximation when S is very small in relation
to km, which is almost certainly the case for the enzymes in question here, and simplifies the
model. Furthermore, these linearised equations can be solved analytically. Therefore,
dS
dt
=−cS,S(0) = S0
and
dP
dt
= cS,P(0) = 0
where c = kcatE0km
At this point it is important to point out the solution of these linear equations:
S(t) = S0e−ct (4.1)
to find substrate concentration depletion over time and:
P(t) = S0(1− e−ct) (4.2)
to find product concentration accumulation over time.
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For the BER system of ODEs, c will be referred to as ci and the S term will be denoted
as yi from this point, both of which are shown in figure 4.1. Therefore, a simple system of
ODEs to describe substrate depletion and product accumulation in BER can be written as
follows:
dy1
dt
= −c1y1 (4.3)
dy2
dt
= c1y1− c2y2 (4.4)
dy3
dt
= c2y2− c3y3 (4.5)
dy4
dt
= c3y3− c4y4 (4.6)
dy5
dt
= c4y4− c5y5 (4.7)
dy6
dt
= c5y5 (4.8)
where the initial concentration of y1(0) = y1,0 and the initial concentration of yi0 = 0 where
i = 2,3,4,5,6.
4.2.3 Parametrisation of the BER model
To construct a model of BER, several unknown parameters must be found: ci, found from
kcat , E0, and km; and y1,0. Due to experimental limitations, y1,0 cannot be accurately found,
but to examine the behaviour of the system an assumption is made that initial substrate
concentration will not affect rates of subsequent reactions and so an arbitrary figure will be
used (y1,0 = 100) to match the biological data where initial substrate levels are considered as
100% damaged oligonucleotide.
Similarly, E0 cannot be accurately measured for each individual enzyme, and instead only
comparative approximations for each enzyme can be estimated. However, by measuring the
effect of each enzyme on a set amount of substrate for a known amount of time at increasing
concentrations of a cell extract containing an unknown amount of each specific BER enzyme,
an approximation of the kcatE0km function can be input to the model by expressing t as a function
of E0 in the exponential expression of equations (4.1) and (4.2) to give:
S(t) = S0e−cE0(t)+C (4.9)
P(t) = S0(1− e−cE0(t)) (4.10)
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Equation (4.9) was used to fit a curve to the UNG and APE1 biological data, and equation
(4.10) was used to fit a curve to gap filling, dRP lyase, and DNA ligase biological data. R2
values were calculated to test goodness of fit of the curves.
The c parameter of the curves describes the gradient of the slopes and so was used as the
activity rate, or ci for the parametrisation of the model. After finding these parameters, the
parameters had to be scaled to allow for the conversion from concentration based data to a
time dependent output in equations (4.9) and (4.10). To achieve this, each parameter was
multiplied by the concentration of cell extract used for the biological data (5µg/100µl) and
then divided by the time point at which the concentration data was collected (60 minutes). The
scaled parameters for each cell type were input to equations (4.1) - (4.6), which were solved
using the ode45 solver in Matlab (Natick, MA, US). In any instance where the biologically
derived parameter ci > 100, it was set to 100 in the Matlab software as the simulation could
not run with higher values than this. As any ci > 100 would not be rate-limiting in this
model this was assumed to not affect the overall model predictions. For Caco-2 and PBMC
cell types, there was no data generated for dRP lyase (c4), and so estimates were made for
these parameters using the activity ratio between gap filling and dRP lyase activities found in
HepG2 extract.
4.2.4 Reaction condition alteration experiments
For each assay, appropriate substrate was prepared as described in section (2.2.4) of chapter
(2) and incubated for one hour at 37°C with HepG2 nuclear extract. A concentration range of
HepG2 nuclear extract in the original DNA repair buffer (30mM Tris-HCl pH 7.8, 100mM
NaCl, 0.4mM EDTA, 3.4% v/v glycerol, 0.4mM DTT, 2mM MgCl2, 1µg/ml herring sperm
DNA) was included on each plate, with the addition of 2mM ATP and 10mM MgCl2 for the
DNA ligase assay, and 2mM ATP, 30µM of each dNTP and 0.05U T4 DNA ligase for the gap
filling and dRP lyase assays. A nuclear extract concentration was selected that would give an
absorbance value at the midpoint of the serial dilution of each assay under standard conditions
for all other wells of the plate (1µg/well for UNG, 0.005µg/well for APE1, 0.04µg/well for
gap filling, 0.5µg/well for dRP lyase and DNA ligase). The appropriate amount of nuclear
extract was diluted in DNA repair buffer with one component altered in each set of triplicate
wells for each assay. For specific values showing the alteration of each buffer condition, see
table 4.1. Following incubation with nuclear extract, the wells were decanted and washed
three times with PBST before alkaline denaturation and colorimetric detection of fluorescein
was performed using the protocol followed in section (2.2) of chapter (2). To determine the
effect of NaCl and MgCl2 on each enzyme, the apparent concentration of nuclear extract
under each condition was interpolated from the standard condition serial dilution of HepG2
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extract, and then expressed as a percentage change from the actual concentration incubated
in the wells for each enzyme. The biological datasets for NaCl and MgCl2, along with
additional buffer component changes to NAD, DTT, EDTA, and ATP concentration, were
converted to ci parameters by comparing the activity change of each BER enzyme assayed
under each buffer condition compared to standard reaction conditions. The parameter set for
each reaction condition change were input to the model in Matlab and the resultant predicted
effect on percentage of complete repair by 10µg/well HepG2 nuclear extract at the 60 minute
time point were generated.
4.2.5 Parameter estimation
Parameter estimation was performed using SimBiology software (Natick, MA, US) which
applied estimation of non-mixed effects with constrained nonlinear least-squares problems.
The BER model was input in order to replicate equations (4.3) - (4.8) and the ode45 solver
was selected. Biological data for complete repair of U:A and U:G containing substrates by
HepG2 and Caco-2 cell lines from 0 - 90 minutes were used to data fit the model, with all
parameters fixed at the biologically measured values except parameters c4 and c5. Biological
data at time points greater than 90 minutes was deemed unreliable and so was omitted from
the parameter estimation model to avoid confounding results. Any instances where estimated
ci > 100, meant that ci was set to 100 in the Matlab software as described in (4.2.3).
4.2.6 Individual PBMC sample model predictions
PBMCs from whole blood samples of 13 apparently healthy volunteers were obtained and
isolated as described in chapter (3), sections (3.2.6) and (3.2.8). Nuclear protein was then
extracted from the PBMCs as described in chapter (2), section (2.2.3). Enzyme activity
assays were used to determine UNG activity against a U:G mispair, APE1, gap filling, and
DNA ligase activity of each nuclear extract as described in chapter (2), section (2.2.4). For
these assays, UNG, APE1 and gap filling activities were found in a reaction buffer containing
2mM MgCl2, and DNA ligase activity was found in a buffer containing 10mM MgCl2.
Following determination of the enzyme activities in each nuclear extract, the apparent
concentration of nuclear extract of each individual compared to a pooled PBMC extract
was found by interpolating from a serial dilution of pooled PBMC extract for each enzyme
activity assay, and then expressed as percentage changed from the pooled PBMC nuclear
extract incubated in the wells for each enzyme. The ci parameter for each individual could
then be calculated as a change in ci compared to the pooled extract.
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Next, each ci parameter was altered to reflect estimated activity in 8mM MgCl2 buffer by
using the same ratio change in parameter value as was seen in the HepG2 extract between
2mM MgCl2 and 8mM MgCl2 for UNG, APE1, and gap filling assays, and between 10mM
MgCl2 and 8mM MgCl2 for the DNA ligase assay. The parameter for dRP lyase activity in
the PBMC nuclear extracts was then estimated by using the same 46.4-fold reduction from
gap filling to dRP lyase parameter observed in the HepG2 nuclear extract.
Finally, this estimated parameter set for each individual PBMC nuclear extract were input
to the model in Matlab and the resultant predicted effect on percentage of intact damaged
base, total SSBs, and complete repair by 10µg/well nuclear extract at the 60 minute time
point were generated.
4.3 Results
4.3.1 Effect of altering reaction conditions on activity parameters
A series of experiments were carried out to generate biological data demonstrating the effect
of different reaction conditions on enzyme activity. The effect of NaCl and magnesium (as
MgCl2) were large and affected the BER enzymes differentially (figure 4.2). For NaCl, a
reduction in concentration from the standard 100mM to 0mM increased UNG activity by
almost 300%. As NaCl concentration increased, there was a gradual decline in UNG activity,
with a low of approximately 20% of standard activity reached by 200mM NaCl. Conversely,
all other BER enzymes assayed showed a reduction in activity at NaCl concentrations
<75mM, with maximum activity found at 100mM for DNA ligase, and 150mM for APE1,
gap filling, and dRP lyase. The activity of all enzymes were inhibited to between 0 - 16%
of activity under standard conditions by an NaCl concentration of 300mM (figure 4.2A).
For MgCl2, a similar trend was seen regarding opposite effects of the compound between
UNG and all other BER enzymes assayed. For UNG, activity was highest at 0mM MgCl2,
and reduced with increasing magnesium concentration, with the exception of an unexpected
second peak in activity at 8mM MgCl2, to 31% of activity under standard conditions at
14mM MgCl2. This unexpected peak was suspected to be an anomaly caused by potential
experimental error, and so equation (4.9) was fitted to the UNG MgCl2 data to model an
expected response (shown as a red line on figure 4.2B). The other BER enzymes showed
low activity at 0mM MgCl2, with APE1, gap filling, and DNA ligase in particular showing
activity of 0 - 12% in the absence of magnesium. APE1 and dRP lyase showed similar
patterns of response to magnesium, with activity increasing initially to a maximum activity
between 4mM and 8mM MgCl2, before reducing in activity as magnesium concentrations
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rise above 10mM. DNA polymerase and DNA ligase did not appear to have any reduction in
activity at magnesium concentrations up to 14mM (figure 4.2B).
As the composition of the reaction buffer for the enzyme activity assays had profound,
and differential, effects on each of the BER enzymes, consequently the reaction buffer
affected intermediate build-up and overall repair of the substrate as predicted by the BER
model (table 4.1 and figure 4.3). Several buffer conditions caused complete inhibition of one
or more BER enzymes and so predicted repair at 60 minutes was 0%, including 0mM NaCl,
25mM NaCl, 300mM NaCl, 0mM MgCl2, and 4mM ATP. The maximal repair at 60 minutes
of 59.49% was predicted when MgCl2 concentration was 8mM, a modest increase compared
to the predicted repair with standard buffer of 52.15 - 56.85%. However, as previously noted
the UNG activity rise observed at 8mM MgCl2 could have been an anomaly, and so the
predicted repair using expected UNG activity at 8mM MgCl2 was also calculated and found
to be 52.95%, only a modest decrease compared to the model results using the actual UNG
activity parameter. As a result of these findings, the overall repair assays were carried out
in a DNA repair buffer containing 8mM MgCl2, 100mM NaCl, 2mM ATP, 1mM DTT, and
0mM NAD.
Where more than one enzyme parameter equalled 0 under the same buffer conditions, the
reaction that occurs first sequentially was denoted as the rate limiting step. The most common
rate limiting enzyme of the pathway was dRP lyase, which was rate limiting under standard
conditions as well as 50mM, 75mM and 300mM NaCl, 6 - 14mM MgCl2, 0.1mM and
0.3mM NAD, 0mM EDTA, and 2mM and 4mM ATP. Gap filling became rate limiting when
NaCl concentration was <50mM, and in the absence of magnesium. DNA ligase activity was
rate limiting at 150mM and 200mM NaCl, 4mM MgCl2, 0mM DTT, and 1mM ATP. The
activity parameters for UNG and APE1 were not rate limiting under any buffer condition,
and as a consequence of this the percentage of intact substrate containing a damaged base
remaining in the system after 60 minutes incubation with 10µg/well HepG2 nuclear extract
was universally low, with a maximum predicted value of 27.80% when NaCl concentration
was 300mM.
4.3.2 Predictive models of BER in three cell types
Parameter values for each individual enzyme activity in a standard DNA repair buffer
containing 8mM MgCl2 were obtained for pooled samples of HepG2, Caco-2, and PBMC
nuclear extract through either direct experimental measurement or numerical manipulation
using existing datasets for enzyme activity parameters in buffer containing 2mM and 10mM
MgCl2 (table 4.2). For each cell type, parameter values for UNG excising uracil from a
U:A base pair and a U:G base pair, APE1, gap filling, and DNA ligase were determined
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Figure 4.2. Effect of sodium and magnesium on BER enzyme activity in HepG2 nuclear
extract. (A) Increasing concentrations of sodium decreases UNG activity and increases
the activity of all other enzymes, with an apparent optimum concentration of 100mM for
DNA ligase, 150mM for APE1, gap filling, and dRP lyase and 50mM for UNG. By the
top concentration tested of 300mM NaCl, all enzymes have reduced activity compared to
100mM NaCl standard; (B) Magnesium is required by all enzymes except UNG, which
it inhibits. Solid black line = UNG; dashed black line = APE1; dotted black line = DNA
polymerase; solid grey line = dRP lyase; dashed grey line = DNA ligase; solid red line
= model of expected response of UNG to MgCl2 concentration. Data shown represent
the mean of triplicate technical repeats. UNG - human uracil DNA glycosylase; APE1 -
apurinic/apyrimidic endonuclease.
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Reaction component altered
Enzyme activity parameter (ci) Model prediction (%)
UNG1 APE1 Polymerase dRP lyase Ligase Damaged base intact2 Total SSB 3 Repaired base4
0mM NaCl 3.466 23.600 0.000 0.000 0.003 0.000 100.000 0.000
25mM NaCl 3.873 22.600 0.000 0.000 0.024 0.000 100.000 0.000
50mM NaCl 3.897 32.960 0.290 0.003 0.026 1.190×10−19 99.820 0.180
75mM NaCl 2.143 63.880 2.510 0.026 0.032 4.933×10−8 97.085 2.915
100mM NaCl 1.223 233.290 5.985 0.144 0.333 4.882×10−4 44.538 55.462
150mM NaCl 0.664 524.310 12.934 0.245 0.062 0.131 74.982 24.887
200mM NaCl 0.186 160.660 7.143 0.101 0.036 15.567 79.331 5.1019
300mM NaCl 0.128 8.530 0.386 0.000 0.015 27.804 72.196 0.000
0mM MgCl2 2.054 32.800 0.000 0.057 0.000 0.000 100.000 0.000
2mM MgCl2 1.267 379.550 3.861 0.152 0.033 5.843 87.242 6.616
4mM MgCl2 0.698 540.930 5.695 0.156 0.143 0.093 64.326 35.581
6mM MgCl2 0.408 474.450 9.749 0.159 0.223 1.691 57.744 40.566
8mM MgCl2 (actual) 0.755 384.750 9.556 0.206 0.275 0.053 40.463 59.485
8mM MgCl2 (predicted) 0.442 384.750 9.556 0.206 0.275 1.203 45.849 52.948
10mM MgCl2 0.520 273.950 9.942 0.129 0.262 0.552 58.112 41.337
12mM MgCl2 0.302 155.560 9.556 0.100 0.287 4.880 65.253 29.867
14mM MgCl2 0.252 104.210 8.108 0.093 0.302 8.046 65.436 26.518
0.1mM NAD 2.294 431.180 6.564 0.066 0.115 1.090×10−8 80.470 19.530
0.3mM NAD 1.579 400.320 6.274 0.077 0.132 1.388×10−5 76.593 23.407
0mM DTT 1.607 561.200 3.958 0.100 0.037 1.049×10−5 89.650 10.350
0mM EDTA 2.081 95.510 3.958 0.024 0.025 9.169×10−8 97.782 2.219
1mM ATP 1.360 147.590 6.274 0.168 0.097 1.241×10−4 68.284 31.716
2mM ATP 1.385 97.780 3.861 0.127 0.347 9.661×10−5 47.848 52.152
4mM ATP 2.066 41.490 0.869 0.000 0.144 0.000 100.000 0.000
U:A bp 0.284 277.000 3.861 0.127 0.347 5.843 57.828 36.330
Table 4.1. The effect of altering reaction conditions on the enzyme activity parameters,
and predicted repair output after 60 minutes. The rate-limiting enzyme parameter under
each buffer condition is highlighted in bold.1UNG activity to excise uracil opposite guanine,
unless otherwise stated. 2Total amount of substrate predicted by the model to have intact
damaged base following 60 minutes incubation with 10µg/well of HepG2 nuclear extract.
3Total amount of single strand break (SSB) repair intermediates predicted by the model
following 60 minutes incubation of the damaged substrate with 10µg/well HepG2 nuclear
extract. 4Repair predicted by the model by 10µg HepG2 nuclear extract following 60 minutes
incubation with the damaged substrate.
4.3 Results 103
(A)
(B)
Figure 4.3. Modelled predictions of the effect of sodium chloride and magnesium on
repair profiles in HepG2 nuclear extract. (A) Predicted total SSBs are minimised and
predicted overall repair is maximised at 100mM sodium chloride; (B) Predicted total SSBs
are minimised and predicted overall repair is maximised at 8mM magnesium. Black line =
intact damaged base; blue line = total SSBs; red line = repaired base. BER - base excision
repair; SSB - single strand break.
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biologically. Additionally, for HepG2 nuclear extract, parameter values were determined
biologically for dRP lyase.
The UNG parameter for excision of uracil from a U:A base pair was lower than that
found for excision of uracil from a U:G base pair by 2.75-fold for HepG2, 4.72-fold for
Caco-2, and 138-fold for PBMC nuclear extract, agreeing with the biological data in chapter
(3), section (3.3.2). Caco-2 nuclear extract had a higher parameter value for UNG activity
on both types of lesion than both HepG2 and PBMC. For APE1 activity, the parameters for
all three cell types were markedly higher than for all other enzymes, agreeing with the very
high activity of this enzyme seen in the biological data (chapter (2), section (2.3.3)). As with
the UNG (U:A) parameters, Caco-2 nuclear extract had the highest APE1 parameter value
in comparison to HepG2 and PBMC. The APE1 parameter values for HepG2 and PBMC
nuclear extract were similar, with HepG2 having the lowest APE1 parameter value of the
three cell types.
The gap filling parameter was very similar between HepG2 and PBMC nuclear extracts,
with HepG2 having a slightly higher parameter value of 9.556 compared to the PBMC
parameter value of 9.306. Caco-2 nuclear extract had an approximately 4.0-fold lower gap
filling parameter value than both HepG2 and PBMC nuclear extract.
HepG2 nuclear extract was the only cell type to have biological experimental data
available to find a dRP lyase parameter value, and the parameter for this enzyme was the
lowest out of the five BER enzymes assayed for this cell type at 0.206. For Caco-2 and
PBMC, time constraints meant that dRP lyase assays were not carried out but instead it was
assumed that the ratio between gap filling and dRP lyase activities would be the same as
for HepG2 at 46.4-fold lower dRP lyase parameter than gap filling parameter. Predicted
dRP lyase activities were calculated accordingly at c4 = 0.050 for Caco-2 and c4 = 0.201
for PBMC nuclear extract.
For DNA ligase, HepG2 had the lowest parameter value with Caco-2 having a slightly
higher but similar value and PBMC having 4.88-fold higher DNA ligase activity than HepG2.
Overall, dRP lyase appears to be rate limiting in HepG2 and Caco-2 nuclear extract, with
excision of a uracil from a U:A base pair the rate limiting parameter in PBMC nuclear extract.
With regards to the curve fit to the biological data for HepG2 enzyme activity, all enzymes
assayed showed a very good fit of data to curves (4.9) and (4.10) (r2 > 0.90) with the exception
of the curves fitted to dRP lyase data (r2 < 0.65).
The differences between the cell types and uracil excision specificity can also be seen in
the model output for each set of data (figure 4.4). In figure 4.4 each stage of the BER pathway
is represented as percentage of total material over time. Damaged DNA (y1) is shown as an
exponential decay curve, whilst repaired DNA (y6) increases over time in accordance with
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Cell type Assay R2 ci t adjusted ci1
HepG2
UNG (U:A)2 0.988 0.275 0.023
UNG (U:G) 0.972 0.755 0.063
APE1 0.988 384.750 32.063
Gap filling 0.984 9.556 0.796
dRP lyase 0.637 0.206 0.017
DNA ligase 0.991 0.275 0.023
Caco-2
UNG (U:A) - 0.506 0.042
UNG (U:G) - 2.386 0.199
APE1 - 9.32×107 7.77×106
Gap filling - 2.354 0.196
dRP lyase3 - 0.050 0.004
DNA ligase - 0.324 0.027
PBMC
UNG (U:A) - 0.002 0.000
UNG (U:G) - 0.237 0.020
APE1 - 466.006 38.834
Gap filling - 9.306 0.776
dRP lyase4 - 0.201 0.017
DNA ligase - 1.346 0.112
Table 4.2. Parameter values for BER enzyme activities of three cell types under identical
reaction conditions. Values for HepG parameters were found by fitting curves to biological
data and using the gradient of the curve as a proxy for enzyme activity. Values for Caco-2
and PBMC nuclear extract were estimated by scaling parameter values for each respective
cell type found under differing buffer conditions (2mM MgCl2 for all enzymes except DNA
ligase, which was 10mM MgCl2) using the same fold-change as was observed between 2mM
or 10mM MgCl2 and 8mM MgCl2 for each HepG2 enzyme parameter. 1Each parameter was
adjusted to account for the amount of nuclear extract used in the time course experimental
data by multiplying by the nuclear extract concentration (5.0µg/well) and dividing by the
time point that parameters were derived from (60 minutes). 2UNG excision activity against
a U:A base pair was not measured in 8mM MgCl2 and so this was estimated by applying
the ratio of U:A to U:G excision activity of UNG in 2mM MgCl2.3,4dRP lyase activity was
not directly measured for Caco-2 and PBMC cell types, and so this was estimated using the
same fold-change as was observed between DNA polymerase and dRP lyase activity for the
HepG2 enzyme parameters.
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Figure 4.4. Predicted rates of appearance and disappearance of substrate (y1), intermediates
(y2− y5) and final product (y6) of the BER pathway. (A) HepG2 nuclear extract acting on a
U:G mispair; (B) HepG2 nuclear extract acting on a U:A base pair; (C) Caco2 nuclear extract
acting on a U:G mispair; (D) Caco2 nuclear extract acting on a U:A base pair; (E) PBMC
nuclear extract acting on a U:G mispair; (F) PBMC nuclear extract acting on a U:A base
pair. Black solid line = y1; black dashed line = y2; black dotted line = y3; grey solid line = y4;
grey dashed line = y5; red solid line = y6; blue solid line = y3 + y4 + y5 (total SSB-containing
intermediate species). PBMC - peripheral blood mononuclear cell; SSB - single strand break.
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Michaelis-Menten enzyme kinetics. The results depicted in the plot are in agreement with
expected results based on what is known about the pathway.
For HepG2 nuclear extract, initial substrate (y1) is depleted to <1% of total material by
the action of glycosylase (c1) in less than half the time when the initial substrate is U:G
than when the substrate is U:A (75 minutes compared to 202 minutes, respectively). The
difference in the effect of the first enzyme activity parameter leads to differences in the rest
of the pathway with regards to intermediate build-up and the appearance of repaired DNA.
y2 levels begin at the same point as y1 but reduce to 0 much more quickly, reflecting the
high activity parameter of AP endonuclease (c2). In terms of cellular consequences, the
y3,y4, and y5 intermediates all present as SSBs, and so for the purposes of clarity, these
were grouped together for comparison between cell lines, although the exact predicted levels
of each species can be examined in figure 4.4. When HepG2 extract is acting upon a U:G
substrate, the predicted maximum combined amount of SSB intermediate in the system is
82.46%, which occurs at minute 41, whereas when the initial substrate is U:A, the maximal
SSB is 62.83%, which occurs at minute 68. Overall, more repaired substrate is predicted
when HepG2 nuclear extract is acting on a U:G mispair compared to a U:A base pair, at
92.77% and 86.50% at 240 minutes, respectively.
For Caco-2 nuclear extract, the ode45 solver was unable to complete the model simulation
initially due to the extremely high c2 parameter (shown in table 4.2). As c2 is non-rate limiting
in any of the nuclear extracts characterised, the APE1 parameter was reduced to match the c2
parameter of the next highest cell type (PBMC; t adjusted c2 = 38.834) in order to complete
the simulation and compare Caco-2 repair activity to the other two cell types. To confirm
that this would have no unexpected effects on the model output, numerical experiments were
carried out in Matlab where c2 was varied incrementally and effects on the model output
compared. This found that as long as t adjusted c2 > 5.42, no effect was seen on the initial
substrate, intermediate species, or final product predictions in the model output (data not
shown).
The model output for Caco-2 nuclear extract differs considerably from the HepG2 models.
Substrate depletion by c1 in Caco-2 nuclear extract is more rapid than in the HepG2 model
for both types of initial substrate, as expected due to the higher numerical values found for
the c1 enzyme activities. The time taken for Caco-2 nuclear extract to deplete c1 levels to
<1% of the species in the system was 25 minutes for a U:G mispair and 111 minutes for a
U:A base pair, so as well as faster removal of c1 by Caco-2 than by HepG2, there was also a
a greater increase in the rate of removal of this species when excising a U:G compared to a
U:A, with c1 being reduced to <1% 2.69-fold faster in the U:G system compared to the U:A
system by HepG2 extract, and 4.44-fold faster by Caco-2 extract.
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As previously mentioned, c2 is so much greater in comparison to all other enzyme activi-
ties it does not affect intermediate generation or overall repair in any cell type investigated.
With regards to SSB accumulation in the Caco-2 model, the parameters calculated for c3 and
c4 were markedly lower in Caco-2 than in HepG2, causing a much greater build-up of the y4
and y5 intermediate species level in the Caco-2 cell type. In total, there were 98.10% SSB
intermediates at minute 26 of the model prediction for U:G repair, and 87.56% at minute
71 for U:A repair. Finally, the c5 parameter for Caco-2 was similar to the c5 parameter for
HepG2. Repaired product (y6) was generated by Caco-2 extract to a maximum of 53.02%
and 49.17% for U:G and U:A repair at 240 minutes, respectively.
For PBMC nuclear extract, the parameter for UNG activity on a U:A substrate equals 0,
and this is reflected in the model output which shows no reduction in y1 after 240 minutes,
and a corresponding lack of total repaired y6 product. There is no build-up of intermediates
in this model due to the lack of y2 substrate (figure 4.4F). Conversely, the model predictions
for PBMC extract acting on U:G substrate are markedly different to both the U:A repair
by PBMC, and the model predictions for HepG2 and Caco-2 cell lines, and show a slow
depletion of c1 to <1% by 232 minutes. Peak SSB levels were also predicted as lower in the
PBMC models than in either of the cell lines, with a maximum of 46.49% at minute 57. The
y6 output was joint highest out of all cell lines with 92.12% at 240 minutes (figure 4.4E). The
differences in individual enzyme parameters between PBMC, HepG2 and Caco-2 cell types
led to observably different repair profiles, with PBMCs showing the least, and Caco-2 having
the greatest, accumulation of SSB-containing repair intermediates.
4.3.3 Comparison of model predictions with biological data
The next step of the mathematical modelling process was to verify the model output pre-
dictions with biological data. Biological assay data was available for y6 for 5.0µg/well of
HepG2, Caco-2, and PBMC nuclear extract acting on both a U:A base pair and U:G mispair
over a time course of 240 minutes, and so this was compared with the model predictions for
the same data sets (figure 4.5).
For HepG2 and Caco-2 cell lines, the mathematical model under-estimated the percentage
of total repair compared to biological data, particularly at earlier time points. At the 60
minute time point, the percentage of total repair was underestimated by 71.13% for HepG2
repairing U:G and 42.62% for HepG2 repairing U:A (figures 4.5A and 4.5B), and by 44.49%
for Caco-2 repairing U:G and 30.61% for Caco-2 repairing U:A (figures 4.5C and 4.5D).
For PBMC data, the model overestimated repair of a U:G mispair by 20.29% (figure 4.5E),
but accurately predicted the repair (or lack thereof) of a U:A base pair with only 3.95%
difference between the model prediction and biological data (figure 4.5F).
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Figure 4.5. A comparison of model output prediction (y6) with biological data from the
complete repair assay of uracil opposite either adenine or guanine in three cell types. (A)
HepG2 nuclear extract acting on a U:G mispair; (B) HepG2 nuclear extract acting on a U:A
base pair; (C) Caco2 nuclear extract acting on a U:G mispair; (D) Caco2 nuclear extract
acting on a U:A base pair; (E) PBMC nuclear extract acting on a U:G mispair; (F) PBMC
nuclear extract acting on a U:A base pair. Black circles = biological data; red solid line =
model prediction. PBMC - peripheral blood mononuclear cells.
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4.3.4 Estimation of mathematical parameters to improve model fit to
biological data
Following the marked underestimation of total repair activity by the model compared to
the biological data (figure 4.5), parameter estimation was carried out to improve the fit of
the model to the biological data and identify which enzymatic steps of BER are potentially
responsible for the discrepancies observed between the model and biological data. As PBMC
nuclear extract did not appear to be able to repair any DNA lesions under the experimental
conditions used, HepG2 and Caco-2 cell line biological data are the focus of this analysis.
Biological knowledge was used in the selection of which enzyme parameters to designate
as variable in the parameter estimations. The hypothesis for this section was that the model
was underestimating repair due to cooperativity between enzymes which was not captured
when assaying individual enzymes; notably, this is the identical problem that Sokhansanj and
colleagues encountered when using purified enzyme parameters to predict abasic site repair.
Due to this, the UNG parameter was not altered as this is the first step in the pathway and so
should not be affected by cooperativity as there are no enzymes before it to enhance activity
or ‘pass the baton’ on from. The APE1 and gap filling parameters were discounted as they
had much higher activity than UNG, dRP lyase and DNA ligase and so did not affect overall
repair if increased even by 10-fold (data not shown). This left dRP lyase and DNA ligase
activity parameters as likely candidates to affect overall repair if altered.
The parameter estimation software estimated the c4 parameter to be the rate limiting
step for both cell lines acting on both types of damage, in agreement with the measured
parameter values. The c4 parameter was estimated to be 13.3-fold greater than the measured
value for HepG2 acting on a U:G mispair and 2.7-fold greater than the measured value for
HepG2 acting on a U:A base pair. For the Caco-2 cell line, the c4 parameter was estimated to
be 4.6-fold greater than the measured value when acting on a U:G mispair, and 3.25-fold
greater than the measured value when acting on a U:A base pair (table 4.3). The estimated
parameters for c5 were extremely high as c4 was rate limiting and so for the fitting process
the actual c5 value was considered unimportant as long as it was non-rate limiting. As the
parameter estimation software made the c5 parameters markedly higher than necessary to
become non-rate limiting, a large discrepancy is seen between estimated and actual parameter
values for DNA ligase. The parameter estimation data is preliminary at this stage and further
experimentation is needed to refine these results, which could not be completed within the
timeframe of this project.
When the overall BER model was run for each cell line and initial damage type, the
overall rate of repair shown by y6 was much closer to the measured values for overall repair
(figure 4.6). In particular, the data modelled for the Caco-2 cell line with the estimated
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Cell line Initial damage
c4 c5
Measured Estimated Measured Estimated
HepG2
U:G 0.017 0.133 0.023 3.29×1010
U:A 0.017 0.046 0.023 3.08×106
Caco-2
U:G 0.004 0.018 0.027 0.110
U:A 0.004 0.013 0.027 2.62×103
Table 4.3. Parameters for c4 and c5 as measured biologically and estimated by Simbiology
software.
parameter values very closely matched the biological data, with complete repair of a U:G
mispair measured at 70.6% and estimated at 71.2%, and complete repair of a U:A base pair
measured at 50.95% and estimated at 52.3% (figures 4.6C and 4.6D). For the HepG2 cell line,
the adjusted estimated parameter model slightly underestimated repair at 90 minutes, with
complete repair of a U:G mispair measured at 89.1% and estimated at 99.2%, and complete
repair of a U:A base pair measured at 65.3% and estimated at 75.1% (figures 4.6A and 4.6B).
4.3.5 DNA repair capacity predictions in individuals based on individ-
ual enzyme activity data
To demonstrate the potential usefulness of the mathematical model constructed here, biolog-
ical enzyme activity data for UNG, APE1, DNA polymerase, and DNA ligase activity in
PBMC nuclear extract from 13 apparently healthy volunteers (see chapter (3), figure (3.6))
was converted into ci parameters, in order to input to the model. Values for intact base, total
SSBs, and repaired substrate generated by 10µg/well PBMC nuclear extract following 60
minutes incubation were generated in order to compare DNA repair capacity between the
individuals (table 4.4). The model predicted variable repair profiles across the dataset, with
intact uracil estimated to range between 6 - 69%, total SSBs estimated to range between 25 -
67%, and an estimated 13.5-fold variation in total substrate repaired by the PBMC nuclear
extract from apparently healthy volunteers.
4.3 Results 112
(A) (B)
(C) (D)
Figure 4.6. BER model fit to biological data following parameter estimation by SimBiology.
Biological data at time points greater than 90 minutes was deemed unreliable and so was
omitted from the parameter estimation model to avoid confounding results. (A) Biological
data and model predictions for total repair of a U:G mispair by HepG2 nuclear extract
(c4 = 0.133,c5 = 100); (B) Biological data and model predictions for total repair of a U:A
base pair by HepG2 nuclear extract (c4 = 0.046,c5 = 100); (C) Biological data and model
predictions for total repair of a U:G mispair by Caco-2 nuclear extract (c4 = 0.018,c5 = 100);
(D) Biological data and model predictions for total repair of a U:A base pair by Caco-2
nuclear extract (c4 = 0.013,c5 = 100). Closed circles - biological data; red solid line - model
prediction.
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Sample ID
Model prediction (%)
Damaged base intact1 Total SSB 2 Repaired base3
1 16.530 67.248 16.222
2 23.693 46.917 29.390
3 48.675 31.480 19.845
4 48.675 39.002 12.325
5 40.657 52.326 7.017
6 69.768 25.931 4.302
7 61.878 33.580 4.542
8 5.287 46.100 48.614
9 26.714 51.155 22.131
10 9.072 50.985 39.943
11 28.365 42.196 29.438
12 31.982 58.216 9.802
13 51.685 44.702 3.613
Table 4.4. Predicted rates of repair intermediate generation and overall repair by 13 individual
PBMC nuclear extracts. 1Total amount of substrate predicted by the model to have intact
damaged base following 60 minutes incubation with 10µg/well of PBMC nuclear extract.
2Total amount of single strand break (SSB) repair intermediates predicted by the model
following 60 minutes incubation of the damaged substrate with 10µg/well PBMC nuclear
extract. 3Repair predicted by the model by 10µg PBMC nuclear extract following 60 minutes
incubation with the damaged substrate.
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4.4 Discussion
4.4.1 Assay buffer composition has large effects on overall model pre-
dictions
To produce high quality biological data for obtaining modelling parameters, a universal
buffer for each enzyme activity assay was desired in order to maintain consistency between
individual enzyme activity measurements and total repair assay conditions. To this end,
experiments were designed using pooled HepG2 nuclear extract in a range of buffers based
on the standard DNA repair buffer described in chapter (2), with one component altered in
each set of wells. The buffer components altered for these experiments were NaCl, MgCl2,
NAD, DTT, EDTA, and ATP. MgCl2 concentration is of particular biological relevance as
glycosylases are often inhibited by magnesium, but it is a required element for the function
of other BER enzymes including APE1 and Polβ [204].
MgCl2 had differential effects on different BER enzymes, as expected based on the
literature [204, 205]. For UNG activity, a gradual reduction in activity parameter was
observed as MgCl2 concentration increased, with the exception of a slight increase in activity
at 8mM MgCl2. This anomalous result caused an increase in predicted repair at 8mM
MgCl2. To account for a potential error in this measurement, a curve was fitted to the
data showing the effect of MgCl2 on UNG activity and used to predict repair if the activity
parameter had followed the trend shown by the rest of the data. The resultant predicted
overall repair was 52.95% repair at 60 minutes, which was a modest reduction of 6.54%. For
all other enzymes of the BER pathway measured, activity parameters increased as MgCl2
concentration increased. Based on the parameters found and the model prediction for overall
repair, a DNA repair buffer containing 8mM MgCl2 was used for subsequent total repair
assays.
When altering NaCl concentrations in the reaction buffer, again differential effects were
observed between the BER enzymes. UNG had high activity from 0 - 50mM, but then began
to drop as the NaCl concentration rose. All other enzymes required at least 50 - 75mM NaCl
for their function, with most peaking in activity at 150mM NaCl. However, DNA ligase
appeared to be highly sensitive to NaCl concentration, with a peak at 100mM but otherwise
fairly low activity, meaning that subsequent assays were always carried out in 100mM NaCl
reaction buffer.
Each enzyme activity parameter was calculated in the presence or absence of NAD in
order to allow PARP activity; there did not appear to be any positive effect, with both NAD
concentrations causing a predicted approximately 30% reduction in overall repaired base after
4.4 Discussion 115
60 minutes incubated with 10µg HepG2 nuclear extract. Therefore, subsequent experiments
did not use NAD in the reaction buffer.
The reducing agent DTT was removed from the reaction buffer to assess the effect on
enzyme activity parameters and overall repair. The removal of DTT caused the rate limiting
step to switch from dRP lyase to DNA ligase, and reduced overall repair of bases to 10.35%,
so DTT continued to be included in the reaction buffer.
EDTA is a chelating agent and the removal of it from the reaction buffer caused a
reduction in overall repair of a damaged base to 2.22% by reducing the activity parameter
of dRP lyase, which remained the rate limiting step in this case. EDTA was included in all
subsequent reaction buffers.
ATP provides energy for certain enzymatic reactions and is required for the action of Polβ
and DNA ligase. As expected, UNG activity parameters were therefore largely unaffected
by changes in ATP concentrations. APE1, gap filling, and dRP lyase activity parameters
reduced as ATP concentration increased, which is counter-intuitive as more available energy
should lead to an increase in enzyme activity. However, it is possible that ATP is also acting
as a magnesium chelator and reducing enzyme activity by removing magnesium as a cofactor.
DNA ligase has the highest activity parameter at 2mM ATP leading a predicted repaired base
value of 52.15%, the highest out of the three ATP concentrations tested. As a result of this
finding, 2mM ATP was used in the reaction buffer for all subsequent experiments.
To the author’s knowledge, this is the first in depth examination of so many components
of the reaction buffer for multiple DNA repair enzymes in order to maximise repair outcomes
as predicted by a mathematical model. Furthermore, the findings here emphasize the potential
confounding effects of buffer composition when assessing BER enzyme activity data.
4.4.2 Differential model predictions based on data from three cell types
Overall, mathematical techniques have been successfully used to parametrise a model of
BER, and predict the rates of appearance and disappearance of each species in the BER
pathway in several cell types with two distinct initial substrates. The three cell types modelled
were the hepatocellular carcinoma cell line HepG2, the colorectal adenocarcinoma cell line
Caco-2, and primary human PBMCs. Each cell type had obvious differences both in overall
model output, and in the repair response to DNA damage opposite different base pairs.
When the aberrant base uracil was paired to a guanine, the model predicted that >99% of
available uracil would be excised by 75 minutes incubation with 5µg/well of HepG2 nuclear
extract, SSB levels would reach a maximum of 82.46% at 41 minutes and drop to 7.35% by
240 minutes, and that repaired product would reach 92.77% by 240 minutes. For repair of the
same mispair by Caco-2 nuclear extract, the model predicted that the damaged base would be
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>99% excised in a third of the time that it took HepG2, but there would be a large intermediate
build-up of close to 100% by 26 minutes due to the low activity of dRP lyase indicated by the
c4 parameter. Consequently, complete repair of damage was predicted at approximately half
that achieved by HepG2 extract at 240 minutes. The PBMC model showed a very different
repair profile of a U:G mispair to both HepG2 and Caco-2 immortalised cell lines. Firstly,
the c1 parameter was comparatively lower in this cell type than in the two cell lines, resulting
in a much longer time frame for >99% of uracil to be excised (232 minutes compared to 75
minutes and 25 minutes for HepG2 and Caco-2, respectively). This led to a slower build-up
and lower peak of SSB intermediates but a similar overall complete repair level to HepG2
extract at 240 minutes due to the higher c5 parameter. These results suggest that the three cell
types would have very different responses and cellular outcomes to increased occurrence of
U:G mispairs in the genome. Where the model suggests HepG2 would successfully repair the
damage, Caco-2 would quickly create a large amount of harmful SSB intermediates and only
be able to repair this damage comparatively slowly, and PBMCs are predicted to be capable
of maximising repair whilst minimising harmful intermediate levels, but at the potential risk
of longer durations with aberrant bases in the DNA sequence.
When repairing uracil opposite an adenine, all three cell types had lower excision effi-
ciency parameters of c1 compared to U:G mispair excision, with a 0.0 c1 value in PBMCs. In
the two immortalised cell line predictions, this caused a slower build-up of SSB intermediates
to a lower peak than in the U:G repair models. The lower c1 parameter also led to lower
overall repair compared to U:G predictions. In terms of mutagenic potential to the cell, a
U:A base pair is not particularly harmful as uracil is paired with adenine in the same way
as a thymine during transcription and translation, and so the PBMC approach of either not
replacing the uracil or only replacing very slowly and without creating harmful intermediates
may be the safest strategy for dealing with this type of DNA damage. On the other hand,
Caco-2 cells would apparently generate high levels of SSBs, which are far more cytotoxic
than misincorporated uracil, even though the SSBs are reduced compared to the U:G model
of Caco-2 BER. Overall, the model suggests that Caco-2 cells would cope worst under
conditions leading to high levels of uracil in the genome.
4.4.3 Model predictions underestimate observed repair in all cell types
The findings presented in this chapter are generally in agreement with models of BER from
other groups, particularly in that dRP lyase appears to be the rate limiting step [168]. Where
this model differs from other work is in the use of whole nuclear extract from cells rather
than using recombinant enzyme. The rationale for this approach was that as our assay used
whole nuclear extract, we would overcome the underestimation of predicted repair in cells
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by the model encountered by Sokhansanj and colleagues. In practice, the model described
here also underestimated repair compared to biological data, which will be discussed in this
section.
Two major differences between the model predictions and biological data are immediately
apparent in all cases; firstly, the model predictions underestimate actual repair by up to
71.13%, particularly at early points of the time course, and secondly, the biological data
shows a moderate but obvious decline in total repair after 90 - 180 minutes incubation with
nuclear extract, whilst the model prediction tends towards 100% repair.
With regards to the underestimation of total repair by the model, a potential explanation
would be a cooperative effect in BER enzymes when repairing a base entirely compared to
repairing a specific site of damage, which was forced in the individual enzyme assays in order
to gain activity parameters for each enzyme. As introduced in chapter (1), there are two main
coordination hypotheses for BER based on ‘passing the baton’ and ‘repair complex’ theories
[113]. Both of these theories involve close cooperation of BER enzymes to repair a damaged
base or abasic site. Although whole nuclear extract was used here to try and overcome the
issues seen in previous modelling attempts and account for enzyme cooperativity, it would
appear that there is still some aspect of the pathway that is unaccounted for when using these
methods to model the overall pathway based on individual enzyme activity data.
The observed decline in percentage repair at time points greater than 90 minutes is
most likely due to proteins such as exonucleases present in the nuclear extract degrading
the oligonucleotide substrate non-specifically. Although this was tested for during assay
development (figure 2.10), substrate was incubated with nuclear extract for 60 minutes and
up to 2.0µg/well, compared to the 5.0µg/well nuclear extract for up to 240 minutes used in
this set of experiments. Another contributory factor could be that the ATP in the DNA repair
buffer was exhausted by the 90 minute time point, meaning that no further joining of SSBs
could be carried out, or that the repair incubation conditions generated new sites of damage
that caused more SSBs to form as the initial ones were being repaired.
The PBMC time course showed an almost total lack of repair of both U:A base pairs
and U:G mispairs even at early time points. The model predicted this for the repair of a
U:A-containing substrate due to the low excision efficiency of PBMCs when acting on a U:A
base pair, but the lack of repair of U:G-containing substrate by PBMCs observed here was
not predicted, and is not easily explained. Further experimentation and assay optimisation
would be required here with a variety of PBMC samples to try and elucidate the reason for
the lack of complete repair observed.
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4.4.4 Mathematical manipulation of enzyme parameters gives insight
into the model underestimation of total repair
An advantage of mathematical modelling in the fashion described in the current chapter is
that numerical manipulation of the model to try to determine which specific BER enzyme
activity is contributing to the predicted repair underestimation seen in figure 4.5 can be
achieved quickly and easily, with no complicated laboratory experiments required.
As the hypothesis for the observed underestimation of repair by the model was cooperativ-
ity between enzymes, c1 was excluded from the manipulations as the first step in the pathway
should have the same activity whether or not the repair pathway is allowed to continue past
base excision. The parameters c2 and c3 were also not altered as the activity parameters
for these steps was already markedly higher than all other enzyme activity parameters, and
so increasing c2 and c3 would not substantially increase overall repair. This left c4 and c5
parameters, which were estimated by SimBiology software to achieve the closest possible fit
to the biological data. Only the biological data from time points 0 - 90 minutes were included
in this analysis, due to the aforementioned decrease in repair observed after this time point.
HepG2 and Caco-2 cell lines were the subject of the parameter estimation numerical
experiments, and PBMCs were excluded due to the total lack of repair in the biological data.
For HepG2, an improved fit of the model prediction to the biological data was seen when
the c4 parameter was increased by 2.7 - 13.3-fold, and c5 was made non-rate limiting by
an extensive amount; in fact, to values much higher than the originally greatest parameter,
c2. The same pattern was seen when estimating repair of a U:A base pair by Caco-2. For
repair of a U:G mispair by Caco-2, the c5 parameter did not increase by as great a margin as
for the other cell line and initial substrate repair, and remained the second lowest parameter
value after c4. This indicates that although c4 is the slowest and therefore rate limiting, c5
also contributes to overall pathway throughput when Caco-2 is repairing a U:G base pair.
However, there is no biological reason for repair of U:A and U:G to proceed any differently
following the initial excision of uracil as all other enzymes of BER should interact in the
same way downstream of UNG, so the assumption that UNG activity should not be included
in the parameter estimation may need revisiting in future work.
The effect of linearising the equations describing enzyme activity should also be consid-
ered, as it could be the case that the model dynamics should be altered as well, or instead of,
the imputed parameters. Linearisation of the equations is valid if S is very low in comparison
to km. In this system, substrate concentration is at most 0.5nM, and is very likely substantially
smaller than this value. Values for km for BER enzymes in this system have been found by
other researchers to range between a low of 32.5nM for APE1 to a high of 500nM for the
dRP lyase activity of Polβ [168]. Therefore, at a minimum km is 65-fold higher than S. For
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this reason, altering the dynamics of the system was not considered worthwhile in this case,
although in future work the effect of linearisation could be confirmed if deemed necessary.
Overall, the parameter estimation experiments indicated that there is likely some level
of cooperativity between the enzymes of the BER pathway not captured by the individual
enzyme activity assays in some way, particularly affecting dRP lyase activity in both cell lines.
Further experimentation into this apparent cooperativity would be fascinating to unravel the
effect of individual enzyme contributions to BER pathway throughput.
4.4.5 Insights into BER capacity in apparently health volunteers using
a combination of biological data and mathematical modelling
Finally, the mathematical model was applied to predict an answer to a biological question:
can BER capacity be predicted in individuals based on their individual enzyme activity data?
Several assumptions were made when converting the activity data for UNG, APE1, gap
filling, and DNA ligase from the PBMC nuclear extract into activity parameters for model
input. The effect of magnesium had to be accounted for as the UNG, APE1 and gap filling
datasets were obtained in the presence of 2mM MgCl2 and the DNA ligase data in 10mM
MgCl2, which was achieved by assuming that the effect of magnesium on these enzymes
activity was the same in PBMC nuclear extract as in HepG2 nuclear extract where biological
data was available. Also, the c4 parameter had to be estimated based on the assumption that
the ratio between c3 and c4 parameters in HepG2 nuclear extract would be the same in PBMC
nuclear extract. No adjustments were made to try and account for the underestimation of
repair by the model observed in section (4.3.3) as the paramter estimation was not considered
robust enough to alter parameters confidently for this analysis. As each set of PBMC data
were adjusted in the exact same way, comparisons within the dataset regarding total SSB
and overall repair predictions could be made, with the caveat that the estimated values are
unlikely to reflect an accurate absolute value.
After these adjustments were made, the model predictions found a wide variation between
individuals for each of the three outputs predicted. In terms of total repaired base, a 13.5-fold
variation was predicted by the model, which was a much greater variation than seen in any
of the individual enzyme activity datasets (average variation = 5.3-fold for UNG, APE1,
gap filling, and DNA ligase biological data). This highlights that the use of the model was
able to predict variation in BER capacity in individuals that would not have been possible to
intuit. Furthermore, the model gives some insight into the amount of SSB generation by each
individual; a future experiment could test this prediction by measuring SSBs and use it to
predict the resilience of each set of PBMC samples to induced DNA damage.
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Ultimately, the work presented here supports the original hypothesis, as the cancer cell
lines responded differently to primary cells isolated from apparently healthy individuals
when repairing a site of DNA damage, with the cancer cell lines appearing to generate more
cytotoxic intermediates in a faster time frame than the healthy cells, and also tended to be
less selective in the type of base damage that they repaired. Furthermore, all cell types were
found to have a common rate limiting step of dRP lyase, and this remained the slowest step
even after substantial increases in the parameter value following parameter estimation.
Chapter 5
Discussion
5.1 Overview
Imbalances in DNA repair have been implicated in the development of genomic instability,
leading to the formation of cancer cells, amongst other pathologies [6]. A better understanding
of the rate-limiting step of this pathway could lead to a target for activation or inhibition
to increase or decrease overall BER capacity, as required. Also, a holistic approach to
examining the flux through the pathway may help identify ways to reduce the build-up of
cytotoxic intermediates of the DNA repair process. In this context, the aim of the current
work was to firstly develop an assay to measure each of the BER enzyme activities, use
these in combination with a mathematical model to assess differences between cell types
in terms of intermediate accumulation and overall repair, and investigate whether lifestyle
interventions might represent a way in which to influence BER capacity.
5.1.1 Measurement of BER enzyme activity
The first aim set out in the introductory comments of this thesis was to develop a method for
determining the activity of several individual enzymes of the BER pathway, as well as being
able to determine multiple combined BER steps using the same assay format. The research
presented in chapter (2) is evidence that this aim was adequately achieved; a novel assay
format was successfully developed and optimised to measure UNG, APE1, DNA polymerase,
Polβ , DNA ligase, AP site repair and complete repair of a uracil paired with either an adenine
or a guanine.
The data clearly demonstrated that a linear relationship between nuclear extract concentra-
tion and repair activity was observed for each of these assays, and detailed analytical analysis
proved that the assays were both reliable and reproducible. Confirmatory experiments showed
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very little non-specific degradation of oligonucleotide substrate up to 2µg/well of nuclear
protein and a the fragment size of eluted nucleotide substrate matched that prepared by
in-tube digestion with recombinant enzyme.
Although the units of activity measured in the assay could not be directly compared
between enzymes due to the differing definitions of a unit by the manufacturers of the
recombinant enzyme, some quantitative conclusions could be drawn regarding the compara-
tive levels of each enzyme activity in the HepG2 nuclear extract used for optimisation. In
particular, it was clear that the nuclear extract had very high APE1 activity compared to UNG
activity due to the finding that APE1 activity was detectable in 100-fold lower quantities
of HepG2 nuclear extract than UNG activity, in agreement with published kinetic work
regarding these enzymes [156].
No other assay format published in the literature thus far has demonstrated the ability to
measure the individual enzyme activity of each step of BER in addition to multi-step assays
for abasic site repair and complete repair in this manner, and so this work represents a step
forward in the potential for measuring activity of DNA repair enzymes and pathways.
5.1.2 BER enzyme activity characterisation in a range of cell types
The novel assay format presented in chapter (2) was successfully used to measure enzyme
activity in a range of cell types, including nuclear extract from primary human cells. The
linear relationship between apparent BER enzyme activity and nuclear extract concentration
that was considered validation of the assay’s ability to specifically measure enzyme activity
in HepG2 nuclear extract was also demonstrated in PBMC nuclear extract from apparently
healthy human volunteers. Therefore, the assays were successfully used in the fulfilment
of the second aim of this work, to investigate correlation between enzyme activity levels in
apparently healthy individuals, and the effect of nutritional interventions on BER capacity,
amongst some other additional data collection using the assays.
The assays found significant differences between DNA repair enzyme activities in the
Caco-2 and HepG2 cell immortalised cell lines, indicating that these particular cancer cells
may have distinct and potentially abnormal DNA repair profiles. In particular, the UNG
activity, allowed for an interesting finding regarding the excision efficiency of glycosylases
depending on the opposite base to the aberrant uracil. Excision efficiency was much greater
with recombinant UDG, HepG2 nuclear extract and PBMC nuclear extract when the uracil
was mispaired to a guanine rather than base paired to an adenine; a difference magnified in
the PBMC nuclear extract compared to the HepG2 nuclear extract.
Additionally, the assays were used to investigate correlation of BER enzyme activity
in primary human cells, and several significant associations were found, with the strongest
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correlation being between UNG and DNA ligase; the first and last steps of BER. This result
definitely warrants further investigation into the potential mechanisms behind the observed
correlation due to published work regarding co-ordination between BER enzymes [113].
Another interesting research question would be whether the same level of correlation holds
true in a larger sample size and in disease states.
Finally, in the first study of its kind, the assays were used in preliminary investigations
into the relationship between weight loss via differential methods and DNA repair activity
in human samples. Although findings were far from conclusive, preliminary data indicated
a differential effect of weight loss regimen on Polβ activity following 5% weight loss in
overweight participants. Vitally, the novel assay format was reliable, reproducible, and
produced viable results regarding the effects of weight loss on DNA repair activities.
5.1.3 Mathematical model of BER
The work presented in the mathematical modelling chapter gave novel and interesting
insights into some aspects of the BER pathway, as well as confirming previous findings in the
literature. Firstly, in the most thorough characterisation of a BER reaction buffer completed
to the author’s knowledge, a buffer was optimised to maximise complete repair in order to
generate biological data for comparison to the mathematical model predictions. The data
generated by the novel assay format allowed for the addressing of the third aim from the
introductory comments, of generating a mathematical model of BER and using it to identify
the rate limiting step of BER and any differences between the BER profiles of cancer cell
lines and healthy human cells.
The comparison of predicted repair profiles in two immortalised cell lines and primary
human cells is the first of its kind, and was made possible by the individual enzyme activity
data gathered using the novel assay format developed in chapter (2). Likewise, no published
work has investigated the differences in repair profiles of cells repairing U:A versus U:G
in DNA. The prediction that healthy primary cells are likely to vastly favour repair of the
mutagenic U:G mispair over the more benign U:A base pair both makes biological sense, and
opens up new avenues of research into the finer points of the cellular DNA damage response
in health and disease.
Although the biological data for complete repair would have benefited from further
optimisation, the observed consistent underestimation of repair by the model in all cell types
gave further evidence towards cooperativity postulated by Sokhansanj and colleagues [168].
Also in agreement with Sokhansanj and colleagues work was the finding that dRP lyase tends
to be the rate limiting step of the BER pathway. Future experiments that stimulate or inhibit
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this step of repair would be useful to confirm whether the effects of this affect the overall
pathway in the way predicted by the model.
Finally, the model was used to predict repair profiles in PBMC nuclear extract from
apparently health individuals, and gave insights into variation in total SSBs and overall repair
that would not have been possible based on the individual enzyme activity data measured
biologically.
5.2 Future work
The research described here could be expanded in a number of directions; an ultimate aim
would be to identify one enzyme, most likely Polβ as the rate limiting step of the pathway,
that could be developed into a biomarker for disease risk. Already, a reduction in BER
capacity has been associated with lung cancer incidence [206] but a good deal more work
needs to carried out to be able to use BER capacity as a reliable and sensitive biomarker
for diseases of genome stability. Biomarker discovery is of particular relevance as early
detection of cancers such as lung cancer reduces mortality by up to 20% [207].
In the short term, an obvious next step would be to link the identified rate limiting step
directly to its effect on overall repair with the use of stimulatory or inhibitory factors in
cultured cells, and also measure cellular health endpoints related to an increase or decrease
in DNA repair capacity such as cell death and DNA mutation levels. Additionally, the
relationship between DNA damage, mutation and repair could be investigated in a more
holistic way by considering whole genome DNA mutations as an indicator of sources of
damage and efficiency of DNA repair mechanisms within individuals. The assays developed
in this thesis could be used to verify DNA repair activity in individuals after predicting their
repair capacity based on the damage seen in their genome and the persistence of mutations
following the damage observed.
In terms of assay development, future work would be to expand the range of DNA
glycosylases that can be measured by altering the damaged base in the oligonucleotide
substrate. Initial work has been carried out to develop OGG and AAG activity assays during
the timeframe of this thesis, but further optimisation is required to ensure these assays are
as reliable and reproducible as the UNG assay. It may also be possible to adapt the BER
assay format for the measurement of other DNA repair pathways by suitable alterations of
the initial substrate.
To add to this, the dataset shown in chapter (3) (figure 3.6) could be expanded to
include a much larger cohort, and data could be collected on potential DNA repair affecting
factors to try and identify some reasons why there is such a large variation in repair seen
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between individuals. A comparison of DNA repair activities between individuals who are
healthy and diagnosed with diseases linked to defective DNA repair such as cancer and
progressive neurological disorders would be the next step to try and identify if there are
certain biochemical risk factors for ill-health.
The buffer composition optimisation work confirmed that magnesium is essential for
every BER enzyme except UNG, the first step of the pathway, which it strongly inhibits (figure
4.2B), leading to an interesting research question for future work; what is the mechanism by
which the nucleus deals with these opposing magnesium requirements in a confined space?
Furthermore, the cooperativity in the pathway predicted here by the mathematical model
has previously been alluded to by more than one researcher and warrants further research
into both the exact mechanism of cooperativity, and how this could be used to our advantage
when considering BER as a pathway to ensure genomic integrity. To add to the validation of
the modelling work, SSBs generated by the action of BER could also be measured in cells in
order to match overall predicted SSB levels with values seen in biology.
Using a combination of biological and mathematical approaches, the most effective
targets for drug and nutritional interventions to improve, or indeed reduce BER capacity can
be detected. Previous articles have also highlighted the need for assays such as the ones
described here to examine the cause of inter-individual variation in DNA repair capacity
[193]. Another important aspect to consider is the connection between BER capacity and
chemotherapy resistance, where increased BER can lead to DNA-damaging agent resistance,
and as such an inhibition in BER capacity may be desirable [208]. A possible application for
the assays, in combination with the model, would be to generate repair profiles from cells
obtained from tumour biopsies, and choose chemotherapeutic agents according to the results
found.
5.3 Concluding remarks
Overall, the work presented here adds to the research field of BER pathway characterisation.
With the development of a novel assay format, enzyme activity data was generated that
allowed the determination of activity parameters to be input to a mathematical model of
the pathway. For the first time, this model predicted the rate of accumulation of BER
intermediates in both cancer cell lines and primary human cells, and highlighted distinct
repair profiles between the cancer and healthy cells in response to U:A and U:G sites of
DNA damage. Furthermore, the assay was used to investigate several biologically relevant
questions, including to examine correlations between BER enzyme activities in primary
human cells from apparently healthy volunteers, and to assess the effects of different weight
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loss methods on BER capacity in overweight participants. Although there are areas of this
research that require further optimisation and investigation, it is hoped that this body of work
could serve as a springboard for developing BER enzyme activity as a biomarker for health
and disease.
The hypothesis that the BER pathway has an overall rate of repair of damaged bases in
DNA that is controlled by a single rate-limiting step that can be altered to directly influence
pathway throughput was supported by the findings regarding parameter estimation in chapter
(4). The question of how to alter the activity rate of this enzyme to best improve health
outcomes remains to be answered, but the finding that the method by which weight is lost can
predict Polβ activity indicates that nutritional influences may affect BER capacity. Finally,
it was hypothesized that distinct cell types have different baseline BER enzyme activities
leading to altered flux through the pathway. Caco-2 and HepG2 immortalized cell lines, and
PBMCs from apparently healthy individuals were characterized in terms of individual BER
enzyme activity and repair profiles, and profound differences were discovered in the response
of all three cell types to U:A and U:G DNA damage.
To conclude, the aims set out at the beginning of this piece of work were fulfilled, and
supported the original hypthesis in the most part; future research can add to this in order to
work towards a more thorough understanding of the BER pathway and manipulation of DNA
repair for improved healthspan and disease outcomes.
References
[1] R E FRANKLIN and R G GOSLING. Evidence for 2-chain helix in crystalline
structure of sodium deoxyribonucleate. Nature, 172(4369):156–7, jul 1953.
[2] J D WATSON and F H CRICK. Molecular structure of nucleic acids; a structure for
deoxyribose nucleic acid. Nature, 171(4356):737–8, apr 1953.
[3] J D WATSON and F H CRICK. Genetical implications of the structure of deoxyri-
bonucleic acid. Nature, 171(4361):964–7, may 1953.
[4] P Alberts, B; Johnson, A; Lewis, J; Raff, M; Roberts, K; Walter. Molecular Biology
of the Cell, 4th edition. Garland Science, New York, 4th edition, 2002.
[5] James A Swenberg, Kun Lu, Benjamin C Moeller, Lina Gao, Patricia B Upton, Jun
Nakamura, and Thomas B Starr. Endogenous versus exogenous DNA adducts: their
role in carcinogenesis, epidemiology, and risk assessment. Toxicological sciences : an
official journal of the Society of Toxicology, 120 Suppl:S130–45, mar 2011.
[6] J H Hoeijmakers. Genome maintenance mechanisms for preventing cancer. Nature,
411(6835):366–374, may 2001.
[7] D Hanahan and R A Weinberg. The hallmarks of cancer. Cell, 100(1):57–70, jan
2000.
[8] Douglas Hanahan and Robert A Weinberg. Hallmarks of cancer: the next generation.
Cell, 144(5):646–674, mar 2011.
[9] S A Wajed, P W Laird, and T R DeMeester. DNA methylation: an alternative pathway
to cancer. Annals of surgery, 234(1):10–20, jul 2001.
[10] James M Flanagan, Angela Wilson, Chail Koo, Nahal Masrour, John Gallon, Erick
Loomis, Kirsty Flower, Charlotte Wilhelm-Benartzi, Alexander Hergovich, Paula
Cunnea, Hani Gabra, Elena Ioana Braicu, Jalid Sehouli, Silvia Darb-Esfahani, Adri-
aan Vanderstichele, Ignace Vergote, Caroline Kreuzinger, Dan Cacsire Castillo-Tong,
G Bea A Wisman, Els Mjj Berns, Nadeem Siddiqui, James Paul, and Robert Brown.
Platinum-Based Chemotherapy Induces Methylation Changes in Blood DNA Associ-
ated with Overall Survival in Patients with Ovarian Cancer. Clinical cancer research :
an official journal of the American Association for Cancer Research, 23(9):2213–2222,
may 2017.
[11] Colvin M. Holland-Frei Cancer Medicine. BC Decker, 6th editti edition, 2003.
References 128
[12] C von Sonntag. New aspects in the free-radical chemistry of pyrimidine nucleobases.
Free radical research communications, 2(4-6):217–224, 1987.
[13] B Halliwell. Biochemistry of oxidative stress. Biochemical Society transactions, 35(Pt
5):1147–1150, nov 2007.
[14] K C Cheng, D S Cahill, H Kasai, S Nishimura, and L A Loeb. 8-Hydroxyguanine,
an abundant form of oxidative DNA damage, causes G—-T and A—-C substitutions.
The Journal of biological chemistry, 267(1):166–172, jan 1992.
[15] D A Kreutzer and J M Essigmann. Oxidized, deaminated cytosines are a source of
C –> T transitions in vivo. Proceedings of the National Academy of Sciences of the
United States of America, 95(7):3578–3582, mar 1998.
[16] L Berg, JM; Tymoczko, JL; Stryer. Biochemistry. 5th edition. W H Freeman, New
York, 5th edition, 2002.
[17] T Lindahl. Instability and decay of the primary structure of DNA. Nature,
362(6422):709–715, apr 1993.
[18] Wendy J Cannan and David S Pederson. Mechanisms and Consequences of Double-
strand DNA Break Formation in Chromatin, jan 2016.
[19] Alessandro Torgovnick and Bjorn Schumacher. DNA repair mechanisms in cancer
development and therapy. Frontiers in genetics, 6:157, 2015.
[20] Ellenberger T Friedberg EC, Walker GC, Siede W, Wood RD, Schultz RA. DNA
Repair and Mutagenesis. ASM Press, Washington, DC, USA, 2006.
[21] T Lindahl. An N-glycosidase from Escherichia coli that releases free uracil from DNA
containing deaminated cytosine residues. Proceedings of the National Academy of
Sciences of the United States of America, 71(9):3649–53, sep 1974.
[22] R S Lahue, K G Au, and P Modrich. DNA mismatch correction in a defined system.
Science (New York, N.Y.), 245(4914):160–4, jul 1989.
[23] A Sancar and W D Rupp. A novel repair enzyme: UVRABC excision nuclease
of Escherichia coli cuts a DNA strand on both sides of the damaged region. Cell,
33(1):249–60, may 1983.
[24] Tomas Lindahl, Paul Modrich, and Aziz Sancar. The 2015 Nobel Prize in Chemistry
The Discovery of Essential Mechanisms that Repair DNA Damage. Journal of the
Association of Genetic Technologists, 42(1):37–41, 2016.
[25] J Tyson and J C Mathers. Dietary and genetic modulation of DNA repair in healthy
human adults. Proc Nutr Soc, 66(1):42–51, 2007.
[26] Markus Christmann, Barbara Verbeek, Wynand P Roos, and Bernd Kaina. O(6)-
Methylguanine-DNA methyltransferase (MGMT) in normal tissues and tumors: en-
zyme activity, promoter methylation and immunohistochemistry. Biochimica et bio-
physica acta, 1816(2):179–90, dec 2011.
References 129
[27] A E Pegg, M E Dolan, and R C Moschel. Structure, function, and inhibition of O6-
alkylguanine-DNA alkyltransferase. Progress in nucleic acid research and molecular
biology, 51:167–223, 1995.
[28] Chengqi Yi and Chuan He. DNA repair by reversal of DNA damage. Cold Spring
Harbor perspectives in biology, 5(1):a012575, jan 2013.
[29] Klaus Brettel and Martin Byrdin. Reaction mechanisms of DNA photolyase. Current
opinion in structural biology, 20(6):693–701, dec 2010.
[30] R D Wood. DNA repair in eukaryotes. Annu Rev Biochem, 65:135–167, 1996.
[31] C J Lord and A Ashworth. The DNA damage response and cancer therapy. Nature,
481(7381):287–294, 2012.
[32] A. B. Robertson, A. Klungland, T. Rognes, and I. Leiros. DNA Repair in Mammalian
Cells. Cellular and Molecular Life Sciences, 66(6):981–993, mar 2009.
[33] Nicholas C Bauer, Anita H Corbett, and Paul W Doetsch. The current state of
eukaryotic DNA base damage and repair, dec 2015.
[34] G L Dianov, N Souza-Pinto, S G Nyaga, T Thybo, T Stevnsner, and V A Bohr. Base
excision repair in nuclear and mitochondrial DNA. Progress in nucleic acid research
and molecular biology, 68:285–297, 2001.
[35] S Rahmanian, R Taleei, and H Nikjoo. Radiation induced base excision repair (BER):
a mechanistic mathematical approach. DNA Repair (Amst), 22:89–103, 2014.
[36] Jordan Woodrick, Suhani Gupta, Sharon Camacho, Swetha Parvathaneni, Sujata
Choudhury, Amrita Cheema, Yi Bai, Pooja Khatkar, Hayriye Verda Erkizan, Furqan
Sami, Yan Su, Orlando D Scharer, Sudha Sharma, and Rabindra Roy. A new sub-
pathway of long-patch base excision repair involving 5’ gap formation. The EMBO
journal, 36(11):1605–1622, jun 2017.
[37] U Sattler, P Frit, B Salles, and P Calsou. Long-patch DNA repair synthesis during
base excision repair in mammalian cells. EMBO Rep, 4(4):363–367, 2003.
[38] Aya Masaoka, Julie K Horton, William A Beard, and Samuel H Wilson. DNA
polymerase beta and PARP activities in base excision repair in living cells. DNA
repair, 8(11):1290–1299, nov 2009.
[39] H E Krokan, R Standal, and G Slupphaug. DNA glycosylases in the base excision
repair of DNA. Biochem J, 325 ( Pt 1:1–16, 1997.
[40] J Laval, J Jurado, M Saparbaev, and O Sidorkina. Antimutagenic role of base-excision
repair enzymes upon free radical-induced DNA damage. Mutat Res, 402(1-2):93–102,
1998.
[41] Lee Wiederhold, John B Leppard, Padmini Kedar, Feridoun Karimi-Busheri, Aghdass
Rasouli-Nia, Michael Weinfeld, Alan E Tomkinson, Tadahide Izumi, Rajendra Prasad,
Samuel H Wilson, Sankar Mitra, and Tapas K Hazra. AP endonuclease-independent
DNA base excision repair in human cells. Molecular cell, 15(2):209–220, jul 2004.
References 130
[42] Susan S Wallace. Base excision repair: a critical player in many games. DNA repair,
19:14–26, jul 2014.
[43] C D Mol, T Izumi, S Mitra, and J A Tainer. DNA-bound structures and mutants reveal
abasic DNA binding by APE1 and DNA repair coordination [corrected]. Nature,
403(6768):451–456, 2000.
[44] S L Allinson, Dianova II, and G L Dianov. DNA polymerase beta is the major dRP
lyase involved in repair of oxidative base lesions in DNA by mammalian cell extracts.
EMBO J, 20(23):6919–6926, 2001.
[45] A E Tomkinson and Z B Mackey. Structure and function of mammalian DNA ligases.
Mutat Res, 407(1):1–9, 1998.
[46] Y Kubota, R A Nash, A Klungland, P Schär, D E Barnes, and T Lindahl. Reconstitution
of DNA base excision-repair with purified human proteins: interaction between DNA
polymerase beta and the XRCC1 protein., dec 1996.
[47] K W Caldecott, C K McKeown, J D Tucker, S Ljungquist, and L H Thompson. An
interaction between the mammalian DNA repair protein XRCC1 and DNA ligase III.,
jan 1994.
[48] E Cappelli, R Taylor, M Cevasco, A Abbondandolo, K Caldecott, and G Frosina.
Involvement of XRCC1 and DNA ligase III gene products in DNA base excision
repair. J Biol Chem, 272(38):23970–23975, 1997.
[49] G Frosina, P Fortini, O Rossi, F Carrozzino, G Raspaglio, L S Cox, D P Lane, A Ab-
bondandolo, and E Dogliotti. Two pathways for base excision repair in mammalian
cells. The Journal of biological chemistry, 271(16):9573–9578, apr 1996.
[50] Y Matsumoto, K Kim, and D F Bogenhagen. Proliferating cell nuclear antigen-
dependent abasic site repair in Xenopus laevis oocytes: an alternative pathway of base
excision DNA repair. Molecular and cellular biology, 14(9):6187–6197, sep 1994.
[51] X Wu, J Li, X Li, C L Hsieh, P M Burgers, and M R Lieber. Processing of branched
DNA intermediates by a complex of human FEN-1 and PCNA. Nucleic acids research,
24(11):2036–2043, jun 1996.
[52] Jennifer A Thompson, Melissa R Marzahn, Mike O’Donnell, and Linda B Bloom.
Replication Factor C Is a More Effective Proliferating Cell Nuclear Antigen (PCNA)
Opener than the Checkpoint Clamp Loader, Rad24-RFC, jan 2012.
[53] Maxim Isabelle, Xavier Moreel, Jean-Philippe Gagné, Michèle Rouleau, Chantal
Ethier, Pierre Gagné, Michael J Hendzel, and Guy G Poirier. Investigation of PARP-1,
PARP-2, and PARG interactomes by affinity-purification mass spectrometry, 2010.
[54] Cecilia E Strom, Fredrik Johansson, Mathias Uhlen, Cristina Al-Khalili Szigyarto,
Klaus Erixon, and Thomas Helleday. Poly (ADP-ribose) polymerase (PARP) is not
involved in base excision repair but PARP inhibition traps a single-strand intermediate.
Nucleic acids research, 39(8):3166–3175, apr 2011.
References 131
[55] E Theodoratou, H Campbell, A Tenesa, R Houlston, E Webb, S Lubbe, P Broderick,
S Gallinger, E M Croitoru, M A Jenkins, A K Win, S P Cleary, T Koessler, P D
Pharoah, S Kury, S Bezieau, B Buecher, N A Ellis, P Peterlongo, K Offit, L A
Aaltonen, S Enholm, A Lindblom, X-L Zhou, I P Tomlinson, V Moreno, I Blanco,
G Capella, R Barnetson, M E Porteous, M G Dunlop, and S M Farrington. A large-
scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH
variants. British journal of cancer, 103(12):1875–1884, dec 2010.
[56] Kohsuke Imai, Geir Slupphaug, Wen-I Lee, Patrick Revy, Shigeaki Nonoyama, Nadia
Catalan, Leman Yel, Monique Forveille, Bodil Kavli, Hans E Krokan, Hans D Ochs,
Alain Fischer, and Anne Durandy. Human uracil-DNA glycosylase deficiency associ-
ated with profoundly impaired immunoglobulin class-switch recombination. Nature
immunology, 4(10):1023–1028, oct 2003.
[57] Changxing Shao, Shuling Xiong, Guo-Min Li, Liya Gu, Guogen Mao, William R
Markesbery, and Mark A Lovell. Altered 8-oxoguanine glycosylase in mild cognitive
impairment and late-stage Alzheimer’s disease brain. Free radical biology & medicine,
45(6):813–819, sep 2008.
[58] Tomasz Obtulowicz, Alicja Winczura, Elzbieta Speina, Maja Swoboda, Justyna
Janik, Beata Janowska, Jaroslaw M Ciesla, Pawel Kowalczyk, Arkadiusz Jawien,
Daniel Gackowski, Zbigniew Banaszkiewicz, Ireneusz Krasnodebski, Andrzej Chaber,
Ryszard Olinski, Jagadesaan Nair, Helmut Bartsch, Thierry Douki, Jean Cadet, and
Barbara Tudek. Aberrant repair of etheno-DNA adducts in leukocytes and colon tissue
of colon cancer patients. Free radical biology & medicine, 49(6):1064–1071, sep
2010.
[59] Ziv Sevilya, Yael Leitner-Dagan, Mila Pinchev, Ran Kremer, Dalia Elinger, Hedy S
Rennert, Edna Schechtman, Laurence S Freedman, Gad Rennert, Tamar Paz-Elizur,
and Zvi Livneh. Low integrated DNA repair score and lung cancer risk. Cancer
prevention research (Philadelphia, Pa.), 7(4):398–406, apr 2014.
[60] Elisabeth Larsen, Trine J Meza, Liv Kleppa, and Arne Klungland. Organ and cell
specificity of base excision repair mutants in mice. Mutation research, 614(1-2):56–68,
jan 2007.
[61] N Schormann, R Ricciardi, and D Chattopadhyay. Uracil-DNA glycosylases-structural
and functional perspectives on an essential family of DNA repair enzymes. Protein
Sci, 23(12):1667–1685, 2014.
[62] Torkild Visnes, Berit Doseth, Henrik Sahlin Pettersen, Lars Hagen, Mirta M L Sousa,
Mansour Akbari, Marit Otterlei, Bodil Kavli, Geir Slupphaug, and Hans E Krokan.
Uracil in DNA and its processing by different DNA glycosylases, mar 2009.
[63] E H Radany, K J Dornfeld, R J Sanderson, M K Savage, A Majumdar, M M Seidman,
and D W Mosbaugh. Increased spontaneous mutation frequency in human cells
expressing the phage PBS2-encoded inhibitor of uracil-DNA glycosylase. Mutation
research, 461(1):41–58, sep 2000.
References 132
[64] Lachelle D Weeks, Pingfu Fu, and Stanton L Gerson. Uracil-DNA glycosylase
expression determines human lung cancer cell sensitivity to pemetrexed. Molecular
cancer therapeutics, 12(10):2248–2260, oct 2013.
[65] D M 3rd Wilson and D Barsky. The major human abasic endonuclease: formation,
consequences and repair of abasic lesions in DNA. Mutation research, 485(4):283–307,
may 2001.
[66] Y Masuda, R A Bennett, and B Demple. Rapid dissociation of human apurinic
endonuclease (Ape1) from incised DNA induced by magnesium. The Journal of
biological chemistry, 273(46):30360–30365, nov 1998.
[67] S Xanthoudakis and T Curran. Redox regulation of AP-1: a link between transcription
factor signaling and DNA repair. Advances in experimental medicine and biology,
387:69–75, 1996.
[68] Mark R Kelley, Millie M Georgiadis, and Melissa L Fishel. APE1/Ref-1 role in
redox signaling: translational applications of targeting the redox function of the DNA
repair/redox protein APE1/Ref-1. Current molecular pharmacology, 5(1):36–53, jan
2012.
[69] Boris M Brenerman, Jennifer L Illuzzi, and David M 3rd Wilson. Base excision repair
capacity in informing healthspan. Carcinogenesis, 35(12):2643–2652, dec 2014.
[70] L B Meira, S Devaraj, G E Kisby, D K Burns, R L Daniel, R E Hammer, S Grundy,
I Jialal, and E C Friedberg. Heterozygosity for the mouse Apex gene results in
phenotypes associated with oxidative stress. Cancer research, 61(14):5552–5557, jul
2001.
[71] Jessica Huamani, C Alex McMahan, Damon C Herbert, Robert Reddick, John R
McCarrey, Mark I MacInnes, David J Chen, and Christi A Walter. Spontaneous
mutagenesis is enhanced in Apex heterozygous mice. Molecular and cellular biology,
24(18):8145–8153, sep 2004.
[72] Archana Unnikrishnan, Julian J Raffoul, Hiral V Patel, Thomas M Prychitko, Njwen
Anyangwe, Lisiane B Meira, Errol C Friedberg, Diane C Cabelof, and Ahmad R
Heydari. Oxidative stress alters base excision repair pathway and increases apoptotic
response in apurinic/apyrimidinic endonuclease 1/redox factor-1 haploinsufficient
mice. Free radical biology & medicine, 46(11):1488–1499, jun 2009.
[73] Byeong Hwa Jeon, Gaurav Gupta, Young Chul Park, Bing Qi, Azeb Haile, Firdous A
Khanday, Yan-Xia Liu, Jin-Man Kim, Michitaka Ozaki, Anthony R White, Dan E
Berkowitz, and Kaikobad Irani. Apurinic/apyrimidinic endonuclease 1 regulates
endothelial NO production and vascular tone. Circulation research, 95(9):902–910,
oct 2004.
[74] Joohyun Woo, Heejung Park, Sun Hee Sung, Byung-In Moon, Hyunsuk Suh, and
Woosung Lim. Prognostic value of human apurinic/apyrimidinic endonuclease 1
(APE1) expression in breast cancer. PloS one, 9(6):e99528, 2014.
References 133
[75] Vittorio Di Maso, Claudio Avellini, Lory Saveria Croce, Natalia Rosso, Franco Quadri-
foglio, Laura Cesaratto, Erika Codarin, Giorgio Bedogni, Carlo Alberto Beltrami,
Gianluca Tell, and Claudio Tiribelli. Subcellular localization of APE1/Ref-1 in hu-
man hepatocellular carcinoma: possible prognostic significance. Molecular medicine
(Cambridge, Mass.), 13(1-2):89–96, 2007.
[76] Z Tan, N Sun, and S S Schreiber. Immunohistochemical localization of redox factor-1
(Ref-1) in Alzheimer’s hippocampus. Neuroreport, 9(12):2749–2752, aug 1998.
[77] Gianluca Tell, Franco Quadrifoglio, Claudio Tiribelli, and Mark R Kelley. The Many
Functions of APE1/Ref-1: Not Only a DNA Repair Enzyme, mar 2009.
[78] N Sugo, Y Aratani, Y Nagashima, Y Kubota, and H Koyama. Neonatal lethality with
abnormal neurogenesis in mice deficient in DNA polymerase beta. The EMBO journal,
19(6):1397–1404, mar 2000.
[79] Diane C Cabelof, Julian J Raffoul, Sunitha Yanamadala, ZhongMao Guo, and Ah-
mad R Heydari. Induction of DNA polymerase beta-dependent base excision repair in
response to oxidative stress in vivo. Carcinogenesis, 23(9):1419–1425, sep 2002.
[80] Diane C Cabelof, ZhongMao Guo, Julian J Raffoul, Robert W Sobol, Samuel H
Wilson, Arlan Richardson, and Ahmad R Heydari. Base excision repair deficiency
caused by polymerase beta haploinsufficiency: accelerated DNA damage and increased
mutational response to carcinogens. Cancer research, 63(18):5799–5807, sep 2003.
[81] Diane C Cabelof, Yuji Ikeno, Abraham Nyska, Rita A Busuttil, Njwen Anyangwe, Jan
Vijg, Larry H Matherly, James D Tucker, Samuel H Wilson, Arlan Richardson, and
Ahmad R Heydari. Haploinsufficiency in DNA polymerase beta increases cancer risk
with age and alters mortality rate. Cancer research, 66(15):7460–7465, aug 2006.
[82] A Iwanaga, M Ouchida, K Miyazaki, K Hori, and T Mukai. Functional mutation of
DNA polymerase beta found in human gastric cancer–inability of the base excision
repair in vitro. Mutation research, 435(2):121–128, oct 1999.
[83] Y Canitrot, C Cazaux, M Frechet, K Bouayadi, C Lesca, B Salles, and J S Hoffmann.
Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a
decreased sensitivity to anticancer drugs. Proceedings of the National Academy of
Sciences of the United States of America, 95(21):12586–12590, oct 1998.
[84] Tom Ellenberger and Alan E Tomkinson. Eukaryotic DNA Ligases: Structural and
Functional Insights, 2008.
[85] Nahum Puebla-Osorio, Devin B Lacey, Frederick W Alt, and Chengming Zhu. Early
embryonic lethality due to targeted inactivation of DNA ligase III. Molecular and
cellular biology, 26(10):3935–3941, may 2006.
[86] Caroline Harrison, Ann-Marie Ketchen, Nicola J Redhead, Maureen J O’Sullivan,
and David W Melton. Replication failure, genome instability, and increased cancer
susceptibility in mice with a point mutation in the DNA ligase I gene. Cancer research,
62(14):4065–4074, jul 2002.
References 134
[87] Guo-Min Li. Mechanisms and functions of DNA mismatch repair. Cell research,
18(1):85–98, jan 2008.
[88] P Modrich and R Lahue. Mismatch repair in replication fidelity, genetic recombination,
and cancer biology. Annual review of biochemistry, 65:101–33, 1996.
[89] H T Lynch and A de la Chapelle. Genetic susceptibility to non-polyposis colorectal
cancer. Journal of medical genetics, 36(11):801–18, nov 1999.
[90] Orlando D Scharer. Nucleotide excision repair in eukaryotes. Cold Spring Harbor
perspectives in biology, 5(10):a012609, oct 2013.
[91] Ludovic C J Gillet and Orlando D Scharer. Molecular mechanisms of mammalian
global genome nucleotide excision repair. Chemical reviews, 106(2):253–276, feb
2006.
[92] Philip C Hanawalt and Graciela Spivak. Transcription-coupled DNA repair: two
decades of progress and surprises. Nature reviews. Molecular cell biology, 9(12):958–
970, dec 2008.
[93] T Nouspikel. DNA repair in mammalian cells : Nucleotide excision repair: variations
on versatility. Cellular and molecular life sciences : CMLS, 66(6):994–1009, mar
2009.
[94] John J DiGiovanna and Kenneth H Kraemer. Shining a light on xeroderma pig-
mentosum. The Journal of investigative dermatology, 132(3 Pt 2):785–796, mar
2012.
[95] Alan R Lehmann. DNA repair-deficient diseases, xeroderma pigmentosum, Cockayne
syndrome and trichothiodystrophy. Biochimie, 85(11):1101–1111, nov 2003.
[96] Bernd Kaina. DNA damage-triggered apoptosis: critical role of DNA repair, double-
strand breaks, cell proliferation and signaling. Biochemical pharmacology, 66(8):1547–
1554, oct 2003.
[97] M Takata, M S Sasaki, E Sonoda, C Morrison, M Hashimoto, H Utsumi, Y Yamaguchi-
Iwai, A Shinohara, and S Takeda. Homologous recombination and non-homologous
end-joining pathways of DNA double-strand break repair have overlapping roles in
the maintenance of chromosomal integrity in vertebrate cells., sep 1998.
[98] Maria Jasin and Rodney Rothstein. Repair of Strand Breaks by Homologous Recom-
bination, nov 2013.
[99] Eleni P Mimitou and Lorraine S Symington. Sae2, Exo1 and Sgs1 collaborate in DNA
double-strand break processing. Nature, 455(7214):770–774, oct 2008.
[100] Zhu Zhu, Woo-Hyun Chung, Eun Yong Shim, Sang Eun Lee, and Grzegorz Ira. Sgs1
helicase and two nucleases Dna2 and Exo1 resect DNA double-strand break ends.
Cell, 134(6):981–994, sep 2008.
[101] Alessandro A Sartori, Claudia Lukas, Julia Coates, Martin Mistrik, Shuang Fu, Jiri
Bartek, Richard Baer, Jiri Lukas, and Stephen P Jackson. Human CtIP promotes DNA
end resection. Nature, 450(7169):509–514, nov 2007.
References 135
[102] Q Zhong, C F Chen, S Li, Y Chen, C C Wang, J Xiao, P L Chen, Z D Sharp, and W H
Lee. Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA
damage response. Science (New York, N.Y.), 285(5428):747–750, jul 1999.
[103] X Yu, L C Wu, A M Bowcock, A Aronheim, and R Baer. The C-terminal (BRCT)
domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway
of transcriptional repression. The Journal of biological chemistry, 273(39):25388–
25392, sep 1998.
[104] Jeremy M Stark, Andrew J Pierce, Jin Oh, Albert Pastink, and Maria Jasin. Ge-
netic steps of mammalian homologous repair with distinct mutagenic consequences.
Molecular and cellular biology, 24(21):9305–9316, nov 2004.
[105] Pierre-Olivier Mari, Bogdan I Florea, Stephan P Persengiev, Nicole S Verkaik, Hen-
nie T Bruggenwirth, Mauro Modesti, Giuseppina Giglia-Mari, Karel Bezstarosti,
Jeroen A A Demmers, Theo M Luider, Adriaan B Houtsmuller, and Dik C van Gent.
Dynamic assembly of end-joining complexes requires interaction between Ku70/80
and XRCC4. Proceedings of the National Academy of Sciences of the United States of
America, 103(49):18597–18602, dec 2006.
[106] Anthony J Davis and David J Chen. DNA double strand break repair via non-
homologous end-joining, jun 2013.
[107] J Knoch, Y Kamenisch, C Kubisch, and M Berneburg. Rare hereditary diseases with
defects in DNA-repair. Eur J Dermatol, 22(4):443–455, 2012.
[108] Julie K Horton, Donna F Joyce-Gray, Brian F Pachkowski, James A Swenberg, and
Samuel H Wilson. Hypersensitivity of DNA polymerase beta null mouse fibroblasts
reflects accumulation of cytotoxic repair intermediates from site-specific alkyl DNA
lesions. DNA repair, 2(1):27–48, jan 2003.
[109] Yuan Liu, Rajendra Prasad, William A Beard, Padmini S Kedar, Esther W Hou,
David D Shock, and Samuel H Wilson. Coordination of Steps in Single-nucleotide
Base Excision Repair Mediated by Apurinic/Apyrimidinic Endonuclease 1 and DNA
Polymerase β , may 2007.
[110] Vikas Malhotra and Michael C Perry. Classical chemotherapy: mechanisms, toxicities
and the therapeutic window. Cancer biology & therapy, 2(4 Suppl 1):S2–4, 2003.
[111] Ram N Trivedi, Karen H Almeida, Jamie L Fornsaglio, Sandra Schamus, and
Robert W Sobol. The role of base excision repair in the sensitivity and resistance to
temozolomide-mediated cell death. Cancer research, 65(14):6394–6400, jul 2005.
[112] Genevieve Housman, Shannon Byler, Sarah Heerboth, Karolina Lapinska, Mckenna
Longacre, Nicole Snyder, and Sibaji Sarkar. Drug Resistance in Cancer: An Overview,
sep 2014.
[113] Jason L Parsons and Grigory L Dianov. Co-ordination of base excision repair and
genome stability. DNA repair, 12(5):326–333, may 2013.
References 136
[114] Megan E Fitzgerald and Alexander C Drohat. Coordinating the initial steps of base
excision repair. Apurinic/apyrimidinic endonuclease 1 actively stimulates thymine
DNA glycosylase by disrupting the product complex. The Journal of biological
chemistry, 283(47):32680–32690, nov 2008.
[115] S S Parikh, C D Mol, G Slupphaug, S Bharati, H E Krokan, and J A Tainer. Base
excision repair initiation revealed by crystal structures and binding kinetics of human
uracil-DNA glycosylase with DNA. The EMBO journal, 17(17):5214–5226, sep 1998.
[116] J W Hill, T K Hazra, T Izumi, and S Mitra. Stimulation of human 8-oxoguanine-DNA
glycosylase by AP-endonuclease: potential coordination of the initial steps in base
excision repair. Nucleic acids research, 29(2):430–438, jan 2001.
[117] R A Bennett, D M 3rd Wilson, D Wong, and B Demple. Interaction of human
apurinic endonuclease and DNA polymerase beta in the base excision repair pathway.
Proceedings of the National Academy of Sciences of the United States of America,
94(14):7166–7169, jul 1997.
[118] Rajendra Prasad, David D Shock, William A Beard, and Samuel H Wilson. Substrate
channeling in mammalian base excision repair pathways: passing the baton. The
Journal of biological chemistry, 285(52):40479–40488, dec 2010.
[119] O I Lavrik, R Prasad, R W Sobol, J K Horton, E J Ackerman, and S H Wilson. Pho-
toaffinity labeling of mouse fibroblast enzymes by a base excision repair intermediate.
Evidence for the role of poly(ADP-ribose) polymerase-1 in DNA repair. The Journal
of biological chemistry, 276(27):25541–25548, jul 2001.
[120] Jason L Parsons, Irina I Dianova, Sarah L Allinson, and Grigory L Dianov. DNA
polymerase beta promotes recruitment of DNA ligase III alpha-XRCC1 to sites of
base excision repair. Biochemistry, 44(31):10613–10619, aug 2005.
[121] Sabine A S Langie, Kerry M Cameron, Gabriella Ficz, David Oxley, Bartłomiej
Tomaszewski, Joanna P Gorniak, Lou M Maas, Roger W L Godschalk, Frederik J van
Schooten, Wolf Reik, Thomas von Zglinicki, and John C Mathers. The Ageing Brain:
Effects on DNA Repair and DNA Methylation in Mice, feb 2017.
[122] Isabel Gaivao, Anita Piasek, Asgeir Brevik, Sergey Shaposhnikov, and Andrew R
Collins. Comet assay-based methods for measuring DNA repair in vitro; estimates of
inter- and intra-individual variation. Cell biology and toxicology, 25(1):45–52, feb
2009.
[123] Fiona Caple, Elizabeth A Williams, Alison Spiers, John Tyson, Brian Burtle, Ann K
Daly, John C Mathers, and John E Hesketh. Inter-individual variation in DNA damage
and base excision repair in young, healthy non-smokers: effects of dietary supple-
mentation and genotype. The British journal of nutrition, 103(11):1585–1593, jun
2010.
[124] B Myrnes, K E Giercksky, and H Krokan. Interindividual variation in the activity of
O6-methyl guanine-DNA methyltransferase and uracil-DNA glycosylase in human
organs. Carcinogenesis, 4(12):1565–1568, dec 1983.
References 137
[125] Stephen S Hecht. Lung carcinogenesis by tobacco smoke. International journal of
cancer, 131(12):2724–2732, dec 2012.
[126] Hyun-Wook Lee, Hsiang-Tsui Wang, Mao-wen Weng, Chiu Chin, William Huang,
Herbert Lepor, Xue-Ru Wu, William N Rom, Lung-Chi Chen, and Moon-shong Tang.
Cigarette side-stream smoke lung and bladder carcinogenesis: inducing mutagenic
acrolein-DNA adducts, inhibiting DNA repair and enhancing anchorage-independent-
growth cell transformation. Oncotarget, 6(32):33226–33236, oct 2015.
[127] Hyun-Wook Lee, Sung-Hyun Park, Mao-Wen Weng, Hsiang-Tsui Wang, William C
Huang, Herbert Lepor, Xue-Ru Wu, Lung-Chi Chen, and Moon-Shong Tang. E-
cigarette smoke damages DNA and reduces repair activity in mouse lung, heart, and
bladder as well as in human lung and bladder cells. Proceedings of the National
Academy of Sciences of the United States of America, 115(7):E1560–E1569, feb 2018.
[128] A R Collins, A Azqueta, and S A Langie. Effects of micronutrients on DNA repair.
Eur J Nutr, 51(3):261–279, 2012.
[129] Adela Castello, Miguel Martin, Amparo Ruiz, Ana M Casas, Jose M Baena-Canada,
Virginia Lope, Silvia Antolin, Pedro Sanchez, Manuel Ramos, Antonio Anton,
Montserrat Munoz, Begona Bermejo, Ana De Juan-Ferre, Carlos Jara, Jose I Cha-
con, Maria A Jimeno, Petra Rosado, Elena Diaz, Vicente Guillem, Ana Lluch, Eva
Carrasco, Beatriz Perez-Gomez, Jesus Vioque, and Marina Pollan. Lower Breast
Cancer Risk among Women following the World Cancer Research Fund and American
Institute for Cancer Research Lifestyle Recommendations: EpiGEICAM Case-Control
Study. PloS one, 10(5):e0126096, 2015.
[130] S B Astley, R M Elliott, D B Archer, and S Southon. Evidence that dietary supple-
mentation with carotenoids and carotenoid-rich foods modulates the DNA damage:
repair balance in human lymphocytes. Br J Nutr, 91(1):63–72, 2004.
[131] A R Collins, V Harrington, J Drew, and R Melvin. Nutritional modulation of DNA
repair in a human intervention study. Carcinogenesis, 24(3):511–515, 2003.
[132] Asgeir Brevik, Anette Karlsen, Amaya Azqueta, Anna Estaban Tirado, Rune Blomhoff,
and Andrew Collins. Both base excision repair and nucleotide excision repair in
humans are influenced by nutritional factors. Cell biochemistry and function, 29(1):36–
42, 2011.
[133] Patrizia Riso, Daniela Martini, Peter Moller, Steffen Loft, Gaia Bonacina, Massimo
Moro, and Marisa Porrini. DNA damage and repair activity after broccoli intake in
young healthy smokers. Mutagenesis, 25(6):595–602, nov 2010.
[134] A R Collins, S J Duthie, L Fillion, C M Gedik, N Vaughan, and S G Wood. Ox-
idative DNA damage in human cells: the influence of antioxidants and DNA repair.
Biochemical Society transactions, 25(1):326–331, feb 1997.
[135] Y Sheng, R W Pero, A R Olsson, C Bryngelsson, and J Hua. DNA repair enhancement
by a combined supplement of carotenoids, nicotinamide, and zinc. Cancer detection
and prevention, 22(4):284–292, 1998.
References 138
[136] A C Torbergsen and A R Collins. Recovery of human lymphocytes from oxidative
DNA damage; the apparent enhancement of DNA repair by carotenoids is probably
simply an antioxidant effect. European journal of nutrition, 39(2):80–85, apr 2000.
[137] G P Basten, S J Duthie, L Pirie, N Vaughan, M H Hill, and H J Powers. Sensitivity of
markers of DNA stability and DNA repair activity to folate supplementation in healthy
volunteers. British journal of cancer, 94(12):1942–1947, jun 2006.
[138] M Tomasetti, R Alleva, B Borghi, and A R Collins. In vivo supplementation with
coenzyme Q10 enhances the recovery of human lymphocytes from oxidative DNA
damage. FASEB journal : official publication of the Federation of American Societies
for Experimental Biology, 15(8):1425–1427, jun 2001.
[139] S Guarnieri, S Loft, P Riso, M Porrini, L Risom, H E Poulsen, L O Dragsted, and
P Moller. DNA repair phenotype and dietary antioxidant supplementation. Br J Nutr,
99(5):1018–1024, 2008.
[140] D C Cabelof, S Yanamadala, J J Raffoul, Z Guo, A Soofi, and A R Heydari. Caloric
restriction promotes genomic stability by induction of base excision repair and reversal
of its age-related decline. DNA Repair (Amst), 2(3):295–307, 2003.
[141] N Habermann, K W Makar, C Abbenhardt, L Xiao, C Y Wang, H K Utsugi, C M
Alfano, K L Campbell, C Duggan, K E Foster-Schubert, C E Mason, I Imayama, G L
Blackburn, J D Potter, A McTiernan, and C M Ulrich. No effect of caloric restriction
or exercise on radiation repair capacity. Med Sci Sports Exerc, 47(5):896–904, 2015.
[142] Leonie K Heilbronn, Lilian de Jonge, Madlyn I Frisard, James P DeLany, D Enette
Larson-Meyer, Jennifer Rood, Tuong Nguyen, Corby K Martin, Julia Volaufova,
Marlene M Most, Frank L Greenway, Steven R Smith, Walter A Deutsch, Donald A
Williamson, and Eric Ravussin. Effect of 6-month calorie restriction on biomarkers
of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a
randomized controlled trial. JAMA, 295(13):1539–1548, apr 2006.
[143] Amaya Azqueta, Jana Slyskova, Sabine A S Langie, Isabel O’Neill Gaivão, and
Andrew Collins. Comet assay to measure DNA repair: approach and applications.
Frontiers in genetics, 5:288, 2014.
[144] Andrew R Collins. The comet assay: a heavenly method! Mutagenesis, 30(1):1–4,
jan 2015.
[145] A R Collins, M Dusinska, E Horvathova, E Munro, M Savio, and R Stetina. Inter-
individual differences in repair of DNA base oxidation, measured in vitro with the
comet assay. Mutagenesis, 16(4):297–301, 2001.
[146] A Azqueta, S Costa, Y Lorenzo, N E Bastani, and A R Collins. Vitamin C in
cultured human (HeLa) cells: lack of effect on DNA protection and repair. Nutrients,
5(4):1200–1217, 2013.
[147] L Fillion, A Collins, and S Southon. Beta-carotene enhances the recovery of lym-
phocytes from oxidative DNA damage. Acta biochimica Polonica, 45(1):183–90,
1998.
References 139
[148] David K Wood, David M Weingeist, Sangeeta N Bhatia, and Bevin P Engelward.
Single cell trapping and DNA damage analysis using microwell arrays. Proceedings of
the National Academy of Sciences of the United States of America, 107(22):10008–13,
jun 2010.
[149] S B Astley, R M Elliott, D B Archer, and S Southon. Increased cellular carotenoid
levels reduce the persistence of DNA single-strand breaks after oxidative challenge.
Nutr Cancer, 43(2):202–213, 2002.
[150] Sujata Choudhury, Sanjay Adhikari, Amrita Cheema, and Rabindra Roy. Evidence of
complete cellular repair of 1,N6-ethenoadenine, a mutagenic and potential damage
for human cancer, revealed by a novel method. Molecular and cellular biochemistry,
313(1-2):19–28, jun 2008.
[151] T Paz-Elizur, D Elinger, Y Leitner-Dagan, S Blumenstein, M Krupsky, A Berrebi,
E Schechtman, and Z Livneh. Development of an enzymatic DNA repair assay for
molecular epidemiology studies: distribution of OGG activity in healthy individuals.
DNA Repair (Amst), 6(1):45–60, 2007.
[152] E L Kreklau, M Limp-Foster, N Liu, Y Xu, M R Kelley, and L C Erickson. A novel
fluorometric oligonucleotide assay to measure O( 6)-methylguanine DNA methyl-
transferase, methylpurine DNA glycosylase, 8-oxoguanine DNA glycosylase and
abasic endonuclease activities: DNA repair status in human breast carcinoma cells
overexpressin. Nucleic Acids Res, 29(12):2558–2566, 2001.
[153] I Hamann, T Schwerdtle, and A Hartwig. Establishment of a non-radioactive cleavage
assay to assess the DNA repair capacity towards oxidatively damaged DNA in subcel-
lular and cellular systems and the impact of copper. Mutat Res, 669(1-2):122–130,
2009.
[154] P Georgiadis, N Polychronaki, and S A Kyrtopoulos. Progress in high-throughput
assays of MGMT and APE1 activities in cell extracts. Mutat Res, 736(1-2):25–32,
2012.
[155] David Svilar, Conchita Vens, and Robert W Sobol. Quantitative, real-time analysis of
base excision repair activity in cell lysates utilizing lesion-specific molecular beacons.
Journal of visualized experiments : JoVE, (66):e4168, aug 2012.
[156] A Maksimenko, A A Ishchenko, G Sanz, J Laval, R H Elder, and M K Saparbaev.
A molecular beacon assay for measuring base excision repair activities. Biochem
Biophys Res Commun, 319(1):240–246, 2004.
[157] Sylvie Sauvaigo, Valérie Guerniou, Delphine Rapin, Didier Gasparutto, Sylvain Caillat,
and Alain Favier. An oligonucleotide microarray for the monitoring of repair enzyme
activity toward different DNA base damage. Analytical biochemistry, 333(1):182–192,
oct 2004.
[158] Melanie Flaender, Guillaume Costa, Guillaume Nonglaton, Christine Saint-Pierre,
and Didier Gasparutto. A DNA array based on clickable lesion-containing hairpin
probes for multiplexed detection of base excision repair activities. The Analyst,
141(22):6208–6216, oct 2016.
References 140
[159] Yawei Qiao, Margaret R Spitz, Zhaozheng Guo, Mohammad Hadeyati, Lawrence
Grossman, Kenneth H Kraemer, and Qingyi Wei. Rapid assessment of repair of
ultraviolet DNA damage with a modified host-cell reactivation assay using a luciferase
reporter gene and correlation with polymorphisms of DNA repair genes in normal
human lymphocytes. Mutation research, 509(1-2):165–174, nov 2002.
[160] Zachary D Nagel, Carrie M Margulies, Isaac A Chaim, Siobhan K McRee, Patrizia
Mazzucato, Anwaar Ahmad, Ryan P Abo, Vincent L Butty, Anthony L Forget, and
Leona D Samson. Multiplexed DNA repair assays for multiple lesions and multiple
doses via transcription inhibition and transcriptional mutagenesis. Proceedings of the
National Academy of Sciences of the United States of America, 111(18):E1823–32,
may 2014.
[161] Isaac A Chaim, Zachary D Nagel, Jennifer J Jordan, Patrizia Mazzucato, Le P Ngo,
and Leona D Samson. In vivo measurements of interindividual differences in DNA
glycosylases and APE1 activities. Proceedings of the National Academy of Sciences
of the United States of America, 114(48):E10379–E10388, nov 2017.
[162] Christoph Mussel, Martin Hopfensitz, and Hans A Kestler. BoolNet–an R package for
generation, reconstruction and analysis of Boolean networks. Bioinformatics (Oxford,
England), 26(10):1378–1380, may 2010.
[163] Jeffrey D Orth, Ines Thiele, and Bernhard Ø Palsson. What is flux balance analysis?
Nature biotechnology, 28(3):245–248, mar 2010.
[164] D A Fell. Metabolic control analysis: a survey of its theoretical and experimental
development. The Biochemical journal, 286 ( Pt 2):313–330, sep 1992.
[165] Martin D Brand and R Keira Curtis. Simplifying metabolic complexity. Biochemical
Society transactions, 30(2):25–30, apr 2002.
[166] Fabian Frohlich, Carolin Loos, and Jan Hasenauer. Scalable Inference of Ordinary
Differential Equation Models of Biochemical Processes. Methods in molecular biology
(Clifton, N.J.), 1883:385–422, 2019.
[167] Laura M F Bertens, Jetty Kleijn, Sander C Hille, Monika Heiner, Maciej Koutny,
and Fons J Verbeek. Modeling biological gradient formation: combining partial
differential equations and Petri nets. Natural computing, 15(4):665–675, 2016.
[168] Bahrad A Sokhansanj, Garry R Rodrigue, J Patrick Fitch, and David M 3rd Wilson.
A quantitative model of human DNA base excision repair. I. Mechanistic insights.
Nucleic acids research, 30(8):1817–1825, apr 2002.
[169] Hans E Krokan and Magnar Bjørås. Base Excision Repair, apr 2013.
[170] K Nealon, I D Nicholl, and M K Kenny. Characterization of the DNA polymerase
requirement of human base excision repair. Nucleic acids research, 24(19):3763–3770,
oct 1996.
[171] Bahrad A Sokhansanj and David M 3rd Wilson. Oxidative DNA damage background
estimated by a system model of base excision repair. Free radical biology & medicine,
37(3):422–427, aug 2004.
References 141
[172] Bahrad A Sokhansanj and David M 3rd Wilson. Estimating the effect of human base
excision repair protein variants on the repair of oxidative DNA base damage. Cancer
epidemiology, biomarkers & prevention : a publication of the American Association
for Cancer Research, cosponsored by the American Society of Preventive Oncology,
15(5):1000–1008, may 2006.
[173] Evren Gurkan-Cavusoglu, Sriya Avadhani, Lili Liu, Timothy J Kinsella, and Ken-
neth A Loparo. Developing an In Silico Model of the Modulation of Base Excision
Repair using Methoxyamine for More Targeted Cancer Therapeutics, apr 2013.
[174] P S Crooke and F F Parl. A mathematical model for DNA damage and repair. J
Nucleic Acids, 2010, 2010.
[175] R Savva, K McAuley-Hecht, T Brown, and L Pearl. The structural basis of specific
base-excision repair by uracil-DNA glycosylase. Nature, 373(6514):487–493, 1995.
[176] B Demple and J S Sung. Molecular and biological roles of Ape1 protein in mammalian
base excision repair. DNA Repair (Amst), 4(12):1442–1449, 2005.
[177] S S Wallace, D L Murphy, and J B Sweasy. Base excision repair and cancer. Cancer
Lett, 327(1-2):73–89, 2012.
[178] W A Beard, W P Osheroff, R Prasad, M R Sawaya, M Jaju, T G Wood, J Kraut, T A
Kunkel, and S H Wilson. Enzyme-DNA interactions required for efficient nucleotide
incorporation and discrimination in human DNA polymerase beta. J Biol Chem,
271(21):12141–12144, 1996.
[179] B B Knowles, C C Howe, and D P Aden. Human hepatocellular carcinoma cell
lines secrete the major plasma proteins and hepatitis B surface antigen. Science,
209(4455):497–499, 1980.
[180] J Fogh, J M Fogh, and T Orfeo. One hundred and twenty-seven cultured human tumor
cell lines producing tumors in nude mice. J Natl Cancer Inst, 59(1):221–226, 1977.
[181] M Takeshita, C N Chang, F Johnson, S Will, and A P Grollman. Oligodeoxynu-
cleotides containing synthetic abasic sites. Model substrates for DNA polymerases
and apurinic/apyrimidinic endonucleases. J Biol Chem, 262(21):10171–10179, 1987.
[182] D Schuermann, S P Scheidegger, A R Weber, M Bjoras, C J Leumann, and P Schar.
3CAPS - a structural AP-site analogue as a tool to investigate DNA base excision
repair. Nucleic Acids Res, 44(5):2187–2198, 2016.
[183] Matt Carter and Jennifer Shieh. Chapter 14 - Cell Culture Techniques BT - Guide to
Research Techniques in Neuroscience (Second Edition). pages 295–310. Academic
Press, San Diego, 2015.
[184] Harm HogenEsch and Alexander Yu Nikitin. Challenges in pre-clinical testing of
anti-cancer drugs in cell culture and in animal models, dec 2012.
[185] Maliha Agha and Riaz Agha. The rising prevalence of obesity: part A: impact on
public health, aug 2017.
References 142
[186] Subbroto Kumar Saha, Soo Bin Lee, Jihye Won, Hye Yeon Choi, Kyeongseok Kim,
Gwang-Mo Yang, Ahmed Abdal Dayem, and Ssang-goo Cho. Correlation between
Oxidative Stress, Nutrition, and Cancer Initiation, jul 2017.
[187] Elaina Marie Maldonado. An investigation of the role of glucose and fructose in
non-alcoholic fatty liver disease using systems approaches., 2017.
[188] M K McMillian, E R Grant, Z Zhong, J B Parker, L Li, R A Zivin, M E Burczynski,
and M D Johnson. Nile Red binding to HepG2 cells: an improved assay for in vitro
studies of hepatosteatosis. In vitro & molecular toxicology, 14(3):177–190, 2001.
[189] Rona Antoni, Kelly L Johnston, Adam L Collins, and M Denise Robertson. Intermit-
tent v. continuous energy restriction: differential effects on postprandial glucose and
lipid metabolism following matched weight loss in overweight/obese participants. The
British journal of nutrition, 119(5):507–516, mar 2018.
[190] B de Roos, S J Duthie, A C Polley, F Mulholland, F G Bouwman, C Heim, G J
Rucklidge, I T Johnson, E C Mariman, H Daniel, and R M Elliott. Proteomic
methodological recommendations for studies involving human plasma, platelets, and
peripheral blood mononuclear cells. J Proteome Res, 7(6):2280–2290, 2008.
[191] S E Bennett, R J Sanderson, and D W Mosbaugh. Processivity of Escherichia coli
and rat liver mitochondrial uracil-DNA glycosylase is affected by NaCl concentration.
Biochemistry, 34(18):6109–6119, may 1995.
[192] B K Duncan and J H Miller. Mutagenic deamination of cytosine residues in DNA.
Nature, 287(5782):560–561, oct 1980.
[193] Z D Nagel, I A Chaim, and L D Samson. Inter-individual variation in DNA repair
capacity: a need for multi-pathway functional assays to promote translational DNA
repair research. DNA Repair (Amst), 19:199–213, 2014.
[194] Douglas G Bonett and Thomas A Wright. Sample size requirements for estimating
pearson, kendall and spearman correlations. Psychometrika, 65(1):23–28, 2000.
[195] P Neddermann and J Jiricny. Efficient removal of uracil from G.U mispairs by the
mismatch-specific thymine DNA glycosylase from HeLa cells. Proceedings of the
National Academy of Sciences of the United States of America, 91(5):1642–1646, mar
1994.
[196] T Haug, F Skorpen, P A Aas, V Malm, C Skjelbred, and H E Krokan. Regulation of
expression of nuclear and mitochondrial forms of human uracil-DNA glycosylase.,
mar 1998.
[197] Patrick Autissier, Caroline Soulas, Tricia H Burdo, and Kenneth C Williams. Evalua-
tion of a 12-color flow cytometry panel to study lymphocyte, monocyte, and dendritic
cell subsets in humans. Cytometry. Part A : the journal of the International Society
for Analytical Cytology, 77(5):410–419, may 2010.
[198] K N Frayn, C M Williams, and P Arner. Are increased plasma non-esterified fatty acid
concentrations a risk marker for coronary heart disease and other chronic diseases?,
apr 1996.
References 143
[199] Leanne Hodson, C Murray Skeaff, and Barbara A Fielding. Fatty acid composition
of adipose tissue and blood in humans and its use as a biomarker of dietary intake.
Progress in lipid research, 47(5):348–380, sep 2008.
[200] Mi-Rha Lee, Soo-Hyun Kim, Hyun-Ju Cho, Kun-Yeong Lee, Ae Ran Moon,
Hye Gwang Jeong, Jung-Sup Lee, Jin-Won Hyun, Myung-Hee Chung, and Ho Jin
You. Transcription factors NF-YA regulate the induction of human OGG1 following
DNA-alkylating agent methylmethane sulfonate (MMS) treatment. The Journal of
biological chemistry, 279(11):9857–9866, mar 2004.
[201] Lucia Marseglia, Sara Manti, Gabriella D’Angelo, Antonio Nicotera, Eleonora Parisi,
Gabriella Di Rosa, Eloisa Gitto, and Teresa Arrigo. Oxidative stress in obesity: a
critical component in human diseases. International journal of molecular sciences,
16(1):378–400, dec 2014.
[202] Caroline Himbert, Henry Thompson, and Cornelia M Ulrich. Effects of Intentional
Weight Loss on Markers of Oxidative Stress, DNA Repair and Telomere Length - a
Systematic Review. Obesity facts, 10(6):648–665, 2017.
[203] A Unnikrishnan, T M Prychitko, H V Patel, M E Chowdhury, A B Pilling, L F
Ventrella-Lucente, E V Papakonstantinou, D C Cabelof, and A R Heydari. Folate
deficiency regulates expression of DNA polymerase beta in response to oxidative
stress. Free Radic Biol Med, 50(2):270–280, 2011.
[204] S Adhikari, J A Toretsky, L Yuan, and R Roy. Magnesium, essential for base excision
repair enzymes, inhibits substrate binding of N-methylpurine-DNA glycosylase. J
Biol Chem, 281(40):29525–29532, 2006.
[205] Tadahide Izumi, Lee R Wiederhold, Gargi Roy, Rabindra Roy, Arun Jaiswal, Kishor K
Bhakat, Sankar Mitra, and Tapas K Hazra. Mammalian DNA base excision repair
proteins: their interactions and role in repair of oxidative DNA damage. Toxicology,
193(1-2):43–65, nov 2003.
[206] T Paz-Elizur, M Krupsky, S Blumenstein, D Elinger, E Schechtman, and Z Livneh.
DNA repair activity for oxidative damage and risk of lung cancer. J Natl Cancer Inst,
95(17):1312–1319, 2003.
[207] Team National Lung Screening Trial Research, D R Aberle, A M Adams, C D Berg,
W C Black, J D Clapp, R M Fagerstrom, I F Gareen, C Gatsonis, P M Marcus, and J D
Sicks. Reduced lung-cancer mortality with low-dose computed tomographic screening.
N Engl J Med, 365(5):395–409, 2011.
[208] Y J Kim and D M Wilson 3rd. Overview of base excision repair biochemistry. Curr
Mol Pharmacol, 5(1):3–13, 2012.
Appendix A
Chapter 2 raw data listings
145
Figure 2.3 
Initial oligonucleotide concentration (nM)
0 0.035 0.033
0.08 0.352 0.256
0.16 0.81 0.935
0.31 1.134 1.336
0.63 1.517 1.606
1.25 1.688 1.655
2.5 1.765 1.715
Figure 2.4
(A)
Nuclear extract concentration (g/well)
0 0.082681 0.1091 0.103229
0.031 0.079746 0.078278 0.119374
0.063 0.059198 0.09002 0.125245
0.125 0.104697 0.197162 0.150196
0.25 0.241194 0.238258 0.264677
0.5 0.405577 0.454012 0.459883
1 0.430528 0.528865 0.492172
(B)
Enzyme concentration (U/100l)
0 1.009709 1.0019417 1.007767 0.9383202 1.0091864 0.985564
0.0025 0.996117 0.9728155 1.001942 0.9835958 0.9816273 0.989501
0.005 1.03301 1.0291262 0.998058 1.0328084 1.0229659 1.007218
0.01 0.943689 0.8174757 0.932039 0.9461942 0.9520997 0.97769
0.05 0.466019 0.4932039 0.462136 0.5170604 0.5643045 0.591864
0.1 0.194175 0.2019417 0.178641 0.2375328 0.2572178 0.270997
0.15 0.067961 0.038835 0.054369 0.0800525 0.0958005 0.113517
0.2 0 0 0 -0.000656 -0.004593 0.005249
(C)
Nuclear extract concentration (g/100l)
0.25 0.959223 0.945631 0.943689 0.959974 0.948163 0.961942
0.5 1.007767 0.986408 1.003883 0.932415 0.950131 0.989501
0.75 1.023301 1.040777 1.040777 0.902887 0.85958 0.924541
1 1.046602 1.066019 1.064078 0.828084 0.828084 0.85958
2 1.01165 1.019417 0.95534 0.635171 0.617454 0.625328
3 0.947573 0.932039 0.949515 0.456037 0.41273 0.469816
4 0.937864 0.918447 0.883495 0.286745 0.26706 0.28084
The effect of increasing initial plate-bound concentrations of 
URA03 oligonucleotide on absorbance values
HepG2 nuclear extract on a U:A base pair with no herring sperm 
DNA in the reaction buffer, then treated with excess recombinant 
UDG
Recombinant UDG with and without herring sperm 
DNA in the reaction buffer
HepG2 nuclear extract on a U:A base pair with and without 
herring sperm DNA in the reaction buffer
Absorbance (450nm)
Relative absorbance (450nm)
0g/100l DNA 0.2g/100l DNA
0g/100l DNA 0.2g/100l DNA
Effect of herring sperm DNA in DNA repair buffer on UNG 
activity in HepG2 nuclear extract
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(D)
Nuclear extract concentration (g/100l)
0.25 0.00548331 0.00642175 0.00655685 0.00627531 0.00732943 0.00610073
0.5 0.00222946 0.00364278 0.00248438 0.0087523 0.00715302 0.00368733
0.75 0.00121898 9.9108E-05 9.9108E-05 0.01147564 0.01560791 0.00947134
1 0 0 0 0.01872337 0.01872337 0.01560791
2 0.00197552 0.00147028 0.00575014 0.04024803 0.0424764 0.04147995
3 0.00628691 0.00737278 0.00615232 0.06543289 0.07259923 0.06325569
4 0.00696364 0.00833672 0.01087737 0.09691968 0.1013121 0.0982173
Figure 2.5
(A) Recombinant UDG
Enzyme concentration (U/100l)
0 0.957106 0.981912 1.081137
0.001 1.020672 1.059432 0.966408
0.002 0.977261 1.045478 1.042377
0.004 0.922997 0.97261 0.958656
0.006 0.865633 0.907494 0.901292
0.008 0.81447 0.910594 0.837726
0.01 0.771059 0.760207 0.797416
0.025 0.538501 0.549354 0.496641
0.05 0.313695 0.321447 0.316796
0.075 0.157106 0.160207 0.166408
0.1 0.087339 0.087339 0.119897
0.125 0.062532 0.067183 0.068734
0.15 0.020672 0.034625 0.05323
0.175 0.025323 0.009819 0.022222
0.2 0.000517 -0.00103 0.000517
(B) HepG2 nuclear extract
Nuclear extract concentration (g/100l)
0.25 0.826873 0.890439 0.910594
0.5 0.789664 0.803618 0.888889
0.75 0.709044 0.746253 0.766408
1 0.650129 0.684238 0.73385
1.25 0.580362 0.603618 0.580362
1.5 0.529199 0.546253 0.529199
1.75 0.476486 0.470284 0.499742
2 0.378811 0.386563 0.405168
2.25 0.434625 0.354005 0.416021
2.5 0.406718 0.417571 0.417571
2.75 0.33385 0.343152 0.391214
3 0.299742 0.287339 0.335401
3.25 0.267183 0.264083 0.313695
3.5 0.233075 0.247028 0.240827
3.75 0.219121 0.195866 0.180362
4 0.160207 0.112145 0.146253
Apparent UNG activity of HepG2 nuclear extract with and without 
herring sperm DNA in reaction buffer
0g/100l DNA 0.2g/100l DNA
Relative absorbance (450 nm)
Relative absorbance (450 nm)
Effect of uracil DNA glycosylase on substrate containing U:A 
base pair
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(C) Apparent UNG activity in HepG2 nuclear extract
Nuclear extract concentration (g/100l)
0.25* 0.00895284303663913*0.0060 597773672388*0.00512900608717085*
0.5* 0.0107801608237485*0.0100848452702387*0. 0608502944971312*
0.75 0.01505899 0.01302587 0.01196717
1 0.01851119 0.01647559 0.01369191
1.25 0.02303707 0.02146952 0.02303707
1.5 0.02672411 0.02545612 0.02672411
1.75 0.03092534 0.03145067 0.02901601
2 0.04015043 0.03933334 0.03743925
2.25 0.03461616 0.04288601 0.03637527
2.5 0.03728551 0.03622565 0.03622565
2.75 0.04525877 0.04414578 0.03885118
3 0.04963424 0.05135502 0.04507098
3.25 0.05432369 0.05480094 0.04778479
3.5 0.05992538 0.05753611 0.05857998
3.75 0.06247031 0.067118 0.07055481
4* 0.0755278561308316*0. 908023146224107*0.0793831546041856*
Figure 2.6 Effect of AP endonuclease on substrate containing AP site
(A) Recombinant APE1
Enzyme concentration (U/100l)
0 1.053665 0.974548 0.976388
0.01 0.950629 0.937749 0.891751
0.02 0.90831 0.829193 0.720638
0.03 0.733517 0.729837 0.744557
0.04 0.751917 0.65624 0.509046
0.06 0.555044 0.490647 0.431769
0.08 0.42441 0.492487 0.40601
0.15 0.234897 0.229377 0.271696
0.2 0.345293 0.269856 0.251457
0.3 0.130021 0.17418 0.15762
0.35 0.089543 0.085863 0.102423
0.4 0.001227 0.074824 0.085863
0.45 0.030665 0.006746 0.025146
0.5 0.001227 -0.00613 0.004906
(B) HepG2 nuclear extract
Nuclear extract concentration (g/100l)
0.001 0.978228 0.954308 0.972708
0.002 0.957988 0.854952 0.92303
0.004 0.621282* 0.862312 0.875192
0.006 0.472248* 0.707758 0.740877
0.008 0.567924 0.599203 0.599203
0.01 0.389451 0.448329 0.41889
0.012 0.348973 0.396811 0.391291
0.014 0.317694 0.396811 0.299295
0.018 0.286415 0.256976 0.218338
0.04 0.16682 0.135541 0.144741
0.06 0.012266 0.034345 -0.02637
Relative absorbance (450 nm)
UNG activity (U/100l)
Relative absorbance (450 nm)
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(C) Apparent APE1 activity in HepG2 nuclear extract
Nuclear extract concentration (g/100l)
0.001* 0.000907422058409585*0.0034364197749685*0.00148517189592684*
0.002 0.003043 0.01471542 0.00684681
0.004 0.0479979379232697*0.01383308 0.01230817
0.006 0.0774231462505779*.03430613 0.02953795
0.008 0.05753266 0.05182955 0.05182955
0.01 0.09873479 0.08311102 0.09060651
0.012 0.11116454 0.09663746 0.09820616
0.014 0.12200432 0.09663746 0.12900114
0.018* 0.134220308334063*0.147 31590980054*0.167792835499982*
0.04* 0.204313467743272*0.23594351520858*.225516366720801*
Figure 2.7
(A) Recombinant exo
- Klenow
Enzyme concentration (U/100l)
0 0.002034 0.007171 -0.00182
0.0001 0.617254 0.569731 0.541475
0.0002 0.898534 0.884405 0.87413
0.0004 0.875415 0.895965 0.868993
0.0006 0.921653 0.915231 0.809911
0.0008 0.966606 0.989725 0.974312
0.001 1.005138 1.003853 0.991009
(B) HepG2 nuclear extract
Nuclear extract concentration (g/100l)
0.01 0.353955 0.356524 0.317992
0.02 0.542759 0.504228
0.03 0.632666 0.619822 0.612116
0.04 0.722573 0.711014 0.682757
0.05 0.789361 0.830461 0.847158
0.06 0.808627 0.829177 0.849727
0.08 0.883121 0.880552 0.883121
0.1 0.922937 0.920368 0.916515
(C) Apparent DNA polymerase activity in HepG2 nuclear extract
Nuclear extract concentration (g/100l)
0.01 4.5618E-05 4.6041E-05 3.9881E-05
0.02 8.2959E-05 7.409E-05
0.03 0.00010746 0.00010356 0.00010129
0.04 0.00014025 0.00013536 0.00012435
0.05 0.0001746 0.00020393 0.00021893
0.06 0.00018726 0.00020287 0.00022146
0.08* 0.000262173553882565*0.000 8362218484088*0.000262173553882565*
0.1* 0.000355930031476183*0.000346262674711399*0.0003 3352159947061*
APE1 activity (U/100l)
Relative absorbance (450 nm)
Relative absorbance (450 nm)
Gap filling activity (U/100l)
Effect of DNA polymerase on substrate containing single 
nucleotide gap
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Figure 2.8
(A) Recombinant T4 DNA ligase
Enzyme concentration (U/100l)
0 0.002 0.001 0
0.0005 0.51 0.557 0.497
0.001 0.808 0.774 0.73
0.002 0.94 0.961 0.933
0.004 1.043 1.058 0.999
0.006 0.994 1 0.926
0.008 1.037 1.006 0.931
0.01 1.041 0.962 0.997
(B) HepG2 nuclear extract
Nuclear extract concentration (g/100l)
0.03 0.068 0.062 0.065
0.06 0.152 0.151 0.144
0.1 0.232 0.204 0.242
0.15 0.355 0.334 0.365
0.2 0.466 0.447 0.496
0.3 0.636 0.608 0.593
0.4 0.734 0.791 0.731
0.5 0.839 0.768 0.745
(C) Apparent DNA ligase activity in HepG2 nuclear extract
Nuclear extract concentration (g/100l)
0.03 4.7756E-05 4.3404E-05 4.5576E-05
0.06 0.00011181 0.00011101 0.00010544
0.1 0.00017901 0.00015473 0.0001879
0.15 0.0002974 0.00027566 0.00030799
0.2 0.0004255 0.00040179 0.00046473
0.3 0.00068555 0.00063526 0.00060977
0.4 0.00089848 0.00106228 0.00089086
0.5 0.00123961 0.00099136 0.00092716
Figure 2.9 Multi-step assays
(A) Repair % standard curve
Repair standard curve (%)
X Mean SD N
0 0 0.0071 3
15 0.184325 0.0172 3
30 0.35583 0.0146 3
50 0.555273 0.0185 3
70 0.696057 0.0321 3
85 0.820755 0.005 3
100 1 0.0485 3
Relative absorbance (450 nm)
Ligase activity (U/100l)
Relative absorbance (450nm)
Relative absorbance (450 nm)
Effect of DNA ligase on substrate containing DNA backbone nick
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(B) Polβ activity in HepG2 nuclear extract
HepG2 nuclear extract (g/well)
0 -0.3 0 0.3
0.1 10 10.09 10.18
0.2 19.41 18.01 18.62
0.4 37.1 34.02 36.04
0.6 49.24 49.15 48.27
0.8 66.04 64.72 61.99
1 73.87 73.17 73.34
(C) Abasic site repair by HepG2 nuclear extract
Nuclear extract concentration (g/well)
X Mean SD N
0 0.16134237 0.00981495 3
0.063 0.12907389 0.00550757 3
0.125 1.9683769 0.00665833 3
0.25 6.2600839 0.00635085 3
0.5 20.6518232 0.0064291 3
1 51.5972894 0.01276715 3
2 75.2500807 0.03855299 3
(D) Repair of a uracil by HepG2 nuclear extract
Nuclear extract concentration (g/well)
X Mean SD N
0 1.80794739 0.0175 3
0.1 1.17344113 0.0062 3
0.5 3.46831839 0.0105 3
1 9.97790401 0.008 3
5 34.9535167 0.006 3
10 49.4909096 0.0287 3
Figure 2.10 No damage' oligonucleotide experiments
(A) Recombinant UDG on oligonucleotide with no damage site
Enzyme concentration (U/100l)
0 1.073918 1.092925 1.029567
0.005 1.143611 1.111932 1.077086
0.01 1.156283 1.154699 1.078669
0.02 1.127772 1.132524 1.048574
0.03 1.110348 1.1151 1.04699
0.04 1.094509 1.061246 0.969377
0.05 1.040655 1.013728 0.945618
(B) HepG2 nuclear extract on oligonucleotide with no damage site
Nuclear extract concentration (g/100l)
0.25 0.82207 0.796727 0.741288
0.5 0.79831 0.810982 0.776135
0.75 0.809398 0.815734 0.772967
1 0.80623 0.779303 0.752376
1.25 0.795143 0.76188 0.755544
1.5 0.709609 0.81415 0.722281
1.75 0.703273 0.696938 0.711193
2 0.652587 0.700106 0.649419
Relative absorbance (450 nm)
Relative absorbance (450 nm)
Relative absorbance (450nm)
Repair (%)
Repair of uracil (%)
Figure A.1. Raw data listings from all figures in Chapter 2
Appendix B
SysMIC certificates
SysMIC is an online training course designed to equip bioscientists with basic mathematical
and computing skills to further knowledge in these areas with a view to future multidisci-
plinary work and collaborations. Module 1 of the sysMIC course covers an introduction
in quantitative skills for bioscience, including topics such as basic use of Matlab and R
programmes, working with networks, and basic modelling of systems using petri-net and
ordinary differential equation approaches. Module 2 expands upon the content of module
1 and includes principal component analysis, more complex modelling systems such as
bistable, spatio-temporal, and stochastic, and both classical and Bayesian parameter fitting.
Further information on the sysMIC training modules can be found at sysmic.ac.uk.
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Figure B.1. SysMIC module 1 certificate of completion
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It is hereby certiﬁed that	

has satisﬁed the requirements of the course of study 	

Awarded: April 2016	

   MODULE 2 
ADVANCED TOPICS AND APPLICATIONS 
Eleanor Healing 
University OF surrey 
Figure B.2. SysMIC module 2 certificate of completion
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Summer Meeting, 11–14 July 2016, New technology in nutrition research and practice
Measurement of DNA repair activity in hepatocytes exposed to fatty acids
E. Healing1, L.B. Meira1, P.J. Aston2, M.J. Tindall3 and R.M. Elliott1
1School of Biosciences, Faculty of Health and Medical Sciences, 2Department of Mathematics, Faculty of Engineering
and Physical Sciences, University of Surrey, GU2 7XH and 3Department of Mathematics and Statistics and Institute
for Cardiovascular and Metabolic Research, Faculty of Science, University of Reading, RG6 7BE
DNA repair capacity varies greatly between individuals(1), and evidence has begun to link this variation to cancer risk, obesity and
related chronic diseases(2). There is also emerging evidence that dietary components can affect DNA repair(3), but research to date has
been restricted by methods for measuring DNA repair(4). This study made use of newly developed microplate-based assays for the
direct determination of DNA repair enzyme activities. Lipid loading of the HepG2 human hepatocellular carcinoma cell line was
employed as a model to test the hypothesis that hepatic steatosis affects DNA repair activity via induction of oxidative stress.
HepG2 cells were treated with palmitic acid (PA), oleic acid (OA) or vehicle for 24 hours before determining cell viability, intra-
cellular lipid levels, and DNA repair enzyme activity (uracil DNA glycosylase (hUNG1) and 8-oxoguanine DNA glycosylase
(hOGG1)). For the repair assays, oligonucleotides designed to form a hairpin loop with a 5′ ﬂuorescein and a damaged base (uracil
for hUNG1 assay or 8-oxoguanine for hOGG1 assay) within the double stranded region were bound to the surface of Nunc
Immobiliser™ plates via a 3′ amino group. HepG2 nuclear extract or recombinant enzyme was incubated with each substrate, creating
alkali-labile abasic sites (hUNG1) or single strand breaks (hOGG1). Following alkaline denaturation, enzyme activity was determined
by quantifying the retained ﬂuorescein.
Treatment with 400μM PA decreased cell viability to 61 % (P< 0·01 compared to vehicle) (Fig. 1A.). Intracellular lipid was sign-
iﬁcantly increased following treatment with 300μM and 400μMOA (P< 0·05 and P < 0·001, respectively), and 300μM and 400μMPA
(P< 0·001 and P< 0·0001, respectively) compared to vehicle (Fig. 1B.). No differences in hUNG1 or hOGG1 activity were detected
between treatment groups (Fig. 1C.).
In conclusion, fatty acid treatment reduced cell viability and increased intracellular lipid levels in a dose-dependent manner. The use
of novel assays enabled quantitative determination of DNA repair enzyme activities in cell extracts. The absence of detectable effects
of lipid loading on DNA repair could be due to the use of cancer cells as a model, which may be lacking certain DNA repair regu-
latory mechanisms normally present in healthy cells. Future work will focus on optimisation of the assays for use with primary cells
samples from human volunteers.
This work was funded by a studentship awarded by the Biotechnology and Biological Sciences Research Council Doctoral Training Programme.
1. Wilson D, Kim D, Berquist B et al. (2011) Mut Res 711, 100–12
2. Sampath H, Vartanian V, Rollins R et al. (2012) PLoS One 7, e51697
3. Collins A, Azqueta A & Langie S (2012) Eur J Nutr 51, 261–279
4. Nagel Z, Chaim I & Samson L (2014) DNA Repair (Amst) 19, 199–213
Fig. 1. HepG2 viability (A), intracellular lipid level (B), and apparent DNA glycosylase activity (C) following 24 hours of growth with SFM, vehicle,
or fatty acid. Data presented as mean + SEM of 6 independent experiments. SFM: serum free media; hUNG1: uracil DNA glycosylase; hOGG1:
8-oxoguanine DNA glycosylase. *P< 0·05, **P< 0·01, ***P< 0·001, ****P< 0·0001 compared to vehicle (ANOVA, followed by Sidak’s test).
Proceedings of the Nutrition Society (2016), 75 (OCE3), E72 doi:10.1017/S0029665116000872
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Figure C.1. Abstract from the Nutrition Society summer meeting 2016, held in Dublin,
published in the Proceedings of the Nutrition Society.
